Implementation of nano-liquid chromatography hyphenated to tandem mass spectrometry for protein identification in gel and non-gel based proteomics by Vanrobaeys, Frank
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
IMPLEMENTATION OF NANO-LIQUID CHROMATOGRAPHY HYPHENATED  
TO TANDEM MASS SPECTROMETRY FOR PROTEIN IDENTIFICATION  
IN GEL AND NON-GEL BASED PROTEOMICS 
 
 
Thesis submitted to obtain the degree of Doctor (Ph.D.) in Sciences: Biochemistry 
 
FRANK VANROBAEYS 
2005 
 
 
 
Promotor: Prof. Dr. J. Van Beeumen 
Department of Biochemistry, Physiology and Microbiology 
Laboratory of Protein Biochemistry and Protein Engineering 
 
Co-promotor: Prof. Dr. R. Van Coster 
Department of Pediatric Neurology and Metabolism 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
“When a thing was new, people said, ‘It is not true’. 
Later, when the truth became obvious, people said,  
‘Anyway, it is not important.’ And when its importance  
could not be denied, people said, ‘Anyway, it is not 
new.”  
   William James (1842–1920) 
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FOREWORD 
 
 
It is now more than fifty years since James Watson and Francis Crick deduced the 
structure of DNA and gave an impetus to the science of molecular biology. Although 
DNA was a difficult macromolecule for the biochemist to study until the early 1970s, 
the development of different recombinant technologies has made that DNA is now 
one of the easiest molecules to analyze.  For example, it is possible to excise a 
specific region of DNA, to produce a virtually unlimited number of copies of it, and to 
determine the sequence of its nucleotides at a rate of hundreds of nucleotides a day.  
In particular, the development of DNA sequencing methods (chemical and enzymatic) 
has had a great impact on further scientific research. As these techniques were 
automated, the determination of the entire DNA sequence of a whole organism 
became possible.  The shotgun genome sequence strategy resulted in the 
elucidation of the first genome in 1995. The complete bacterial genome of 
Haemophilus influenza (~1.8 Mbp) was published, and is one of the milestones in 
molecular microbiology. From that moment onwards, the pace at which new 
genomes are being sequenced has been constantly increasing.  Six genome 
sequences were elucidated in 1996 alone, including the baker's yeast 
Saccharomyces cerevisiae genome. This got much of attention, as it was the first 
eukaryotic genome to be sequenced.  Today, the genome sequences of more than 
200 organisms have been determined.  In 1990, the Human Genome Project was 
started in 20 different sequencing centres from six different countries.  The goal was 
to decipher the human genome within the next 15 years, in order to provide us with a 
‘dictionary of the human being’.  This goal was accomplished in 2003, and is now 
available to anyone with an internet connection at multiple sites on the World Wide 
Web.   
The increasing availability of complete or partially sequenced genome sequences 
has removed the information bottleneck and significantly altered the scale of 
biological experiments.  The access to an organism's or cell's genome paves the way 
for the development of technologies to study whole molecular systems.  These 
comprehensive, global analysis techniques intend to better understand the biological 
processes in a cell or an organism, and all try to address an answer to one of the 
three following questions.  First, what is the 'content' of the biological system (i.e. 
genes and their products)? Second, what is the functioning of each of these 
individual components, and thirdly, how are individual components working together? 
In this work, large-scale strategies for the separation and identification of proteins 
based on electrophoresis, nano-liquid chromatography and mass spectrometry were 
developed to investigate the protein content of particular bacterial, plant and 
mammalian systems.  
 
This thesis is divided into three parts.  Part I deals with the current status of large-
scale strategies for the analysis of proteins in biological systems. In Chapter I, 
genomics and the need to shift towards proteomic approaches are outlined. An 
overview of key technologies used in functional and structural proteomics is provided 
in Chapter II, whereas mass spectrometry and the strategies for profiling of proteins 
are discussed in detail in the final chapter of this part (Chapter III).  Part II describes 
the analysis of cytosolic proteins by two-dimensional polyacrylamide gel 
electrophoresis and mass spectrometry.  First, the techniques are highlighted that 
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were used to identify gel separated proteins, i.e. the implementation of nano-liquid 
chromatography and mass spectrometry (Chapter IV).  The next two chapters are 
applications of the developed methodology in two case studies: the protein 
composition of the dissimilatory iron-reducing bacterium Shewanella oneidensis MR-
1 grown on ferric oxide (Chapter V) and the effect of a short-term heat shock on the 
plant barley (Chapter VI).  Part III deals with the development of alternative 
strategies for the analysis of membrane proteins.  A special electrophoretic technique, 
i.e. blue-native polyacrylamide gel electrophoresis, in combination with mass 
spectrometry, was used for profiling the different subunits of the oxidative 
phosphorylation system (Chapter VII), while multi-dimensional liquid chromatography 
coupled to MALDI tandem mass spectrometry was used for the profiling of the 
proteins present in the murine myelin sheath (Chapter VIII).  
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CHAPTER I 
 
INTEGRATIVE APPROACHES: 
DISCOVERY-DRIVEN RESEARCH 
 
 
1. INTRODUCTION 
 
The goal of molecular biology research is to find out the function of genes and their 
products, i.e. proteins, allowing unraveling the pathways and networks in which they 
function.  The ultimate goal is a detailed understanding of how a biological system 
works.  In the past, biological questions have been mainly approached by studying 
individual genes and gene products.  This was largely due to the lack of information 
and technologies capable of doing large scale investigations.  Until 15 years ago, 
biological systems were mostly examined by a 'reductive' approach.  Reductionism is 
the attempt to explain complex phenomena by defining the functional properties of 
the individual components that compose multi-component systems1.  This focus on 
individual components was extremely successful and has led to the discovery of an 
impressive number of biological principles.  In the future, these reductionist methods 
will certainly continue to be essential in biological research.  However, this kind of 
research alone can not lead to a complete understanding of living organisms.   
Complex biological processes can not simply be unraveled by knowing the individual 
parts and how these work in isolation, because cells and organisms are definitely 
more than the sum of their parts.  This integrative thinking already exists for a long 
time and has led to the discovery of several important regulatory circuits in the 
previous century.  For example, the feedback inhibition of amino acid biosynthetic 
pathways was discovered in 19572,3.  With the study of these regulatory mechanisms, 
molecular biologists began to apply system approaches to unravel the molecular 
components and their cellular processes.  This science is termed Systems Biology 
and can be described as a comprehensive quantitative analysis of the manner in 
which all the components of a biological system interact functionally over time4,5. The 
final goal is an understanding of the information flow from gene to biological function. 
The original approaches were performed on a rather small scale and a major 
technological breakthrough, automated DNA sequencing, shifted integrative 
approaches in biological research to a larger scale. These methods are irrespective 
of any hypothesis and are discovery-driven.  However, prior to the first published 
genome, most research was hypothesis-driven.  Here, a hypothesis was put forward 
for a given observation, and an experiment was designed to prove or disprove it.   
Hence, these methods can provide complementary information to discovery-driven 
research and ideally, therefore, these two research strategies should be used in 
combination.  
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2. THE 21st CENTURY: THE '-OMICS' WORLD 
The complete set of genes in an organism (genome) is transcribed into a complete 
set of mRNA (transcriptome) and is finally translated into a complete set of proteins 
(proteome). The genome is static, context-independent, while the last two levels or 
dynamic or context-dependent.  The transfer of information from the sequence in the 
genes to the functioning proteins is depicted in Figure 1.  
The modern systems biology approach to molecular biology has set out a new 
course and led to the introduction of a new terminology.  While the term genome was 
already launched in 19206 (the elision of the words genes and chromosomes), the 
terms transcriptome and proteome are fairly new.  High-throughput data rich methods 
in these novel fields of research are denoted as '-omic' approaches.  The words 
genome, transcriptome, proteome and metabolome seem to have started a new 
trend, new '-ome' words being coined at an impressive rate.  Examples include the 
glycome, secretome, physiome, phenome and localizome7.  However, these '-ome' 
disciplines are more and more overlapping each other, and are not always referring 
to previously non-existent areas of research. A bizarre and sometimes ridiculous 
terminology has sprung up around these large-scale biological experiments, and has 
resulted in more than 100 "-omic" neologisms to date. A few of the more ghastly 
examples are foldomics, functomics, GPCRomics, inomics, ionomics, 
pharmacomethylomics and separomics8.    
 
2.1. GENOMICS 
The term ‘genomics’ covers many different technologies, all of which are related in 
some way to the information content of a cell, in other words, its DNA.  High-
throughput DNA sequencing has given a drive to genomics, and whole shotgun 
genome sequencing projects came up like mushrooms.  A large number of 
completed sequences from prokaryotes, viruses and eukaryotes are now elucidated9.   
These completed genome sequences result in huge amounts of data, which must be 
reduced to useful information.  After a genome sequence has been completed, the 
first step of genome analysis generally intends to identify the inventory of genes 
(gene prediction and annotation)10 and to compare this inventory with other genomes, 
Figure 1. Overview of the transfer of information from the sequence in the genes to 
the functioning proteins of the cell (the central dogma) in a eukaryotic cell (schematic).  
The possible control mechanisms are indicated (red): (1) transcriptional control; (2) 
RNA editing control; (3) RNA processing control; (4) RNA transport control; (5) mRNA 
degradation control; (6) mRNA translational control; (7) protein activity control. 
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where emphasis is put on similarities, differences and uniqueness among genes11.  
Note that sequence (gene) similarity does not automatically imply functional and/or 
structural accordance, and vice versa12.  Several powerful informatic tools are now 
available for analyzing genome sequence features other than gene comparisons.  
For example, codon bias, dinucleotide relative abundance, and repeat structures can 
all be determined once a genome sequence is completed13.  Despite the advances in 
bioinformatics, the correct prediction of genes from genomic data is still low14,15.  This 
makes that genomes are not fully annotated, and sometimes the gene inventory is 
hotly disputed.  For example, the number of genes present in the human genome16-18 
has not yet been defined precisely19.  The estimated range for the number and the 
identity of the genes varies depending on the method or the criteria used20-23. Even 
the yeast genome, which was assembled in 1996, is still not completely annotated. 
People soon realized that extracting and interpreting the information couched in the 
genome was not as straightforward as initially thought, and it has become widely 
recognized that the genome only represents the first layer of complexity.  How could 
we otherwise explain the biological diversity between humans (~30.000 genes), 
nematodes (~18.000 genes), fruit flies (~12.000 genes)24 and yeast (~6.000 genes)25.  
Therefore, a lot of genetic and biochemical tools are brought into play once a 
genome sequence has been completed, attempting to assign function to genes.  This 
discipline, an outcome of genomics, is referred to as ‘functional genomics’.  This type 
of genomics is defined as the link of information about function to knowledge of DNA 
sequence26. It is obvious that this definition is not stringent and, in the next two 
sections, we will discuss some key tools used in functional genomics at the DNA and 
mRNA level.  As we can be far from complete in this expanding field, we refer to 
excellent reviews for further reading27,28. 
 
2.1.1. LARGE-SCALE GENE DELETION 
Functional information from genome sequences can be obtained by mutagenesis 
strategies, relying on prior advances in large-scale clone preparation and sequencing.  
Phenotypic analysis of mutants has been a powerful approach for determining gene 
function.  Large-scale mutagenesis approaches can be divided into (i) mutagenesis 
by homologous recombination and (ii) random mutagenesis obtained by mutagenic 
chemicals, irradiation or by random insertion of DNA sequences.  While the former 
needs the availability of a complete genome sequence, the latter does not.  If these 
approaches are carried out on whole organisms, this is referred to as ‘phenomics’ 
because the phenotype of an organism is observed29.  The power of systematic 
mutant analysis is well illustrated by an experiment in the yeast Saccharomyces 
cerevisiae30,31.  A gene deletion strain was generated for every single gene and the 
resulting phenotypes analyzed.  The developed tool also allowed quantitative 
measurements.  The technique can compare function and expression and, therefore, 
goes beyond determining whether a gene is essential or not.  Despite their power, 
genome-wide targeted deletions generated by homologous recombination have yet 
to be reported in other organisms than yeast.  On the other hand, insertional 
mutagenesis studies have been successfully applied in different organisms, for 
example in yeast32 and Arabidopsis thaliana33, using transposons or T-DNA. 
However, main disadvantages compared to targeted gene deletion are: (i) some 
regions are hot spots or, on the contrary, not susceptible to insertion, (ii) position of 
integration can lead to complete or partial reduction and, therefore, the site of 
integration needs to be determined for every mutant of interest.   
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A more directed approach to silence the function of a target gene is RNA interference 
(RNAi)34.  This technology is based on the observation from Caenorhabditis elegans 
that adding double-stranded RNA (dsRNA) interferes with gene function in a 
sequence-specific manner.  RNAi has been shown to work in many model organisms 
and current applications are primarily in C. elegans35, Drosophila36, various plants37 
and tissue culture cells of mammals38. 
 
2.1.2. TRANSCRIPTIONAL PROFILING 
Once a DNA sequence is transcribed, the transcript mRNA, is created.  However, a 
single gene can give rise to different transcripts, due to alternative splicing, 
alternative promoter or polyadenylation site usage or RNA editing and, therefore, the 
complexity increases.  On the other hand, the expression profile of a gene provides 
information about its role in the cell and functional links to other genes can be 
deduced.  This function is most of the time predicted on the basis of the 'guilt-by-
association' principle.  Genes with similar expression profiles are likely to be involved 
in similar biological processes.  Various clustering algorithms have been devised to 
identify co-expressed genes for functional annotation39,40. The development of novel 
technologies has allowed large-scale analysis at the mRNA level. The study of 
mRNA expression profiles on a global scale is termed ‘transcriptomics’, a term first 
used in 1997. Two major technologies that emerged from genomics, large-scale 
cDNA sequence sampling and the use of DNA arrays, are nowadays widely applied 
in transcriptomics.    
In sequence sampling, the mRNA is converted to a cDNA library and clones are 
randomly picked and sequenced (200-300bp).  These clones are identified by 
comparison with a sequence database.  The abundance of the clone determines the 
abundance of the corresponding transcript.  If enough clones are sequenced, 
statistical analysis can be performed and an estimation of the relative mRNA levels 
can be made.  Two or more samples may be compared by this method.  However, 
this method is laborious and very expensive because large-scale sequencing is 
required.  An alternative is serial analysis of gene expression (SAGE)41.  This 
technique was first introduced in the transcriptome analysis of the S. cerevisiae 
mitotic cell cycle42.  In this method, each cDNA molecule is reduced to a 
representative short sequence tag, and individual tags are concatenated into a single 
DNA clone.  The clone is sequenced and the sequence tags are indicative for the 
presence of the corresponding mRNA sequences.  Several other sequence sampling 
techniques are now available, like differential display PCR and ‘massively parallel 
signature sequencing’ (MPSS)43.   
Although sequence sampling techniques are very powerful, the method of choice in 
large-scale analysis of mRNA expression levels is the use of microarrays.  These 
miniature devices occur in two major types.  In mechanical spotting, the DNA 
molecules are immobilized onto a coated glass slide in the form of a grid and the 
mRNA expression levels are measured by hybridization44.  The diauxic shift in S. 
cerevisiae was the first transcriptome analysis that made use of these Stanford cDNA 
microarrays45.  Alternatively, the microarrays are produced by in situ oligonucleotide 
synthesis using a photolithographic process46.  Photolithography was developed and 
marketed primarily by Affymetrix Inc. (Santa Clara, CA, USA)47,48 and is well known in 
the computer chip industry.  Here, an ultraviolet light source is passed through a 
mask where a photochemical reaction, the oligonucleotide synthesis, will take place 
on the siliconized glass surface. The openings in the mask can be as small as a few 
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micrometers, allowing a density of several hundred thousands probes per square 
centimeter of glass.  These are also known as high-density oligonucleotide chips or 
Affymetrix GeneChips.  The mRNA expression profiles are again determined by 
hybridization.    
 
2.1.3. COMMENTS 
Transcriptome data contain a lot of information which sometimes can not be clearly 
deduced from the genome sequence. For example, analysis of the promotor regions 
of simultaneously expressed genes can reveal novel promotor elements49 and 
clustering of genes can be employed to characterize genes involved in related 
cellular processes50,51. Moreover, regulatory coupling is revealed by the systematic 
analysis of gene expression changes in knock-out mutants and is called regulatory 
network reconstruction52.  However, the resulting phenotype, obtained by 
mutagenesis (2.1.1.) may not always be informative.  Especially in genome-wide 
strategies, the loss of many proteins may be lethal. Although this is telling us that 
these proteins are essential, this does not reveal what these proteins actually do.  
Moreover, random mutagenesis can definitely provide important information, but 
there is unfortunately no systematic way to achieve this.  
Transcriptome analysis (2.1.2.) displays the relative abundance of the different 
transcripts in the cell.  However, the mRNA expression profile is not always reflecting 
the abundance of the corresponding proteins, due to post-transcriptional gene 
regulation53.  The rates of protein synthesis and protein turn-over will differ among 
transcripts and, therefore, the abundance of a transcript does not automatically 
reflect the abundance of the encoded protein. Notably, the pioneer studies of 
Anderson and Seilhamer54 showed that there is no good correlation between mRNA 
and protein levels in human liver, implying that mRNA-based expression data may be 
of limited value.  The study compared the levels of 19 gene products and yielded a 
correlation coefficient of 0.48 between mRNA and protein abundance. This value is 
half way between perfect and no correlation at all.  Even more so, not all mRNA 
molecules in a cell are translated into proteins and, therefore, the transcriptome may 
contain gene products that are not found in the proteome.  
Although tools for functional genomics at the DNA and/or mRNA level greatly 
enhance our understanding of molecular processes that occur during biological 
processes, nucleic acids are the 'information-carriers'.  Therefore, functional 
genomics, be it either on the DNA or on the mRNA level, can only indirectly inform us 
about protein function.  Oligonucleotides are without doubt important molecules in a 
cell but the real actors are proteins.  Proteins are interacting with each other and with 
numerous other molecules (metabolites), and so they are responsible for almost all 
biochemical activity of a cell.  A true understanding of a system can only come from a 
direct study of proteins, because they are the most functional, relevant components 
of a biological system. For example, mRNA profiling does not capture mechanisms of 
regulation involving changes in subcellular localization, post-translational 
modifications, turnover, and interaction with other proteins, as well as it does not 
capture functional aspects.  In addition, several important biological targets like 
platelets, body fluids and cell secretions can not be analyzed by gene or mRNA 
arrays.  Therefore, there is increasing interest in the field of proteomics, i.e. the large-
scale analysis of proteins as a complement to genomics. 
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2.2. PROTEOMICS 
2.2.1. INTRODUCTION 
The word 'proteome' was coined by Wilkins and colleagues at the first 2D-
electrophoresis conference in Siena (Italy) in September 1994, and was defined as 
the complete protein complement encoded by the genome55-57.  However, this term 
does not take into account the dynamic aspect of the proteome.  Therefore, the term 
should be broadened to include the set of proteins expressed both in space and time.  
The term proteomics, the study of the proteome, is generally used to encapsulate all 
of the technology currently available to analyze global patterns of gene expression at 
the protein level.  A broad, appropriate definition for proteomics could be: "the effort 
to establish the identities, quantities, structures, and biochemical and cellular 
functions of all proteins in an organism, organ, or organelle, and how these 
properties vary in space, time, or physiological state". The idea to investigate 
systematically the proteins present in the human being and to build protein 
databases was already brought forward in the early 1980s (the human protein 
index58).  However, absence of appropriate technologies prevented proteomics from 
becoming prominent before 199559. 
 
2.2.2. CHALLENGES IN PROTEOMICS 
The term protein was introduced in 1838 by J.J. Berzelius to describe a particular 
class of macromolecules made up of linear chains of amino acids.  The term is 
derived from the Greek word 'proteios', meaning 'of the first order', to stress the 
central importance of these molecules.   This definition is more and more suitable as 
our understanding of these macromolecules grows.  Proteins can carry out very 
diverse functions, e.g. they play a role in structure, communication, regulation, and 
are involved in numerous biochemical reactions.  Some proteins catalyze 'simple' 
reactions, e.g. phosphorylation and dephosphorylation, while others coordinate 
complex processes, e.g. DNA replication and transcription.  Thousands of different 
proteins may be present in a cell and in addition, the protein abundance can span a 
five to six orders of magnitude range.  Moreover, proteins are processed and 
modified in complex ways and may be the product of differential splicing.  So, a 
relative low number of predicted genes from a genome sequence have the potential 
to generate a proteome of enormous and yet undetermined complexity.  As a 
consequence, the development of technology to analyze proteins is extremely 
challenging.  Proteomic technologies can not benefit from amplification methods, 
equivalent to the polymerase chain reaction, or make use of automated sequencing 
techniques.  In addition, genome sequencing projects have a defined end point.  
Hence, the experimental complexity of proteomics is far beyond that of genomics, its 
nucleic acid-based counterpart.  
In the future, four main issues will need to be addressed for proteomics in order to 
play a substantial role in systems biology.  First, proteomic technologies should be 
able to cope with the enormous complexity of the proteome.  To date, the detection 
and molecular analysis of this complexity remains an unmatched task. Second, a 
general technology for the targeted manipulation of gene expression is needed.  
Systematic analysis of biological systems relies on targeted perturbations on the 
system and the systematic analysis of the consequences of each perturbation.  A 
third challenge is throughput.  Although today's proteomic technologies are referred 
to as 'high-throughput', these are still limited.  The last challenge is the development 
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of a general, absolute quantification technique for proteins.  This would have far-
reaching implications, as quantification of proteins absolutely eliminates the need of a 
reference sample.  In general, proteomics is a ‘young’ science and better materials, 
instrumental design and methodology will improve sensitivity, resolution and 
repeatability.  The advances in proteomics will lead to a comprehensive analysis of 
complex biological systems. 
 
2.3. METABOLOMICS 
The level of metabolites in a cellular system is determined by proteins, in particular 
enzymes.  A comprehensive view of the cell requires that these small molecules are 
studied.  The large-scale discipline engaged in the characterization of small 
molecules, ‘metabolomics’, is part of the systems biology approach to define the 
phenotype of an organism and bridging the gap between the genotype and 
phenotype.  Metabolomics was first defined by Oliver et al60 as the quantitative 
complement of all of the low molecular weight molecules present in cells in a 
particular physiological or developmental state.  However, it should be mentioned 
that the definition of the metabolome is the theme of active debates.   
The experimental approaches in metabolomics make use of NMR61 or are based on 
gas chromatography and liquid chromatography coupled to mass spectrometry62,63.  
The non-targeted profiling of metabolites in biological samples is certainly 
complementary to proteomics and transcriptomics64. Metabolomics is a burgeoning 
field and a comprehensive discussion is beyond the scope of this work. Therefore, 
we refer to some useful recent surveys65-70. 
 
3. CONCLUSIONS 
At the end of the last century, discovery-driven research made its entry and various 
technologies are nowadays available to study the complete set of (macro)molecules 
at the different levels.  These integrative approaches try to unravel complex biological 
phenomena and their underlying biological processes, and are accompanied by an 
enormous amount of information.  The various approaches are complementary and 
in combination, they can provide us with a detailed phenotype at both the 
transcription and the translation level.  In particular the large-scale analysis of 
proteins is of utmost importance, because proteins are the real 'actors' in any living 
system.  Although proteomics is a nascent technology, a plethora of state-of-the-art 
techniques have been developed the last decade to study protein expression profiles. 
These will be outlined in Chapter II and Chapter III.  
Finally, fueled by ever-growing DNA sequence information, we are at an information 
flood much greater than one could imagine a few years ago.  The challenge is to 
make sense of all this information.  We should think about integration at the 
informatic and experimental levels.  The great complexity underlying biological 
processes can only be tackled by a combination of hypothesis-driven and 
complementary discovery-driven integrative approaches. This can ultimately lead to a 
thorough understanding of living organisms. This is the future, and it promises many 
challenges. 
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CHAPTER II 
 
PROTEOMICS: 
TECHNOLOGY DRIVEN-RESEARCH 
 
 
1. INTRODUCTION 
Technologies to study oligonucleotides, such as sequencing and amplification 
strategies, are now mature technologies.  Proteins can not be amplified, and 
therefore sufficient material must be extracted from the sample in order to be able to 
study proteins.  It is worth mentioning that the first protein sequence, that of insulin, 
was determined ten years before the first RNA sequence was known, a yeast tRNA 
sequence. However, in these years, determination of a protein sequence by Edman 
degradation was tough, and protein science in general was slow and a difficult 'art' 
form.   
It is a frequently debated question whether technology drives biology or whether 
biology drives the development of new technologies1.   Nonetheless, the tremendous 
technological advancements made during the past three decades has led to a huge 
burst of activity in protein science.  New tools have also widened the scope of 
proteomics and fueled the explosion of interest in this discipline.  This technology-
driven research area has matured to become a multi-technological platform.  
Although technology is central to proteomics, there are still several limitations that 
impede the growth of proteomics and, therefore, more mature and potent 
technologies will need to be developed to overcome the existing limitations. 
The discipline proteomics can be currently divided into three distinct classes: profiling, 
functional, and structural proteomics.  In the first section, we will slightly touch the 
application most popular to date, i.e. profiling proteomics.  The very diverse range of 
tools and instruments will be further discussed in Chapter III.  Functional proteomics, 
together with some key technological developments, will be discussed in the next 
sections of this chapter and we will conclude with a current status of structural 
proteomics. 
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2. PROFILING PROTEOMICS 
The term proteomics has been traditionally associated with displaying large number 
of proteins on two-dimensional polyacrylamide gels2,3.  In this sense, proteomics 
dates back to the late 1970s when protein databases were built using the two-
dimensional gel electrophoretic technique4.  The identification of these proteins, 
however, was difficult, due to the lack of a fast, sensitive analytical method for protein 
characterization.  The development of mass spectrometry (MS) for the analysis of 
biomolecules was a turning point in protein analysis.  From then on, protein profiling 
techniques were continuously improved and have resulted in a huge amount of 
information available today.  Protein profiling consists of identifying the proteins 
present in a biological sample and results in a list of proteins present in a cell, tissue 
or organism. When proteins are characterized that are produced differentially (up- or 
down-regulated) between samples, the discipline is often referred to as expression 
proteomics5.  
 
A multitude of different techniques and instruments are currently used in this 
discipline of proteomics.  However, we can distinguish two general strategies that are 
applied in different biological areas today: gel and non-gel based large scale analysis 
experiments6,7. The former uses (two-dimensional) polyacrylamide gel electro-
phoresis (2D-PAGE) to separate the complex mixture of proteins, while the latter 
uses liquid chromatography (LC) as the separation technique.  Protein 
characterization is in both tracks performed by MS.  2D-PAGE is a mature technique 
for more than 25 years, and it is since the development of MS that this technique has 
been widely used and has resulted in numerous applications in profiling proteomics.  
However, this well-established strategy, 2D-PAGE/MS, suffers from some 
shortcomings and, therefore, alternative approaches have been developed.  These 
are non-gel based and were initially put forward as replacements; however it is more 
and more apparent that they will be complementary instead.  For sure, 2D-PAGE/MS 
experiments are now routinely used, while 'gel-free' experiments are not and, 
conversely, are more complex.   The variety of tools and strategies available in 
profiling proteomics will be discussed in Chapter III. 
 
3. FUNCTIONAL PROTEOMICS: PROTEIN-PROTEIN 
INTERACTIONS 
3.1. INTRODUCTION 
Proteins carry out specific functions, and act rarely as single isolated species when 
performing their function in vivo8. Proteins involved in the same cellular processes 
can interact with each other9, and therefore the function of an unknown protein may 
be established by the determination of the interacting partners of which some have a 
known function. Interactions are central to every biological process and many 
analytical methods have been developed to investigate them.  Most of these are 
developed for studying interactions on a small-scale and can not be used on a 
proteomics scale. However, large-scale studies produce a substantial amount of 
false -positives or -negatives and, therefore, small-scale strategies can be useful to 
confirm or reject interactions proposed by large-scale studies.    
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Functional proteomics is a relatively novel discipline in which protein functions are 
tested directly on a large scale. This not only provides insight into protein function, 
but also allows modeling of functional pathways, which elucidates the molecular 
mechanism of cellular processes. One of the first reports was by Martzen and 
colleagues, who tested expressed proteins systematically for different enzymatic 
activities10.  In the following sections, we will highlight some technologies used 
nowadays in functional proteomics.  We will limit the discussion to key technologies 
which have proven their usefulness in proteomics for a couple of years.  For a more 
detailed discussion, we refer the reader to useful reviews11-14. 
 
3.2. TECHNOLOGIES 
3.2.1 PHAGE DISPLAY TECHNIQUE 
Phage display makes use of filamentous phages, bacteriophages, and is an 
expression cloning strategy in which ligands (proteins, antibodies, peptides, etc.) are 
expressed on the surface of these bacteriophages.  This is achieved by cloning the 
gene for a ligand, or repertoire of ligands, into the phage genome, directly upstream 
to one of the genes encoding a phage coat protein.  Bacterial cells, e.g. Escherichia 
coli, are either transfected with the recombinant phage DNA or are transduced with 
bacteriophages that have been packaged with the recombinant DNA in vitro.  
Transcription of the phage genome results in a fusion protein of the ligand and the 
coat protein, which will be incorporated into new phage particles produced within the 
bacteria.  The mature phage will be subsequently released from the bacteria and 
purified 'fusion' phages will bind to any ligand that interacts with the component 
expressed on their surface.  For large-scale protein-protein interaction studies, a 
phage display library is created in which each protein is displayed on the surface of 
the phage. A microtiter plate is prepared where each well is coated with a protein of 
interest, the bait.  The phage display library is pipetted into the wells and the phages 
interacting with the protein will remain bound, while the other phages can be washed 
away.  The interacting proteins, and their respective phages, can be characterized by 
Figure 1. The principle of phage display as applied to 
high-throughput interaction screening.  The bait 
protein is immobilized on the surface of microtiter 
wells.  All other proteins in the proteome are 
expressed on the surface of bacteriophages.  Phage-
carrying interacting proteins will be retained and the 
DNA sequence of the interacting protein determined. 
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infecting E. coli with the phages.  The result is a massive amplification of the 
corresponding cDNA sequence insert, which can be sequenced (Figure 1).   
However, the technique has certain shortcomings, such as being limited to the study 
of small- to medium-sized proteins.  Furthermore, this in vitro assay format would not 
allow proteins to adopt their native structure and thus, the proteins might be non-
functional. 
Besides its use in interaction screening15, phage display technique can be employed 
in the production of antibodies, thereby bypassing immunization and the hybridoma 
technology16.  Antibodies can be constructed as single chain Fv fragments (scFv), 
but also Fab fragments displayed on phages are very potent antibodies (Figure 2).   
This technology was used for the development of scFv arrays containing over 18.000 
probes17. The rapid and high-throughput production of recombinant antibodies can be 
used in protein chips or phage antibodies can reveal biomarkers and novel antigens 
using differential and subtractive selection methods18.  In conclusion, the phage 
display technique is a powerful tool for the high-throughput production of antibodies. 
 
3.2.2. TWO-HYBRID APPROACH 
The yeast two-hybrid approach is a tool to study protein-protein interactions and was 
first used in 198919.  To date, it is a mature and invaluable technology to study binary 
protein-protein interactions20.  The assay is based on the principle of the assembly of 
an active transcription factor from two fusion proteins and the detection of this 
assembly by the activation of a reporter gene.  The general scheme is given in Figure 
3. The protein of interest, called the 'bait', is fused to the DNA binding domain of a 
transcription factor, such as GAL4, which lacks the transcription activation domain.  
The domain is expressed separately as a fusion with another protein, called the 'prey'.  
When both fusions are expressed and the proteins interact with each other, all 
elements are present to turn on the reporter gene.  Thus, the reporter identifies cells 
in which these two proteins interact.  The technique has been automated and 
successfully applied to various large-scale projects.  In the classical high-throughput 
approach, two hybrid fusion proteins are constructed and yeast is simultaneously 
transformed21.  Yeast colonies that incorporate both hybrids, and in which the 
Figure 2. (left) A diagram of the immunoglobulin molecule. (right) Phage 
displayed antibody repertoires are constructed from variable-gene repertoires.  
Antibody fragments can be constructed in several ways.  Most widely used is the 
single chain Fv fragments (scFv), but also Fab fragments can be produced. 
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proteins interact, will turn on the reporter gene.  The number of transformations can 
be reduced by expressing the hybrids in two different haploid yeast strains.  The 
yeast strains are mated with each other to yield a diploid yeast strain and to 
determine whether the proteins interact.  The throughput is increased in matrix and 
pooled matrix screening approaches22-29. 
 
Although the yeast two-hybrid system is a nice in vivo technology for the high-
throughput systematic analysis of binary protein-protein interactions, the technique 
suffers from some drawbacks.  First, the two-hybrid method can only detect binary 
interactions.  In cells, protein interactions are more complicated because proteins are 
involved in multi-protein complexes.  Second, the degree of overlap in the reported 
interactions is very low in similar large-scale studies carried out by independent 
research groups21,22.  Minor differences in the experimental conditions can influence 
the types of detected interactions.  Thirdly, well-characterized interactions are 
sometimes not detected, suggesting a high level of false-negatives.  On the contrary, 
a significant number of interactions appear to be specious when investigated in more 
details (false-positives).  These false-positives and -negatives can arise for several 
reasons.  Non-specific irrelevant interactions, for example, occur for proteins normally 
found in different tissues or different intracellular compartments. Moreover, the 
entrance into the nucleus may be problematical for certain classes of proteins, such 
as integral membrane proteins.  Finally, the yeast two-hybrid assay examines protein 
interactions under artificial conditions and, therefore, not accurately reflects the 
conditions under which most interactions occur.   
Only 50% of the interactions predicted by these experiments are expected to be true 
and therefore, these interactions should be verified by other experiments.  In spite of 
the drawbacks, the data have proven to be valuable when integrated with other 
protein-protein interaction data30.  Further developments of the yeast-two hybrid 
system have led to the study of receptor-ligand interactions, the yeast three-hybrid 
system31, and modifications are also used to find elements inhibiting an interaction, 
the reverse-hybrid system32.  The enhanced systems are useful in drug discovery 
and in the discovery of therapeutic agents.  Finally, other systems have been 
Figure 3. The principle of the yeast 
two-hybrid system. The technique is 
based on the interaction of a 'bait' 
protein with a 'prey' protein inside the 
nucleus of a yeast cell.  The bait 
protein consists of a target protein 
(X) fused to the DNA-binding domain 
(A) of a transcription factor.  The 
prey protein consists of a binding 
protein (Y) fused to the 
transcriptional activator domain (B) 
of a transcription factor.  By the 
interaction of the bait with the prey, a 
functional transcription factor is 
created which turns on the 
transcription of a reporter gene. 
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developed to investigate interactions between membrane proteins, i.e. the 'split 
ubiquitin' system33-37, or to study interacting proteins from both prokaryotes and 
eukaryotes, such as the bacterial two-hybrid system38,39. 
3.2.3. PROTEIN MICROARRAYS 
Another approach for analyzing interactions of proteins is the use of protein 
microarrays. It should be mentioned that the terms protein chip, microchip, biochip, 
array and microarray are used interchangeable for a whole host of different devices 
and the choice is mostly a matter of personal preference.  The concept of protein 
arrays is not new.  In the 1980s, miniaturized, solid-phase immunoassays were 
developed using protein microdots manually spotted onto solid supports, e.g. 
nitrocellulose sheets.  
DNA microarrays, as described before, had a great impact on sequence analysis and 
expression profiling.  The DNA microarray is not bigger than a stamp and allows 
analyzing thousands of genes in parallel.  Moreover, they are very sensitive, easy to 
automate and, it is not thus surprising that similar devices are being developed for 
the analysis of proteins.  As the materials, surface chemistries and printing 
technologies for DNA microarrays evolved, the technologies were modified and 
exploited to develop analogous devices for protein analysis. 
Protein microarrays are very versatile and may be classified in different ways 
according, for example, to their surface chemistry, their specificity, or to how they are 
made40.  A major distinction can be made between analytical and functional arrays 
(Figure 4). 
 
Analytical arrays are mostly used for expression profiling, while functional arrays are 
used to study interactions and biochemical activities.  Several different ligands (e.g. 
proteins, peptides, antibodies, antigens, carbohydrates, small molecules) can be 
spotted onto the derivatized surface in analytical arrays, and the possibilities are 
almost endless.  The most common type of chip is the antibody array, which is a 
Figure 4. (A) Analytical arrays contain immobilized capture agents (which may be 
proteins) and the proteins under investigation are in the analyte. (B) Functional arrays, on 
the contrary, are constructed from immobilization of the proteins under investigation.  
These are used as probes to capture interacting molecules in the analyte. 
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coated glass slide containing a high-density array of specific antibodies.  The 
complex mixture, e.g. cell lysate, is passed over the surface allowing antigens to bind 
to their respective antibodies.  The bound antigen is detected by using either 
fluorescently or radioactively labeled samples or by using a secondary antibody.  The 
antibody arrays have been used in several studies.  The activation of receptor 
tyrosine kinase pathways in tumor cells and the changes in quantities for a number of 
antigens in colon carcinoma cells, for example, have been investigated41,42.  On the 
other hand, it is difficult to obtain and express a sufficient number of specific 
antibodies for large-scale studies43.  
 
Unlike analytical chips, functional chips are used to investigate the different 
properties of proteins.  For example, arrays containing recombinant proteins monitor 
the binding properties of proteins, antibodies, small molecules and drugs44,45.  Such a 
'human' protein chip was used for antibody screening and protein profiling46.  
However, the development of functional chips is hampered by two problems:  
expressing large numbers of proteins and maintaining the proteins in a native 
state47,48.  In addition, these are in vitro assays and therefore, in vivo interactions 
need to be verified.  It should be mentioned that serious efforts are made to surmount 
the problems.  For example, nearly all yeast protein kinases (119 out of 122) were 
produced in functional forms49 and, more recently, the first eukaryotic proteome 
microarray was prepared.  The chip was composed of more than 5800 individually 
cloned, overexpressed, and purified proteins50.  Despite these technological hurdles 
that remain to be overcome, protein chips represent the fastest growing sector of the 
proteomics market, with particular interest in the area of functional proteomics. 
 
3.2.4. AFFINITY-BASED METHODS 
Exploiting the affinity of a particular protein for its interaction partner can be done by 
affinity chromatography.  Here, a particular protein (the 'bait') is expressed or purified 
and immobilized on a matrix, e.g. a column packing material.  The immobilization can 
be achieved by expression the protein as a fusion with gluthatione-S-transferase 
(GST), which binds strongly to a column packing material coated with glutathione, or 
by conjugating antibodies specific for the protein to the matrix.  The sample is passed 
through the column under controlled conditions and those proteins interacting with 
the bait will be retained.  The proteins can be eluted by increasing ionic strength and 
identified by immunoblotting or mass spectrometry.  Different large scale interaction 
analyses are based on this principle, and advantageous is the study of proteins in 
their 'natural' context.  The first reports involved antibody-based affinity purification51.   
A less selective approach is the use of affinity tags.  By its nature, these experiments 
identify protein complexes rather than binary interactions.  Two such studies in yeast 
were reported in 200252,53.  In one study, the bait proteins were expressed as fusions 
with the FLAG epitope.  This short peptide is recognized by a specific antibody.  Cell 
lysates were prepared from each yeast strain and passed through an anti-FLAG 
antibody containing affinity column.  The captured proteins were eluted, separated by 
SDS-electrophoresis, and subsequently identified by mass spectrometry; this 
revealed a total of 3617 interactions.  A second study used a tandem affinity 
purification (TAP) procedure54.  The bait protein is a fusion of a calmodulin-binding 
peptide and the staphylococcal protein A.  The two 'elements' are separated by a 
protease recognition site (Figure 5).   
CHAPTER II                                                PROTEOMICS: TECHNOLOGY DRIVEN-RESEARCH 
 
21 
Gene targeting was used to replace nearly 2000 genes with a TAP fusion cassette.  
The yeast strain was lysed, passed through an immunoglobulin affinity column and, 
after washing, the complexes were eluted by addition of the protease.  In a second 
round of affinity chromatography, highly selective binding was established by using 
calmodulin as matrix in the presence of calcium ions.  After elution by EGTA and gel 
electrophoresis, the proteins were identified by mass spectrometry.  More than 4000 
interactions were displayed of which 60% were novel.  However, these two studies 
also showed a low degree of overlap when similar bait proteins were compared 
between the two studies or previous yeast two-hybrid studies8.  On the other hand, 
both projects reported results consistent with already known complexes. 
Affinity based isolation of interacting proteins can also be achieved in solution by 
techniques such as co-immunopurification and GST pulldown.  In co-
immunopurification, antibodies specific for a protein will result in the precipitation of 
the antibody-antigen complex and will also precipitate the proteins interacting with 
the bait.  The complexes are separated from the lysate by centrifugation and the 
interacting proteins are separated by electrophoresis and identified by mass 
spectrometry.  In GST pull-down, an analogous technique is used.  Here, the bait is 
expressed as a fusion to GST and added to the lysate.  Glutathione-coated beads 
are added to capture the GST part of the fusion.  After centrifugation, the beads are 
washed and the recovered proteins separated by electrophoresis and identified by 
mass spectrometry.  A technique that uses immunopurification and protein tagging 
was developed by Figeys and colleagues for the study of human protein complexes 
in vivo55.  Briefly, a full-length cDNA of a gene was cloned into a transfection vector, 
which is pre-encoded to add an epitope tag to either the N- or C-terminus of the 
protein.  A culture of human cells is then transfected and the tagged proteins are 
expressed.  Cells are collected and lysed, and an immobilized antibody is used to 
capture the epitope tag.  Interacting proteins are separated by electrophoresis and 
identified by mass spectrometry. 
 
 
Figure 5. The tandem affinity purification (TAP) cassette.  It is made up of a PCR-derived 
gene-specific homology region for targeting each yeast gene, a spacer, a calmodulin-
binding peptide, a protease cleavage site recognized by tobacco etch virus protease and 
Staphylococcal protein A. 
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3.2.5. SUMMARY 
The above described strategies all have their advantages and drawbacks and, are 
summarized in Table 1.  In conclusion, no single high-throughput method is final, and 
the integration of multiple sets of data and the verification by alternative methods is 
always required before any clear-cut conclusion can be drawn.  
 
 
 
4. FUNCTIONAL PROTEOMICS: PROTEIN-SMALL MOLECULE 
INTERACTIONS 
Proteins interact with small molecules, which can act as cofactors, enzyme 
substrates, ligands for receptors or allosteric modulators.  In addition, many proteins 
transport or store particular molecules.  Drug companies are particularly interested in 
the elucidation of protein-small molecule interactions, because most drugs act 
directly on proteins.  Mapping these interactions can lead to the discovery of new 
protein targets and might help to explain side effects of a drug before launching it on 
the market.  A promising discipline is activity-based proteomics57-59.  This approach 
fractionates the proteome into families of proteins that are linked by common 
mechanistic functions in their active form. The principle is shown in Figure 6A; the 
pioneering work was done in the Cravatt Laboratory60. A fluorophosphonate probe 
(Figure 6B) was used to characterize protein members of the serine hydrolase family. 
The discipline using small molecules as 'bait' to fish for interacting proteins is also 
called chemiproteomics61,62.   
 
Table 1. Comparison of Different Key Technologies in Functional Proteomics*. 
Approach Application Advantage Disadvantage 
Yeast two-
hybrid 
Protein-protein 
interaction; 
protein-DNA 
interactions 
High-throughput and 
systematic to reveal 
protein interactions 
 
No control over interaction condition; 
interactions are in the nucleus; high rate 
of false positives and false negatives; 
only binary interactions are investigated 
 
Affinity 
tagging/MS 
Dissecting protein 
complexes 
 
In vivo interactions; 
multiple interactions 
partners 
 
Transient or weak interactions may be 
missed; false positives are hard to 
identify 
Antibody 
arrays 
Protein profiling; 
clinical diagnostics 
 
Sensitive; great 
potential in biomarker 
and drug 
development 
 
Restricted by the quantity and quality of 
available antibodies 
Functional 
protein arrays 
 
Diverse, protein-
protein, protein-
small molecule, 
etc. 
 
 
High-throughput; 
potential for 
analyzing 
biochemical activities 
 
In vitro assays 
* adapted from Zhu et al56. 
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Large scale screens for protein interactions with small molecules can be performed in 
vivo and in vitro.  In the in vivo approach, cells are incubated with a drug containing a 
tag and are afterwards lysed.  The drug and the interacting partners are affinity 
purified using the tag, after which the protein drug targets are identified by mass 
spectrometry. Chips can be used in the in vitro approach.  A cell lysate is passed 
over the chip and after rinsing, the extracted proteins are identified by mass 
spectrometry.  Both approaches have some shortcomings. For example, there is an 
increasing risk of degradation and false interactions in vitro, while the tag may disturb 
the localization and the interactions in vivo.   
 
5. STRUCTURAL PROTEOMICS 
‘Structural proteomics’ is often termed 'structural genomics' in the current literature63.  
However, this term was previously used to refer to the physical phase of the genome 
projects, i.e. mapping of physical markers, the assembly of clone contigs, sequencing 
and gene annotation, and therefore care must be taken when consulting papers 
about this topic.  Structural proteomics determines and predicts 3D structures, at 
atomic resolution, of proteins on a genome-wide scale in order to obtain a better 
understanding of their structure-function relationship64,65.  In the past, structural 
analysis was performed when the function of a protein was known.  As proteomics 
came into play, structural biology considerably expanded and structural proteomics 
has become a major initiative in biotechnology66,67.  The enormous increase in 
protein structure elucidation is primarily due to the availability of genome sequences 
and the technical advances made in cloning and expression68,69. However, the 
expression technologies are still limited for membrane proteins and large 
complexes70.    
The most powerful method for structure determination71,72, X-ray crystallography, has 
been subjected to some major technological advances during the last decade73,74. 
For example, high-throughput crystallization has been facilitated by improved 
phasing and model building methods, decreased amounts of sample through 
Figure 6. (A) Principle of activity-based 
proteomics.  The chemical probes contain 
an electrophilic group that is positioned to 
react with a (conserved) nucleophilic amino 
acid residue, which is important for family 
function and/or binding of the active 
proteins.  The probe contains a fluorescent 
group or capture group, attached to the 
electrophilic recognition group via a linker. 
(B) The chemical structure of 
fluorophosphonate-alkyl-biotin. 
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miniaturization, as well as robotization and automation from the stage of 
crystallization up to that of structure determination.  Various projects are currently 
under way for large-scale X-ray crystallography of proteins and domains, either by a 
large-scale crystallization effort75,76 or by systematic elucidation of domains.  NMR 
spectroscopy has also provided insights into the structure-function relationship for a 
large number of proteins.  However, the technique is limited by size constraints and 
lengthy data collection and analysis.  Despite these current limitations, it may still 
play an important role in structural proteomics77.  
Although recent advances in X-ray crystallography78,79 and multidimensional NMR 
spectroscopy80 have resulted in the elucidation of many 3D protein structures, 
computational approaches become alternatives to predict 3D structures.  The 
computational approaches for structure determination are either based on 
comparative structure prediction or on de novo structure prediction.  When proteins 
are member of a gene family and at least one of the protein structures is determined 
by X-ray crystallography or NMR, it is possible to infer the structure of a new family 
member by reference to a known one81,82.  An extension to this approach is to 
computationally fold up a protein based on assembling its primary sequence into a 
three-dimensional shape83,84.  This remains a challenging task but is a very active 
area of current research. Computational methods are continuously being improved 
and accurate models may be predicted using these strategies in the future.  
 
6. CONCLUSIONS 
Today, a powerful set of tools for the large scale analysis of proteins is available. The 
development of new tools in this discipline is still ongoing and demonstrates that 
proteomics research is powered by novel technologies.  The development of 
biological mass spectrometry in the late 1980s, for example, has drastically speeded 
up profiling proteomics.  Knowing the inventory of proteins of a cell or organism is 
important.  However, proteins are also playing their role in protein-protein and 
protein-small molecule interactions.  In functional proteomics, the function of proteins 
is determined.  Several new technologies, e.g. protein microarrays, have already 
shown their great potential in determining protein functions on a bigger scale. Finally, 
structural proteomics is uncovering the 3D structures of proteins and provides a 
framework for the structural modeling of novel proteins. The determination and 
prediction of 3D protein structures will become increasingly important for studying 
protein-protein interactions. 
All of these high-throughput assays produce massive amounts of data and it has 
become obvious that the integration of different sets of data, obtained by different 
strategies, will greatly enhance the understanding of biological systems.  This may 
ultimately lead to the creation of a 'virtual cell' which will allow biologists to approach 
the ultimate question: "How do living organisms operate as systems at the molecular 
level?".  
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PROFILING PROTEOMICS:  
MASS SPECTROMETRY DRIVEN-RESEARCH 
 
 
1. INTRODUCTION 
Determination of the protein composition in a sample is a complex analytical problem, 
as proteins show high physico-chemical variability.  Different strategies have been 
developed to cope with this technically challenging task.  These strategies all involve 
the separation of a complex protein or peptide mixture, followed by identification.  
The end result is a proteome 'map', i.e. the protein composition, of the investigated 
sample.  In addition, samples can be compared with each other, resulting in a 
differential display of the proteins occurring.  However, this goal can only be 
accomplished if a quantification technology is implemented in the profiling proteomics 
strategy.  Mass spectrometry plays a key role in each strategy, regardless of the 
method used for separation of the complex protein mixture.  
Mass spectrometry (MS) is a reputable technique which measures an intrinsic 
property of a molecule, its mass.  MS dates back to the studies performed by J.J. 
Thomson1 and his student F.W. Aston2 in the beginning of the 20th century.  
However, it was only from the early 1980s that MS started to play a significant role in 
biological sciences.  It took that long because MS requires charged, gaseous 
molecules for analysis, and being large and polar, biomolecules are not easily 
ionized and transferred into the gas phase.  The development of two 'soft' ionization 
techniques, electrospray ionization (ESI) and matrix-assisted laser desorption 
ionization (MALDI), has overcome the problems and these methods are now the 
basis for diverse, powerful instrumentation.  In 2002, the inventors of those two key 
revolutionizing ionization techniques were awarded the Nobel Prize in Chemistry, 
showing the importance and influence of these technologies in biological science. In 
the same period that ESI and MALDI were becoming 'routine' in biological MS, the 
concept of proteomics was emerging.  Further development of MS, i.e. more 
sensitive, accurate and high-throughput instruments, goes along with the expansion 
of proteomics, a trend that shows no signs to slow down.  In this chapter, we will give 
some background on MS, followed by the implementation of the technique in profiling 
proteomics strategies. 
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2. MASS SPECTROMETRY  
Basically, a mass spectrometer consists of three components: an ion source, to 
produce ions from the sample, one (or more) mass analyzer(s) to separate the ions 
according to their m/z ratios, and an ion detector to register the number of ions.  The 
MS is controlled by software which allows processing the data and producing the 
mass spectrum in a suitable form. 
 
2.1. ION SOURCES 
2.1.1. MATRIX-ASSISTED LASER DESORPTION IONIZATION 
Laser desorption methods use laser energy to convert molecules into gas-phase ions. 
Tanaka and colleagues3,4 demonstrated that macromolecular ions can be desorbed 
from a glycerol-based liquid laced with a finely powdered metal. This glycerol/metal 
powder method paved the way for a more practical and reliable method to produce 
ions, i.e. MALDI5.  The analytes are mixed with a saturated solution of UV-absorbing 
matrix and the mixture is applied onto a metal substrate, the target.  The solvent 
evaporates and the matrix and analytes co-crystallize6,7.  The target is then irradiated 
by a pulsed laser, mostly a nitrogen laser at 337nm, which is used to deposit energy 
into the matrix.  The energy causes rapid thermal heating and localized sublimation 
of the matrix crystals. This matrix, which is in large excess, contains a chromophore 
with absorption nearby the laser wavelength, and therefore will absorb nearly all of 
the laser radiation.  The matrix expands into the gas phase and takes with it intact 
analyte molecules, which are desorbed into the gas phase.  The most commonly 
used matrix molecules are α-cyano-4-hydroxycinnamic acid for peptides and 
polypeptides with a mass of less than 5000 Da, and 3,5-dimethoxy-4-hydroxy-
cinnamic acid, or sinapinic acid, for proteins. Usually this procedure produces singly 
charged ions that are subsequently analyzed in the mass spectrometer.  The 
fundamental processes of ion generation and desorption are still poorly understood 
and are the subject of an active debate8.  The most widely accepted mechanism 
involves gas phase proton-transfer in the expanding gas-phase plume with photo-
ionized matrix molecules9 (Figure 1). 
Figure 1. The principle of matrix-assisted laser desorption ionization (MALDI). 
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2.1.2. ELECTROSPRAY IONIZATION 
Electrospray is an atmospheric-pressure ionization method that produces small 
charged droplets from a liquid medium under the influence of an electric field.  
Although Dole and colleagues already transferred large molecules to the gas phase 
in the late 1960s10, the first electrospray mass spectra were reported in the late 
1980s by the group of Fenn11,12 at Yale University.  In conventional ESI, a liquid is 
passed through a thin conducting needle at high voltage (3-4kV) and a potential 
difference is applied between the needle and a counter electrode.  Depending on the 
pH of the solvent, the analytes exist in an ionized form and alike charges will 
accumulate at the tip of the needle.  The high density of charges at the tip leads to 
the formation of a Taylor cone13.  When the repulsive forces become stronger than 
the surface tension at the tip of the cone, the liquid is ejected as a mist, which breaks 
up into smaller charged droplets when moving towards the counter electrode.  This 
movement is directed by a potential and pressure gradient, and a counter-current 
flow of gas facilitates solvent evaporation.  Solvent evaporation in the charged 
droplets results into droplets breaking up into smaller droplets14.  This is caused by 
the surface Coulomb forces exceeding the surface tension, the Rayleigh limit15.  The 
process continues until droplets with diameters in the nanometer range are 
generated.  This process is schematically presented in Figure 2.   
Two mechanisms, the charged-residue and the ion evaporation model16, have been 
proposed for the formation of gas phase ions out of these small charged droplets.  In 
the charged-residue model, it is proposed that solvent evaporates and droplets break 
up until those with only a single analyte ion are created and the evaporation 
continues until a gas phase ion is formed.  In the ion evaporation model, it is stated 
that droplets with a radius less than 10 nm allow direct emission of a gaseous ion 
(field desorption).  The charge state of the ion will depend on the number of charges 
transferred from the droplet to the ion during desorption.  As in MALDI, the 
mechanism of ionization is still under debate17-21.  The ESI process occurs at 
relatively low temperature and large, polar molecules can thus be ionized without 
Figure 2. Droplet production in the electrospray interface. 
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decomposition.  If several ionizable sites are present, multiple charged ions ([M + 
nH]n+) will be formed. Denatured proteins typically carry one charge per 1000 Da. 
The conventional ESI source, operating at a flow rate of a few µl/min, has been 
adapted to cope with higher22 and lower flow rates23-25.  However, the first 
electrospray source without continuous infusion, operating at a low flow rate, was 
developed by Wilm and Mann26,27.  In this nanospray source, the sample is sprayed 
from a metal-coated capillary with an orifice of 1-10 µm, which results in a flow rate of 
20-50 nl/min.  The orifice of the needle, the applied voltage, the viscosity and 
volatility of the solvent will all determine the flow rate. 
 
2.2. MASS ANALYZERS 
2.2.1 INTRODUCTION 
When gaseous ions are formed, they are transported to the analyzer and separated 
according to their mass-to-charge (m/z) ratio.  A mass analyzer mainly determines 
the quality of a mass spectrum and the characteristics for these devices are: (i) mass 
range, (ii) resolution and (iii) transmission.  The mass range is the limit of m/z over 
which ions can be detected, while the resolution is defined as the smallest difference 
in mass still able to display two ions as separate peaks in the mass spectrum.  The 
transmission is the ratio of ions reaching the detector and ions produced in the 
source (efficiency). 
Different mass analyzers are now available; they can be divided in two distinct 
classes: those of the electric-field type and those of the magnetic-field type.  The first 
group comprises the quadrupole mass filter, the ion trap and the time-of-flight mass 
analyzer, while the latter includes the magnetic sector type and the ion cyclotron type.  
The mass analyzers are diverse in terms of design and performance.  Hence, they 
differ in sensitivity, speed, mass accuracy, mass resolution and mass range, and may 
be used as stand-alone analyzers or in tandem. The four basic types currently in use 
for proteomics research are: the quadrupole, the ion trap, the time-of-flight and the 
Fourier transform ion cyclotron resonance analyzer.  We will limit the discussion of 
mass analyzers to those implemented in the different tandem MS instruments used in 
this work, i.e. the quadrupole, the ion trap and the TOF analyzer. 
 
2.2.2. THE QUADRUPOLE MASS FILTER  
The quadrupole mass filter28, introduced in 195329, is constructed of four electrically 
conducting cylindrical rods, and mass selection is achieved by properly choosing a 
combination of radio frequency (RF) and direct current (DC) voltages.  A two-
dimensional quadrupole field is established between the four cylindrical, 
equidistantly-spaced electrodes and with the two opposite rods being connected 
electrically.  One rod pair is connected to a positive DC voltage on which a sinusoidal 
RF voltage is superimposed.  The other rod pair is connected to a negative DC 
voltage on which a sinusoidal RF voltage is superimposed.  The DC and RF voltage 
are set such that only the ion of interest has a stable trajectory through the 
quadrupole.  The mass filter is a continuous analyzer and can be set to transmit a 
single isotope or to scan over a wide m/z range.   
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2.2.3. TIME-OF-FLIGHT 
The principle of the time-of-flight (TOF) mass analyzer is to measure the flight time of 
ions accelerated from an ion source into a field-free drift tube to a detector30.  The 
flight time is related to the m/z values of the ions according to the following formula: 
The ions will be separated in the analyzer according to their m/z ratios, light ions 
reaching the detector earlier than heavy ones.  The resolving power of this analyzer 
is limited by the initial spatial spread and initial velocity of the ions.  For example, in a 
MALDI source, the ionization creates a burst of ions that will have different kinetic 
energies and the ions will be at different distances from the detector.  Therefore, ions 
with the same m/z value but with different kinetic energy or at different distances will 
be detected at different times and will cause decreasing resolution.  Two powerful 
techniques have been developed to compensate for temporal (time of ion formation), 
spatial (location of ion formation) and kinetic (energy of ion formation) distribution.  
The first technique is the introduction of ion mirrors, or reflectrons31, which 
compensates for the initial energy spread of the ions.  The reflectron creates a 
retarding field that deflects the ions and sends them back through the flight tube 
(Figure 3).   
The more energy the ion has, the further it penetrates the retarding field of the 
reflectron before it is being reflected.  Therefore, a more energetic ion will travel a 
longer flight path and arrive at the detector at the same time as less energetic ions 
Figure 3. Schematic of a reflectron time-of-flight mass analyzer. Two ions of the same mass but 
different initial kinetic energies, E1 and E2, are produced and extracted into the first field-free 
region.  The ions are then reflected by the ion mirror, the reflectron, travel through the second 
field-free drift region and are detected at the same time by the reflecting detector. 
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with the same mass.  The kinetic energy distribution of ions is also the result from 
their acceleration through the gas-phase plume created during desorption32.  Brown 
and Lennon33 have observed that both mass accuracy and mass resolution are 
significantly improved by introducing a delay between ion formation and extraction of 
the ions from the source.  This time delay compensates for the wide spatial and 
temporal distributions. 
 
2.2.4. ION TRAP 
The ion trap consist of a chamber surrounded by a ring electrode and two end-cap 
electrodes and can be regarded as a quadrupole mass filter bent around on itself to 
form a closed loop34,35.  Hence, the ion trap is also referred to as the 'quadrupole ion 
trap'.  Unlike the quadrupole and TOF analyzers, which separate ions in space, the 
ion trap separates ions in time.  Ions of all m/z values enter the trap at the same time 
and are subjected to oscillating electric fields generated by an RF voltage applied to 
the ring electrode only.  As ions will repel each other, ion losses are prevented by 
introducing a gas inside the trap, typically helium, which will remove excess energy 
from the ions by collision. This has the effect of collisionally damping the ion motion 
and causes the ions to migrate to the center of the ion trap.  The voltage applied to 
the ring electrode determines which ions remain in the trap.  Ions above the threshold 
m/z ratio remain in the trap while others are ejected through small holes in the distal 
end-cap electrode.  By gradually increasing the voltage in the ring electrode, ions of 
increasing m/z ratios are ejected over time.  This process is called ‘mass-selective 
ejection’.  Ions can also be selected for MS/MS analysis by using a RF voltage 
applied to the end caps to eject all ions in the trap, except for the chosen precursor 
ion.  The kinetic energy of the selected ion population is then increased by applying a 
voltage resonant with the frequency of the precursor ion, causing more energetic 
collisions with the gas.  The resulting fragments can then be ejected by 'ramping' the 
voltage of the ring electrode to generate an MS/MS spectrum. 
 
2.3. TANDEM MASS SPECTROMETRY 
2.3.1. INTRODUCTION 
The determination of the intrinsic property, the mass, of an ion can now be readily 
and accurately achieved. However, this information does not provide data on the 
covalent structure of the ion.  During the last two decades, new configurations of 
mass spectrometers have been developed to obtain protein or peptide primary 
structure information.  Therefore, different mass analyzers are put in tandem, in order 
to obtain fragmentation of the protein or peptide.  Tandem mass spectrometers36 
mostly use collision-induced dissociation (CID)37,38 for the acquisition of MS/MS 
spectra.  The mass spectrometric market in these instruments flourishes and different 
types of tandem mass spectrometers are nowadays commercially available, all 
having their own strong features.  
Traditionally, MALDI is coupled to TOF analyzers, while ESI is mostly coupled to 
quadrupoles and ion traps39,40.  However, MALDI ion sources, in tandem mass 
spectrometers, have also been coupled to quadrupole-TOF analyzers and 
quadrupole-ion trap mass spectrometers41.  
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2.3.2. COLLISION-INDUCED DISSOCIATION 
In tandem mass spectrometry, a precursor ion is selected in the first analyzer and 
focused into a collision cell.  In the cell, filled with an inert gas, collisions occur 
between the gas and the precursor ion and translational energy of the precursor ion 
will be partly converted into internal energy, exciting the ions to an unstable state.  
The precursor ions dissociate, i.e. fragment, to product ions.  The masses of the 
product ions are then determined in a second mass analyzer.  This process is called 
‘collision-induced dissociation’, also referred to as ‘collision-activated dissociation’ 
(CAD).  The product ions will have a charge either on the N-terminal or on the C-
terminal side of the cleavage.  The universally accepted nomenclature for the product 
ions is shown in Figure 442,43.   
Although the general fragmentation mechanism of peptides is fairly well 
understood44-49, it remains a topic of investigation.  The fragmentation of peptides is 
believed to be charge mediated.  When non-selective cleavage occurs at multiple 
sites throughout the entire peptide backbone, the charge must be allowed to migrate 
from the initial site of protonation to the site of cleavage.  This has been termed the 
'mobile proton' or 'heterogeneously distributed' model50 and is one of the central 
tenants in peptide fragmentation mechanisms.  The energy required to mobilize the 
proton from the thermodynamically favored site of protonation to less favored sites of 
protonation is provided by the collision energy imparted to the ion.  The relative 
populations of the different protonated forms of a particular peptide depend on the 
internal energy content of the peptide and the gas phase basicities of potential sites 
of protonation. The initial population of protonated peptides is altered via collisional 
activation, the proton 'mobilizes', and the population of protonated forms with higher 
energy than that of the most stable structure increases.  The proton is located at 
various backbone hetero-atoms in these excited molecules.  Once the appropriate 
protonated precursors have been formed, an intramolecular process, a nucleophilic 
attack of amide bond or side chain, results in the cleavage of the peptide.  
Protonation at peptide backbone sites initiates cleavage of the peptide bond to 
produce b- and/or y-type fragments (Figure 5).   
The initial cleavage yields an ion-neutral complex, and proton transfer within this 
complex can account for the competition between formation of two types of ions, e.g. 
b- and y-ions.  The energy required to relocate the proton to a position on the 
backbone, and hence induce dissociation, is dependent on the peptide composition51.  
Dissociation energy requirements are greatest for Arg-containing peptides and 
decrease in order of decreasing gas-phase basicity. 
 
Figure 4. Nomenclature for the product ions generated in the 
fragmentation of peptides by tandem mass spectrometry. 
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Some residues have significant effects on the peptide fragmentation pathway and 
result in the selective cleavage of the peptide at those sites52-57.  For example, the 
acidic side chain of the aspartic residue can donate a proton to the amide bond and 
give rise to the selective cleavage of the protonated peptide bond on their C-terminal 
side, generating an abundant b-/y-ion pair.  This mechanism is also known as the 
‘aspartic acid effect’58,59.   
 
2.3.3. INSTRUMENTATION 
2.3.3.1. Q-TOF 
Historically, TOF mass analyzers have been exclusively coupled with MALDI, due to 
the complementary pulsed nature of both the ion source and mass analyzer.  
However, the development of pulsed orthogonal ion injection into TOF mass 
analyzers has allowed ESI sources to be coupled with TOF for high-resolution MS 
and MS/MS experiments60.   The Q-TOF consists of a quadrupole (Q1) followed by a 
TOF analyzer, where a collision cell (Q2) is put in between (Figure 6).  The operation 
of this type of tandem mass spectrometer is essentially the same as that for a triple-
quadrupole mass spectrometer, except that product ions exiting Q2 are orthogonally 
pulsed into a TOF mass analyzer to acquire the mass spectrum. 
 
 
 
Figure 5. Fragmentation of a doubly charged 
tryptic peptide to produce b- and y-ions.  
Relocation of the N-terminus proton to 
promote charge-directed cleavage via CID 
may occur to either N or O backbone atoms. 
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The hybrid instrument takes advantage of the high-performance resolution 
capabilities of the TOF mass analyzer for product ion assignment, together with the 
ability to obtain efficient precursor ion selection and dissociation using the 
quadrupole mass filter.  In MS analysis, the quadrupole analyzer operates in the 
wide-bandpass mode, i.e. all ions are transmitted irrespective of the m/z value; in 
MS/MS analysis, the quadrupole analyzer selects an ion of particular m/z (narrow-
bandpass mode).  Both ESI and MALDI sources have been successfully coupled to 
Q-TOF instruments61-63.   
 
2.3.3.2. Q-TRAP 
The Q-Trap LC/MS/MS system (Applied Biosystems/MDS Sciex) is a recently 
introduced mass spectrometer64-66 equipped with a nanospray ion source (Protana).  
The system is a modified triple quadrupole (Figure 7) where the Q3 region can be 
operated either as a conventional quadrupole mass filter, or as a linear ion trap (LIT) 
with axial ion ejection, and has several scan mode possibilities, e.g. precursor ion 
and neutral loss scan. When quadrupoles are combined with an ion trap, ions can be 
isolated and fragmented outside the ion trap and then accumulated in the trap for 
analysis of the fragment ions.  Additionally, ions can be simply passed through the 
mass filters and accumulated in the linear ion trap for analysis.  Compared with 
conventional 3D ion trap instruments, the volume of the trapping chamber is 
drastically increased, leading to a larger capacity and less space charging effects, 
and thus to higher sensitivity. 
 
Figure 6. Schematic overview of the Q-TOF instrument (Micromass). 
Figure 7. Picture of the instrument in the laboratory (left) and schematic presentation of the 
Q-TRAP (right). 
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2.3.3.3. MALDI TOF-TOF 
The MALDI-TOF mass spectrometer has already proven its use in proteomics.  
However, the major limitation to a MALDI-TOF instrument is the inability to perform 
true MS/MS.  Although post-source decay (PSD) has been observed, the low 
precursor ion resolution, the poor mass accuracy, and the low abundance of product 
ions, together with the complexity of PSD spectra has made protein identification 
difficult using this method67-69.  Medzihradszky and colleagues70 developed a tandem 
TOF mass spectrometer to use the high-speed capabilities of the mass analyzer to 
create a high-throughput tandem mass spectrometer (Figure 8).  The 4700 
Proteomics analyzer (Applied Biosystems) is a MALDI instrument equipped with a 
Nd:YAG laser which can operate at 200 Hz. 
The instrument combines the advantages of high sensitivity for peptide analysis 
associated with MALDI and comprehensive fragmentation information provided by 
CID. The high kinetic energy of the ions entering the collision cell allows high-energy 
CID processes to be observed.  So, a wider range of product ion types can be 
observed compared to those formed under low-energy CID conditions, including d-, 
v-, and w-type ions resulting from side-chain cleavages.  These ions allow the 
isobaric amino acids, leucine and isoleucine to be differentiated.  
The instrument is divided into three sections based on their functionality: ion 
selection, collision region and the fragment detection.  The ion selection and 
fragment detection are, respectively, achieved by the two TOF analyzers, while a 
collision cell is placed in between the two analyzers.  For precursor selection, a novel 
timed-ion selector (TIS)71 has been developed (Figure 9).  This process employs two 
tandem deflection gates that are quickly opened and closed when an ion of interest 
reaches the entrance. The first gate deflects low-mass ions and the second gate 
deflects high-mass ions. The synchronization of the opening and closing of these 
deflection gates is under software control.   
 
 
 
Figure 8. (left) Picture of the 4700 Proteomics Analyzer in the laboratory.  The insets are detailed 
photographs of the inside of the instrument. (right) Schematic overview of the MALDI TOF-TOF 
mass spectrometer. TIS= Timed-Ion Selector 
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3. STRATEGIES IN PROFILING PROTEOMICS 
Two main routes may be distinguished in profiling proteomics: 'top-down' and 
'bottom-up' proteomics.  The former analyzes intact proteins, while the latter analyzes 
peptides originating from a proteolytic digest of the protein sample.  In both 
approaches, the peptides or proteins are separated from each other in order to 
simplify the complex mixture, and the individual components are, most of the time, 
further identified by mass spectrometry.  The two main and most powerful separation 
methods are liquid chromatography72 and electrophoresis73.  For example, an 
established top-down approach consists in the separation of a protein mixture by 
two-dimensional gel electrophoresis, followed by in-gel digestion and analysis of the 
peptides by mass spectrometry.  However, two-dimensional gel electrophoresis is not 
well suited for the analysis of certain classes of proteins and, therefore, alternative 
top-down strategies based on multi-dimensional chromatography have been 
developed74-76.  Yet, these approaches are far from routine and require expensive 
mass spectrometric instrumentation.  Hence, bottom-up 'shotgun' proteomic methods 
have gained in popularity. Shotgun proteomics involves solution proteolysis of a 
complex protein mixture into a collection of peptides, which are chromatographically 
separated prior to mass spectrometric identification. A schematic overview of the 
strategies used in profiling proteomics is given in Figure 10.   
 
 
 
Figure 9. Schematic of the Timed-Ion Selector, showing the 
deflection of light ions (m1) by gate 1 and heavy ions (m3) by 
gate 2. Only ions of intermediate mass (m2) are allowed to 
pass into the collision cell. Each gate is open when both 
electrodes are grounded and is closed by applying +/- 950V. 
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For differential display purposes, quantification can be done at the gel level in 
electrophoretic based strategies and, therefore, electrophoresis remains the most 
practical method for protein expression comparison.  On the opposite, in non-
electrophoresis approaches using mass spectrometry as the identification technique, 
quantification tools need to be incorporated in the strategy for comparison of protein 
profiles.  Hence, several tools have been developed that allow the level of protein 
synthesis being quantified in the mass spectrometer.  For example, isotopic labeling 
has been successfully applied in various differential display studies, either in vitro77,78 
or in vivo79. 
 
Figure 10. Strategies for the analysis of protein mixtures. (A) Protein mixture can be resolved by 
two-dimensional polyacrylamide gel electrophoresis.  Prior to electrophoresis, a protein purification 
step, e.g. affinity chromatography or subcellular fractionation, can be included.  Proteins of interest 
are excised from the gel, digested to peptides, and analyzed by mass spectrometry. (B)  Separation 
of a complex protein mixture on a 1D gel will result in limited protein resolution.  The excised gel 
slice will contain multiple proteins and the peptide mixture produced from the digest will require a 
further purification step, such as high-performance liquid chromatography (HPLC). (C) In a non-
electrophoretic based strategy, the intact proteins are separated by a combination of several 
chromatographic techniques. (D) The entire complex protein mixture can also be digested to 
peptides and the peptide mixture resolved by multi-dimensional chromatography. 
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4. PROTEIN IDENTIFICATION STRATEGIES 
4.1. INTRODUCTION 
In proteomic analysis, several different techniques and methodologies are employed 
to identify the proteins in the sample.  For example, techniques using antibodies that 
recognize unique epitopes may allow protein identification. However, these 
techniques have severe limitations, such as non-specific binding, the availability of 
antibodies, and the availability of complete genome sequences. Therefore, 
techniques have been developed for the determination of the primary structure of 
proteins. To date, automated N- or C- terminal sequencing and mass spectrometry 
can be used for obtaining amino acid sequence information of proteins, and 
numerous methods are applied using one of these techniques.  However, the 
introduction of biological mass spectrometry has significantly altered the throughput 
of protein identifications and, concomitantly, the use of automated N- or C-terminal 
sequencing procedures has declined markedly.  On the other hand, it must be 
emphasized that many biological problems require knowledge of the amino- or 
carboxyl-terminus of a polypeptide and that mass spectrometric methods to assign 
the amino or the carboxyl terminus of a protein or peptide are still limited in number.  
Therefore, these techniques are still valuable in proteomics and are currently the only 
methods that allow direct confirmation of the sequence at the termini of proteins80.   
The introduction of mass spectrometry provided the necessary technological 
breakthrough, i.e. a high-throughput and sensitive technique. Several methods are 
used in proteomic analyses. The determination of the N- or C- terminus of a protein 
in 'ladder sequencing' techniques81,82, for example, is based on mass spectrometry. 
The peptide fragments are generated, each differing from the next by a single 
residue, and analyzed by MS.  Chemical procedures are mainly used in N-terminal 
approaches, while proteolytic digestion is the method of choice in C-terminal analysis 
of peptides.  These strategies are valuable, but not often routinely used in high-
throughput proteomic studies. In the next section, we will discuss the common 
protein identification methods using mass spectrometric data. 
 
4.2. PRINCIPLES 
4.2.1. PEPTIDE MASS FINGERPRINT 
The first approach for characterization of complex protein mixtures was separation by 
two-dimensional gel electrophoresis followed by in-gel tryptic digestion of visible 
protein spots and subsequent off-line analysis of each digestion mixture by MALDI 
MS (Figure 11).   
The principle of the technique is that each protein can be uniquely identified by the 
masses of its constituent peptides, this unique signature being known as the 
‘fingerprint’.  In peptide mapping, also referred to as ‘peptide mass mapping’ or 
‘peptide mass fingerprinting’ (PMF), proteins are identified by matching the list of 
observed peptide masses with a calculated list of all the expected peptide masses for 
each entry in a database.  Five laboratories83-87, independent of each other, 
simultaneously developed algorithms allowing database searching on the basis of 
peptide mass data.  Things that need to be considered for reliable protein 
identification are the quality and relative intensity of the peaks, the mass accuracy, 
and the coverage of the protein.  Generally, at least five peptide masses, accurately 
measured, should fit to allow a reliable identification.  Although the PMF technique is 
CHAPTER III                                                                                             PROFILING PROTEOMICS 
 
42 
very robust, as the masses of the intact peptides are extremely discriminatory, this 
correlative searching can fail in protein identification, or even worse, can lead to 
incorrect protein identifications.  There are several pitfalls in PMF analysis that can 
ultimately lead to false-positive protein identifications.  There may be an error in the 
sequence database, which leads to incorrect predicted masses.   Proteins might be 
post-translationally modified, or differences in mass may be the result of non-specific 
modifications introduced during sample preparation.  Moreover, several proteins exist 
as polymorphic variants, differing in only a few amino acids.  The protein may be 
non-specifically cleaved and the mass spectrum can be the result of the presence of 
multiple proteins.   The result is that PMF is generally restricted to identifying simple 
protein mixtures (one or two proteins) from microorganisms with fully sequenced 
genomes. 
 
4.2.2. PEPTIDE FRAGMENTATION FINGERPRINT 
Important information is obtained by the acquisition of an MS/MS spectrum of one or 
more peptides.  The CID spectrum provides primary structural information, which is 
not present in PMF and, therefore, protein identification is more reliable.  As peptide 
masses are a fingerprint for a protein, the set of fragment ions generated by MS/MS 
act as a fingerprint for an individual peptide. In ‘peptide fragmentation fingerprinting’ 
(PFF)88, the un-interpreted fragment ion masses are used in a correlative database 
search to identify the peptide which yields a similar fragmentation pattern under 
similar conditions (Figure 12).                                           
 
 
 
 
Figure 11. Principle of the Peptide Mass Fingerprint (PMF) method.  This method does not apply 
to complex protein mixtures, as only peptide masses are measured.  Therefore, this method is 
used for protein mixtures resolved by electrophoresis or for the identification of single proteins, 
e.g. quality control of recombinant proteins.  Because MALDI generates singly charged ions, it is 
generally used in this type of analysis. 
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Two or more peptides identified in this way are usually sufficient to unambiguously 
identify a protein.  Several algorithms have been developed, Sequest89 and Mascot90 
being the most popular. In the cross-correlation approach, Sequest, peptide 
sequences from a database are used to construct theoretical MS/MS spectra and the 
degree of overlap, the cross-correlation, between the experimental and theoretical 
MS/MS spectrum determines the best match.  The Mascot method is a probability-
based matching algorithm.  The experimentally observed peaks are compared with 
the fragment ion masses calculated from peptide sequences in the database, and a 
score is calculated that reflects the statistical significance of the match. These 
programs have one main prerequisite: the sequence, either protein or nucleotide, 
must be known.  Therefore, these database searching tools are excellent to study 
organisms of which the complete genome information is accessible. 
Advantageous to PMF, besides offering more reliable protein identification, un-
interpreted fragment ion masses may be used to search in databases that contain 
incomplete gene information (e.g. EST's), and the identification of proteins from 
complex mixtures becomes possible.  However, the algorithms used for searching 
MS/MS data are not fail-safe.  The scoring schemes used in the database search 
programs are based on a simplified representation of the peptide fragmentation 
process91,92.  Furthermore, the charge state of the precursor ion may not be known 
and many MS/MS spectra are of poor quality or are a mixture of different precursor 
ions.  On the other hand, high-quality MS/MS spectra can be incorrectly assigned if 
the peptide concerned is not in the database.  Therefore, manual verification is 
mostly required to avoid false-positive identifications. 
 
Figure 12. Principle of the Peptide Fragmentation Fingerprint (PFF) method.  A peptide is 
selected and subjected to MS/MS in the mass spectrometer.  The obtained un-interpreted MS/MS 
spectrum is compared with in silico generated MS/MS spectra.  The identified peptide is assigned 
to the protein. 
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4.2.3. PEPTIDE SEQUENCE TAG  
The obtained fragment ion spectrum can also be interpreted, either manually or 
automatically, to derive partial de novo peptide sequences93.  The extracted short, 
unambiguous section of the amino acid sequence of the peptide (the 'tag'), together 
with the measured mass of the precursor ion, is then used in standard database 
search queries.  This correlative search method is more accurate than the one 
mentioned above, because additional information is provided, i.e. the position of the 
determined amino acid sequence within the peptide sequence.  Moreover, if longer 
stretches of amino acid sequences are determined from the MS/MS spectrum, non-
correlative database searching programs, such as the BLAST94 and FASTA95 
sequence alignment tools can be brought into play to identify the peptide, and 
concomitantly the protein. The MS/MS spectra are mainly interpreted manually, 
because de novo sequencing algorithms are computationally intensive and require 
high-quality data96.  However, this is a laborious and time-consuming procedure and 
not really feasible for the analysis of huge data sets; therefore, it are PMF and PFF 
that are generally used in high-throughput proteomic studies.  
 
4.2.4. SUMMARY 
The different protein identification strategies are summarized in Table 1, together 
with some examples of common search engines. 
 
 
Table 1. Protein Identification Strategies using Mass Spectrometric Data 
 Description Comments 
Sequence 
Alignment 
A contiguous amino acid sequence stretch is used 
for protein identification. 
 
Program Name/ Web Site:  
BLAST/ http://www.ncbi.nlm.nih.gov/BLAST/ 
FASTA/ http://www2.ebi.ac.uk/fasta3/ 
 
 
Non-correlative; relative long 
amino acid sequence 
stretches needed (> 10 aa.) 
for reliable protein 
identification; proteins can 
also be identified on the 
base of homology. 
 
Peptide Mass 
Fingerprint 
(PMF) 
 
 
The observed m/z are compared with the 
theoretical fingerprint of each entry in the database  
 
Program Name/ Web Site:  
MS-FIT (part of the ProteinProspector suite of 
tools)/ http://prospector.ucsf.edu 
PeptideSearch/http://195.41.108.38 
ProteinLynx Global SERVER/ 
http://www.micromass.co.uk  
MASCOT/ http://www.matrixscience.com 
 
 
 
No primary structural 
information used 
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Table 1. Continued. 
 
Peptide 
Fragmentation 
Fingerprint 
(PFF) 
 
The experimental MS/MS spectrum is compared 
with theoretical fragment ion spectra, the 
experimental m/z is given for the precursor ion 
 
Program Name/Web Site:  
MS-TAG (part of the ProteinProspector suite of 
tools)/ http://prospector.ucsf.edu 
Sequest/http://www.thermoquest.com 
ProteinLynx Global 
SERVER/http://www.micromass.co.uk 
MASCOT/ http://www.matrixscience.com 
 
 
 
No interpretation needed, 
possible false-positive 
identifications; only MS/MS 
spectra are searched for 
precursor ions having a 
certain m/z 
Peptide 
Sequence Tag 
(PST) 
The mass of the precursor ion, together with a 
short stretch of a contiguous amino acid sequence 
are used.  The mass of the first and last fragment 
can, eventually, specified. 
 
Program Name/Web Site:  
Peptidesearch/http://195.41.108.38 
MASCOT/ http://www.matrixscience.com 
 
Accurate identification, time-
consuming; only for 
experienced users 
 
5. CONCLUSIONS 
Profiling proteomics determines the protein composition of a biological sample and 
may display the result of differential protein synthesis between samples.  The initial, 
now generally accepted 'classical' and well-established approach consists of the 
combination of two-dimensional gel electrophoresis for the separation, detection and 
quantification of the individual proteins, mass spectrometry, and database searching 
for the identification of the proteins.  However, many variations thereof, and different 
strategies, have evolved during the last decade. The technology which always recurs 
in these miscellaneous approaches is mass spectrometry.  MS based profiling 
proteomics has certainly established itself as an indispensable technology to interpret 
the information encoded in genomes.  New instruments are designed to fulfill the 
needs for automated analysis and the progress in instrumentation continues to be 
made at a fast pace.  However, it is still not possible to obtain data at a rate similar to 
that of genomics.  Therefore, we are only at the top of the iceberg and mass 
spectrometry based profiling proteomics is a nascent technology. 
Although MS is the central technique in profiling proteomics, two other elements of 
equal importance may not be lost out of sight: the ability to separate and deliver 
peptides and proteins to the mass spectrometer, and suitable software for data 
handling and for the analysis of the mass spectrometric data.  Although novel 
separation approaches, e.g. multi-dimensional liquid chromatography, provide more 
sensitivity and dynamic range than ever before, no single method replaces all other, 
previously developed strategies to date.  Hence, information obtained from different 
experiments should be gathered and confirmed by the development of novel 
approaches.  Such a platform for comparison of data between laboratories is not yet 
present and, till this stage is reached, the power of profiling proteomics is not fully 
exploited97.    
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AIMS AND RATIONALE 
 
A core component of proteomics is the ability to systematically identify every protein 
present in a cell, tissue or organism, together with the determination of other relevant 
properties, e.g. abundance.  This discipline is now commonly referred to as ‘profiling 
proteomics’ as explained in Chapter III.  The technology for such analyses integrates 
the disciplines of separation science for the separation of peptides and proteins, of 
analytical science for the identification and quantification of the analytes, and of 
bioinformatics for data management and analysis.  At the start of this work, many of 
these tools were not as mature as they are today and, moreover, the limited number 
of completed genome sequences hampered protein identification.  For sure, the 
simplest procedure to identify a protein is to subject it to proteolysis, and to record 
the mass spectrum of the resulting peptides.  The more accurate the experimentally 
determined peptide masses, the more likely the protein will be correctly identified.  
Although MALDI TOF was primarily used for the identification of 2D-PAGE separated 
proteins in the early days of profiling proteomics, peptide mass fingerprinting was 
most of the time not sufficient for accurate protein identification (Chapter III), 
especially if no sequence information is accessible. Therefore, peptide fragmentation 
information, using tandem mass spectrometry, is required for stringent protein 
identification.   
MALDI instruments with MS/MS capabilities were recently developed and, before this, 
mass spectrometers equipped with electrospray ionization sources were the solution 
for 'real' MS/MS analysis.  In order to provide us with the necessary sensitivity and 
throughput, we coupled a miniaturized, nano-HPLC system to an ESI-Q-TOF mass 
spectrometer (Chapter IV). The automated system proved to be reliable and the 
significantly reduced sample quantities allowed us to identify protein spots from a 
single 2D-gel. In this respect, it is worth mentioning that protein spots could be 
identified by homology with proteins of better characterized related organisms, 
especially those of which the genome sequences have been sequenced. This was 
important as, for example, the genome sequence of the organism under investigation 
at the start of this work, Shewanella oneidensis MR-1, was published two years 
thereafter.   
The nanoLC was coupled to the Q-TRAP LC-MS/MS system for the analysis of gel 
separated proteins when this sensitive and fast mass spectrometer was introduced in 
the laboratory at the end of 2002 (Chapter IV).  At the same time, a MALDI 
instrument with MS/MS capabilities became accessible and was used for protein 
identification (Chapter IV). Furthermore, the software delivered with these novel mass 
spectrometers also automated the process of database searching.  
The nanoLC-MS/MS was ready to be used for the identification of 2D-PAGE 
separated proteins and has been applied to two differential display studies. The first 
study fitted within a STWW program (IWT), entitled: "Shewanella putrefaciens: an 
omnipotent bacterium involved in microbial induced corrosion and bioremediation of 
dehalogenated compounds". The growth of this bacterium on a solid substrate, ferric 
oxide, has been investigated by 2D-PAGE/MS (Chapter V).  The second differential 
display study was performed in the framework of a Socrates-Erasmus program and 
examined the effect of a short-term heat shock on barley (Chapter VI).  
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The 2D-PAGE separation technique suffers from some drawbacks as outlined in 
detail in Chapter III: membrane proteins and highly basic proteins are rarely 
represented, and the technique displays limited dynamic range.  In collaboration with 
the Department of Pediatric Neurology and Metabolism (Univerity Hospital, UGent), 
we developed alternative strategies for profiling membrane proteins in order to 
provide answers to particular biological questions.   In the first project, the aim was to 
profile the different subunits of the respiratory oxidative phosphorylation system 
(Chapter VII). The complexes were separated by the technique of ‘blue-native 
polyacrylamide gel electrophoresis’ and the subunits were identified by mass 
spectrometry.  In a second project, we intended to profile the proteins present in a 
specialized membrane, the myelin sheath (Chapter VIII).  Here, the protein sample 
was digested and analyzed by a non-gel based strategy, i.e. a shotgun bottom-up 
proteomic approach using multi-dimensional liquid chromatography. We tried to 
couple nanoLC to MALDI TOF-TOF MS for the analysis of the complex peptide 
mixture. 
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CHAPTER IV 
 
IDENTIFICATION OF PROTEINS SEPARATED  
BY GEL ELECTROPHORESIS USING  
MASS SPECTROMETRY 
 
 
 
This chapter describes different mass spectrometric techniques for the identification 
of gel separated proteins, which were further used in various expression proteomic 
experiments. In particular, the hyphenation of nanoflow liquid chromatography and 
tandem mass spectrometry, which allowed the unambiguous identification of proteins, 
is highlighted. The automated nanoflow LC-MS/MS only needed limited sample 
amount of a tryptic digest mixture obtained from a single Coomassie Blue stained 
2D-spot.  The sample was loaded on the nanoflow LC column using a 
preconcentration/desalting step, and analyzed on-line by either a hybrid quadrupole 
time-of-flight or a hybrid triple quadrupole/linear ion trap mass spectrometer using an 
automated MS to MS/MS switching protocol.  The implementation of nanoflow liquid 
chromatography offers unique opportunities for automation of proteomic research.   
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1. INTRODUCTION 
Since the introduction of the term proteomics, different methodologies have been 
developed that allow global analyses of gene expression at the protein level.  The 
original papers mainly describe the analysis of differential gene expression using 
two-dimensional gel electrophoresis (2D-PAGE).  Today most protein separations in 
profiling proteomics are still accomplished by this technique.  Major advantages for a 
gel-based strategy, in comparison with other methods, are: simplicity, reliability, and 
ready accessibility.  In addition, gels allow for the visualization and selection of 
relevant proteins from a complex mixture.  Although electrophoresis provides the 
opportunity to diagnose quantitative and qualitative differences in the protein 
composition of two or more samples, even long so before gene array techniques to 
measure gene expression were conceived, the technique by itself is essentially 
descriptive and relies on the accessibility of tools for the identification of the 
separated proteins.  A key tool in this respect is mass spectrometry.  The global 
approach involves excision of the gel band of interest, in situ digestion of the proteins 
in the band using the enzyme trypsin, followed by mass spectrometric analysis of the 
peptides produced.  This chapter will deal with the mass spectrometric identification 
of gel separated proteins. 
 
2. TWO-DIMENSIONAL GEL ELECTROPHORESIS 
Two-dimensional polyacrylamide gel electrophoresis (2D-PAGE) separates proteins 
in two dimensions, as its name implies, and was originally described by Klose and 
O'Farrell1-3.  In the first dimension, proteins are separated by their isoelectric point 
(pI).  The proteins migrate through a continuous pH gradient, under the influence of 
an electric field, towards the point where their net charges are zero.  The pH gradient 
consists of a gradient of acidic and basic buffering groups (Immobilines), 
incorporated into a polyacrylamide gel, constituting an immobilized pH gradient 
(IPG)4.  Proteins, being amphoteric molecules, carry either positive, negative or zero 
net charges depending on the pH of their environment. When a protein diffuses away 
from its pI, it gains charge and migrates back. Therefore, this process is called 
‘isoelectric focusing’.  In the second dimension, proteins are separated according to 
their molecular weight (Mw) using standard sodium dodecylsulfate polyacrylamide gel 
electrophoresis (SDS-PAGE).  The technique is based on the exposure of denatured 
proteins to the detergent sodium dodecylsulfate (SDS) which binds stoichiometrically 
to the proteins and carries a negative charge. The intrinsic charge of the protein is 
masked by the SDS molecules, and proteins will therefore be separated only on the 
basis of their molecular weight in the polyacrylamide gel.   
The proteins separated in the two dimensions can be detected by various staining 
methods, using e.g. Coomassie brilliant blue, silver, or fluorescent Sypro Ruby.  The 
visualized spot displays the experimental pI and Mw of the protein and, therefore, 
provides initial information on the identity of the protein.  However, accurate protein 
identification is obtained using mass spectrometric techniques.  
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3. MASS SPECTROMETRIC ANALYSES 
3.1. NanoLC HYPHENATED TO Q-TOF MS 
 
Note: This section has been adapted from a published paper, entitled: "Automated nanoflow liquid 
chromatography/tandem mass spectrometric identification of proteins from Shewanella putrefaciens 
separated by two-dimensional polyacrylamide gel electrophoresis" (Rapid Communications in Mass 
Spectrometry 2001, 15, 50-56). 
 
The introduction5 of nano-electrospray MS has allowed MS/MS spectra to be 
obtained from sub-femtomolar amounts of material, which is within the range of the 
protein load on a 2D-PAGE experiment. The introduction of novel hybrid mass 
spectrometers has dramatically improved the quality of the MS/MS spectra of 
peptides.  The nano-electrospray method requires desalting steps to remove buffer 
salts from the sample. A convenient method to separate contaminated substances 
from the analyte is to use HPLC prior to ionization of the analyte by ESI.  A major 
advantage of ESI is that it is well suited for direct interfacing with liquid 
chromatography instrumentation, particularly of the reversed-phase HPLC-type 
where highly MS compatible solvent systems can be used6. Hyphenation of HPLC 
with ESI-MS, moreover, allows implying automation tools that are well developed 
within the chromatography field, such as autosamplers and valve switching systems.  
Furthermore, the decreasing column size used in reversed-phase HPLC has allowed 
the reduction of flow rates to 100 nl/min7.  Although this flow rate is still higher than in 
borosilicate capillary systems, it is compatible with nano-electrospray sources and it 
allows highly sensitive LC-MS analyses. The technique suffers from the absence of 
pump systems that provide stable gradients at such flow rates, but implementation of 
splitting systems in conventional HPLC largely overcomes this problem.  
In an attempt to increase automatization and sample throughput we have 
implemented a nano-HPLC system on a Q-TOF mass spectrometer.  We compare 
the output to analyses from protein spots of the same gel that had been performed 
using borosilicate nano-electrospray capillaries. 
 
'OFF-LINE' NANO-ELECTROSPRAY MS: EXPERIMENTAL 
 
Digest mixtures were washed using C18 Ziptips™ (Millipore). Prior to nano-
electrospray analysis, the adsorbed peptides were washed with 0.1% formic acid and 
then stepwise eluted using 5 µl of respectively 5%, 30% and 60% acetonitrile in water 
containing 0.1% formic acid. The 30% acetonitrile fraction was loaded into a 
borosilicate Au/Pd coated capillary (Protana), which was then placed into the 
nanospray source delivered with the Q-TOF mass spectrometer. Usually the needle 
was held at 1.3 kV, while spray formation was initially stimulated putting a low 
nitrogen pressure at the back of the capillary. Spectra were taken in the 400-2000 
mass range using 2-s scans, and accumulated over 3 min. Several manually 
selected doubly charged molecular ions were further selected for collision induced 
dissociation (CID) fragmentation using argon as the collision gas (1 bar), with the 
collision energy being set between 25 and 35 kV, depending on the peptide, and 
adjusted for optimum fragmentation.  
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'ON-LINE' NANOLC-MS: EXPERIMENTAL 
 
A commercial nano-HPLC system, i.e. an Ultimate Micro LC system combined with a 
FAMOS autosampler system (Dionex-LC Packings) was coupled to the Q-TOF mass 
spectrometer. The pump is a classical reciprocal pump system used at 150 µl/min. It 
has a built-in flow splitting system to reduce the flow rate to 100 nl/min. Essentials of 
the setup are out-lined in Figure 1 and are comparable with the design for the 
analysis of nucleosides described by Vanhoutte et al8.  
 
The samples, 4 µl of the peptide extract, were loaded onto the column (PEPMAP, 75 
µm I.D., 15 cm, Dionex-LC Packings) using an on-line preconcentration step on a 
micro precolumn (800 µm I.D., 2 mm) cartridge. This was proven to be an essential 
step for both reducing sample loading times and desalting. It should, indeed, be 
realized that loading the sample at a flow rate of 100 nl/min would significantly 
increase analysis time.  The washing step was performed using 0.1% formic acid in 
water delivered at 10 µl/min by a 130A syringe pump (Applied Biosystems). After 10 
min, valve A was switched to connect the pre-column to the separating column and 
the gradient was started. A linear gradient from 5% acetonitrile/ 0.1% formic acid in 
water to 80% acetonitrile/0.1% formic acid in water over a period of 50 min was 
applied. The column was connected to the UV detector, equipped with a U shaped-
cell, and directly linked, via a 20 µm I.D. fused silica capillary, to a nano-LC 
electrospray device developed in the laboratory, using PTFE sleeves (Figure 2).  This 
device holds a New Objective PicoTip needle (Woburn), which is an Au-Pd coated 
nano electrospray needle with a 10µm tip. The instrument was set to perform a MS 
survey scan of 2 s with m/z values of 400-1500.  Any peak with a threshold of 100 
counts/s was automatically detected and selected by the quadrupole for 
fragmentation. The collision gas was argon (1 bar) and the collision energy was kept 
at 40 V. The scan time was 1 s, with m/z ranging from 50 to 2000. The instrument 
was used in the positive ion mode and calibrated prior to analysis using horse 
myoglobin. 
 
Figure 1. Setup of the nanoflow HPLC system. 
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RESULTS 
 
The results for two individual spots, analyzed via either the nano-ESI system using 
borosilicate capillaries or the nanoflow LC-MS/MS strategy, are presented. The spots 
were excised from a 2D-PAGE gel obtained from a total protein extract of the 
bacterium Shewanella oneidensis MR-1. Spot 1 was analyzed via nano-electrospray 
analysis using borosilicate glass capillaries ('off-line'). A few molecular ions were 
observed, and Figure 3 shows the MS/MS spectrum of the peptide with a molecular 
ion at m/z 867.4. This value was easily recognized as a doubly charged ion by the 
0.5 m/z separation of the individual isotopes. A partial sequence was easily read from 
this spectrum, assuming that the larger ions were y"-type ions, as we readily observe 
in the Q-TOF MS/MS spectra of tryptic peptides.  
 
Figure 4A shows the base peak intensity (BPI) chromatogram of the LC-MS analysis 
('on-line') of the tryptic digest mixture generated from spot 2. Figure 4B shows the 
MS/MS spectra of two individual peaks, indicated on the chromatogram, generated 
after automated peak detection.  
Figure 2. Interface adapted for on-line nanoLC-MS/MS analyses. 
Figure 3. MS/MS spectrum of the 867.4 m/z peptide ion obtained by nano-ESI-MS 
from a tryptic digestion of spot 1.  The amino acid deduced from the spectrum is 
VLGAAGGIQALGALLLK, which readily identified the protein spot as malate 
dehydrogenase. 
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Figure 4. (A) Base peak intensity chromatogram of the nanoflow HPLC-MS/MS separation of the 
tryptic digestion of spot 2. (B) MS/MS spectra of the peak eluting at 37.00 min; the deduced partial 
sequence is IALVEGGEAQ. (top) MS/MS spectra of the peak eluting at 39.13 min; the partial 
sequence which can be determined is PLNEVTL (bottom). These sequences identified the protein 
spot unambiguously as a molybdate binding protein from Shewanella oneidensis.  
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DISCUSSION 
 
While the 'off-line' nano-electrospray MS strategy clearly allowed the identification of 
different individual spots, this technique is marginally suitable for high throughput 
analyses. The borosilicate capillary system is difficult to include in an automated 
system, not only because the fragility of the tips makes handling in a robotic system 
rather tricky, but also because a preliminary desalting step, e.g. using the widely 
used Ziptips™, is necessary.  
We previously attempted to analyze similar tryptic digests using capillary LC-MS/MS, 
implementing columns with internal diameters of 300 µm that are used at a normal 
electrospray ionization flow rate of 6 µl/min. The sensitivity of such a system, 
routinely in the 5-10 pmol range9, is too limited to obtain sequence information from a 
2D-PAGE experiment. The protein load on a Coomassie Blue R-250 stained spot is 
approximately 0.1-1 µg, which, for a 50 kDa protein, means 2-20 pmol. Taking into 
account the limited yield of in-gel digestion, we therefore were working near the 
detection limits of that system. Employing the methodology here described, we use 
limited sample amounts, suggesting that the sensitivity of our system is compatible 
with more sensitive staining methods, e.g. colloidal Coomassie or silver.  
The analysis of spot 2 demonstrates that nanoflow LC-MS/MS analysis provides 
similar MS/MS spectra to those obtained from nano-ESI-MS. The Famos 
autosampler makes the analysis of several consecutive spot digestion mixtures 
possible, allowing the identification of some 20 proteins per day. The use of the 
precolumn concentration step was found to be essential to reduce cycle times: 
injection of 4 µl would have taken at least 40 min at the flow rate used. Furthermore, 
the nanoLC-MS interface proved to be reliable, in contrast to connections using zero-
dead volume unions, and provides a stable spray. Generally, over 40 runs can be 
performed without replacing any component without loss of sensitivity  
 
3.2. NanoLC HYPHENATED TO Q-TRAP MS 
The same nano-HPLC system, with identical empirical conditions, was used as 
described above (3.1.). The outlet of the HPLC system was connected to a New 
Objective PicoTip needle (10 µm tip), using PTFE sleeves. Data were acquired 
during the chromatographic run by the hybrid triple quadrupole/linear ion trap 
instrument using ‘Information Dependent Acquisition’ (IDA). In the IDA experiment, 
an automated MS to MS/MS switching protocol was used for LC-MS/MS analysis of 
the peptides.  First, an enhanced MS scan as survey scan (m/z 400–1500) was 
performed followed by an enhanced resolution scan of the two most intense ions. If 
their charge state was +2 or +3, an enhanced product ion scan (MS/MS) of these 
ions was carried out. The total cycle time of this setup was approximately 4.5 s.  If an 
ion was detected twice in an enhanced resolution scan, it was automatically 
‘excluded’ by the software during 300 s so as to obtain as much information as 
possible.  In product ion scanning, the scan speed was set to 4000 Da/s, with Q0-
trapping being activated.  The collision energy and excitation energy was compound 
dependent. Excitation time was 100 ms and the trap fill-time was 20 ms in the MS-
scan mode and 200 ms in the MS/MS-scan mode. For operation in the MS/MS mode, 
the resolution of Q1 was set to “low”, so that all isotopes of a particular precursor 
were transmitted. In the enhanced resolution mode the LIT was scanning at 250 Da/s 
and the ion of interest (± 15 Da) was selected in Q1. The needle voltage was set at 
1800 V and nitrogen was used as curtain (value of 20) and collision gas (set to high). 
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Nebulizer and heater gas were both set to zero. The declustering potential was at 35 
V to minimize in-source fragmentation. 
In Figure 5A, the TIC chromatogram of the tryptic digest of a 2D spot, after LC 
separation, is shown.  The spot was excised from a 2D-PAGE gel of a total protein 
extract from barley. In Figure 5B and 5C, MS/MS spectra of two of the tryptic 
peptides from the same spot (retention times: 28.94 min and 28.23 min) are shown. 
Figure 5. (A) TIC chromatogram, after 
nanoLC separation, from a tryptic 
digest. (B) A typical MS/MS spectrum 
of peak 1277.66Da, obtained via the 
LC-MS/MS system.  (C)  MS/MS 
spectrum of another peptide, 
1307.6Da, in the same peptide mixture.  
The deduced amino acid sequences 
from the two spectra are indicated. 
(A) 
(B) 
(C) 
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3.3. MALDI TOF-TOF MASS SPECTROMETRY 
Recent developments in MALDI technology, implementing this fast and sensitive 
ionization method on typical tandem mass spectrometric platforms (Ion trap, Q-TOF), 
have enabled accurate protein identification in one single step.   The MALDI TOF-
TOF MS10,11 (Applied Biosystems) uses a first time-of-flight tube for the selection of a 
parent ion that is focused into a gas cell, where it is fragmented using collision 
induced dissociation. After reaccelerating, the m/z of the fragments is determined in a 
second reflector TOF tube. Collision energy in the TOF-TOF is defined by the 
potential difference between the source acceleration voltage and the floating collision 
cell (1–2 kV).  
In Figure 6A, a typical MS spectrum of a peptide mixture obtained from an in situ 
tryptic digest of a 2D spot, is shown; the resolution is typically 12 000–20 000 (full 
width half maximum). The peptide with mass 1864.99 Da, labeled by an asterisk, was 
further subjected to MS/MS. The voltage applied to the target plate was 8 kV and the 
CID cell was maintained at 7 kV, which produces peptides with an energy of 
approximately 1 keV. For fragmentation of the peptide, air was introduced in the cell 
and kept at 10-6 Torr. The MS/MS spectrum obtained is shown in Figure 6B.   
Maintaining the CID cell at 6 kV in the MS/MS mode generates peptides with energy 
of approximately 2 keV. A typical example of such an MS/MS spectrum is shown in 
Figure 7A. The advantage of this mode of analysis, besides obtaining numerous 
internal fragment ions that provide information on the amino acid composition of the 
Figure 6. (A) A typical MS spectrum obtained from the tryptic digest of a 2D-gel spot.  The 2D-
PAGE gel was obtained by the separation of a soluble protein extract from Shewanella oneidensis 
MR-1.  Using peptide mass fingerprint analysis, we could identify this protein as the aerobic 
respiration control protein (ArcA).  All masses matched the theoretical calculated values within 50 
ppm. (B) MALDI TOF-TOF CID spectrum obtained at 1kV, from the peak labeled (*) in A.  Beside 
numerous ion fragments, most y-ions are present.  Performing a MS/MS ion search identified this 
protein unambiguously as ArcA.  
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peptide, is the presence of side-chain fragmentation ions. For example, the formation 
of w-type ions allows us to distinguish the isobaric amino acids isoleucine and 
leucine, as shown in Figure 7B. The formation of these ions, typical of the 2 keV 
TOF-TOF fragmentation, will certainly be advantageous in protein identification tools, 
but are not yet implemented in most database searching programs.  Advantageous to 
the MALDI TOF-TOF system are, beside low sample consumption, minimized sample 
preparation, which is time-saving because additional LC-MS/MS analysis can be 
omitted.  
 
 
 
 
 
 
 
Figure 7. (A) MALDI TOF-TOF CID spectrum obtained after calibration, in the 2kV mode, 
from the peak labeled * in Figure 6A.  Due to the higher energy used, more ion fragments 
are now present. They are mostly high-energy side-chain fragmentation ions, of the w-
type, and internal fragments. (B) Detail of the m/z 600-1300 from Figure 6B (upper trace) 
and Figure 7A (lower trace).  Note the presence of the w9a- and w9b-ions in the lower 
trace (2kV mode), due to the presence of an isoleucine instead of a leucine in the amino 
acid sequence of this peptide. 
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4. CONCLUSIONS 
We have shown that the implementation of a commercial nano-HPLC system, linked 
to a tandem mass spectrometer that permits an automated MS to MS/MS switching 
routine, has provided us with a robust, powerful hyphenated technique for the 
unambiguous identification of 2D-gel separated proteins.  Moreover, a high degree of 
automation is obtained using this setup, and multiple proteins can now be identified 
in a day, with minor interference of the analyst.  The introduction of two mass 
spectrometers in the laboratory in 2002, a Q-Trap LC-MS/MS system and a 4700 
Proteomics Analyzer, has not only increased the throughput of identification, but also 
facilitated accurate protein identification.  The former, as the Q-TOF MS, has been 
coupled to the nano-HPLC system, while the latter is an easy-to-use MALDI 
instrument which allows acquiring high quality MS and MS/MS spectra.  When using 
this spectrometer, minimized sample handling and the speed of analysis are major 
improvements in the protein identification strategy. 
The above described tools, nanoLC-MS/MS and MALDI TOF/TOF MS, have been 
used for the analysis and identification of protein spots, and we have implemented 
them in two expression proteomic experiments (Chapters V and VI).    
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CHAPTER V: 
 
SHEWANELLA ONEIDENSIS MR-1: 
A DISSIMILATORY IRON-REDUCING BACTERIUM 
 
 
 
Shewanella oneidensis MR-1, a gram-negative facultative aerobic bacterium, lives at 
oxic-anoxic interfaces in nature and is able to use a plasticity of terminal electron-
acceptors. Remarkable is the reduction of metals and, therefore, the interest in this 
microorganism not only stems from its importance in geochemistry, but also from 
practical applications, such as bioremediation of contaminated environments.   
However, the genetic basis and regulation for these respiration processes in 
Shewanella remain vague, despite extensive research.  In this chapter, we will 
discuss metal reduction by this microorganism. Furthermore, the results obtained by 
an expression profiling proteomic study using 2D-PAGE and mass spectrometry, in 
relation to ferric iron reduction, will be presented. 
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1. INTRODUCTION 
Over 3.5 billion years ago, the first respiratory processes evolved in the reducing 
environment of early Earth, and would possibly have utilized either Fe(III) or S(0) as 
electron acceptors1.  Although the ability of microorganisms to reduce ferric iron is 
already known since the beginning of the 20th century, the capacity to conserve 
energy to support growth via the oxidation of hydrogen or organic compounds was 
only discovered two decades ago.  Since then, the interest in dissimilatory iron 
reduction has considerably increased.   Shewanella oneidensis and Geobacter 
metallidurans were the first organisms explicitly shown to conserve energy for growth 
through the reduction of Fe(III)2-4. Since then, many species of Archea and Bacteria 
have been shown to be capable of growing with ferric iron as the sole electron 
acceptor.  However, research has been mainly focused to a few bacteria, and for the 
moment, the best characterized Fe(III)-respiring bacteria are members of the genus 
Shewanella and Geobacter.   
The Shewanella is an interesting group of microorganisms and the great diversity of 
biological phenomena with which Shewanella is associated, is remarkable. For 
example, Shewanella species have been shown to be involved in metal-reduction5, 
dehalogenation of small halo-alkane compounds6,7, formation of biofilm8,9, corrosion 
phenomena10 and even isolated cases of infections11,12.  Moreover, Shewanella 
oneidensis has been shown to have a rich repertoire of respiratory pathways leading 
to the reduction of over 20 electron-accepting compounds.  This makes Shewanella 
oneidensis a model organism in studies of energy metabolism and of bioremediation 
and resulted in the foundation of a multiinstitutional consortium, the Shewanella 
Federation, funded by the U.S. Department of Energy13-15.   
The genome of Shewanella oneidensis has been sequenced, annotated16 and 
reannotated17, and the current estimate includes 4.467 predicted genes, 1.623 of 
which are annotated as hypothetical (36%)18,19. The availability of the genomic 
sequence makes large-scale analyses, such as proteomic and microarray 
technologies, feasible. Hence, we started a proteomic study of this remarkable 
species, with emphasis on metal reduction.  The expression levels of proteins under 
different growth conditions were monitored by 2D-PAGE and the interesting spots 
identified by mass spectrometry.  The results from this differential display study will 
be presented in this chapter but first, we give a brief biochemical and physiological 
overview of dissimilatory iron reduction.    
 
2. SHEWANELLA ONEIDENSIS: A VERSATILE ORGANISM 
Members of the genus Shewanella are gram-negative facultative aerobic γ-
proteobacteria.  Shewanella contains diverse species occupying a wide range of 
habitats20,21 , including marine and freshwater sediments, the deep sea and oil brines.  
For example, Shewanella species have been isolated from Antarctic sea ice22, the 
Baltic Sea23 and the Amazon River24.  The first Shewanella species, Achromobacter 
putrefaciens25, was isolated out of sour butter in 1931, and the name of the genus 
changed from Pseudomonas26 (1960), to Alteromonas27 (1977), into Shewanella28 
(1985).  Shewanella oneidensis MR-1, formerly known as Shewanella putrefaciens 
MR-129, was isolated from the Oneida Lake (USA)30 and found to be able to reduce 
iron and manganese31.  To date, it is known that the strain MR-1 is able to “eat” and 
“breathe” many soluble or insoluble organic (fumarate, dimethylsulfoxide, 
trimethylamine-N-oxide and humic substances) and inorganic compounds (nitrate, 
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nitrite, thiosulphate and sulphite)32, and therefore, plays an important role in 
geochemical processes33.  In addition, a variety of toxic metals can be reduced, such 
as chromium34 and uranium35,36.  The remarkable diverse respiratory capacities 
pitchfork S. oneidensis MR-1 into a metabolically versatile organism and a model 
organism for studying dissimilatory reduction. 
The directed or spontaneous activity in which microbiological processes are used to 
degrade or transform contaminants into less toxic or non-toxic forms is microbial 
bioremediation. S. oneidensis may be useful in bioremediation.  The reduction from 
the dissolved liquid state of toxic metals into insoluble oxides by this organism, for 
example, can facilitate the removal of dilute metal pollutants in both contained-
storage and natural sites. Additionally, S. oneidensis can produce sulphide from 
either elemental sulphur or thiosulphate37, which can be used to immobilize toxic 
metals through the formation of insoluble metal sulphides. However, it is important to 
consider that the activities of such metal-reducing bacteria can also have negative 
effects.  Many organic pollutants are strongly bound to iron and manganese oxides, 
and when such oxides are reduced, the pollutants are solubilized.  It is therefore 
essential to understand the biochemical pathways used for metal-reduction and for 
degradation of organic pollutants in this organism, before considering environmental 
bioremediation processes.  
 
3. DISSIMILATORY Fe(III)-REDUCTION 
3.1. INTRODUCTION 
Iron, the most abundant transition metal on earth, can be found abundantly in soil 
and sediments or as trace element in aquatic habitats.  While stable under anaerobic 
or acidic conditions, Fe(II) oxidizes chemically to Fe(III) under aerobic conditions, 
which readily react in moist environments to form hydroxide, oxide, phosphates or 
sulphate precipitates with very low solubility.  Therefore, environments apparently 
rich in iron actually contain a limited concentration of free iron (<1µM).  The 
availability of Fe(III) may be increased in environments rich in organic compounds, 
such as humic substances, which can chelate the metal ion.  The chelator, e.g. 
citrate, may be specially synthesized by the microorganism, which makes the metal 
more accessible for reduction and/or cellular uptake38.  A variety of microorganisms 
can reduce ferric iron (Fe3+) to the ferrous (Fe2+) state.  The reduction potential of the 
Fe(III)/Fe(II) couple is very positive (E0'=0.77 V at pH 2, E0'= 0.2 V at pH 7), and 
because of this, Fe(III) reduction can be coupled to the oxidation of a wide variety of 
both organic and inorganic electron donors.  Various organic compounds including 
aromatic compounds can be oxidized anaerobically by ferric iron reducers with 
electrons traveling through an electron transport chain.  Such electron flow 
establishes a proton gradient that can be dissipated to generate ATP.  The reduction 
process, which uses inorganic compounds as electron acceptor in the energy 
metabolism is called ‘dissimilative’ metabolism39.  
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3.2. MECHANISMS FOR DISSIMILATORY IRON REDUCTION 
3.2.1. STRATEGIES FOR Fe(III) OXIDE REDUCTION 
Fe(III) is highly insoluble in most environments at circumneutral pH, unlike other 
commonly considered electron acceptors, e.g. oxygen, sulfate, nitrate or carbon 
dioxide.  Soluble electron acceptors can freely diffuse into cells, whereas Fe(III)-
reducers face the challenge of how to transfer electrons onto an insoluble, 
extracellular, electron acceptor. It was originally considered that, in order to transfer 
electrons from the cell to the Fe(III) oxide surface, Fe(III)-reducing microorganisms 
established a direct contact with the mineral. However, studies40 have demonstrated 
alternative pathways in which bacteria release electron shuttling compounds and 
Fe(III) chelators and thus do not need this physical contact. For example, mutant 
analysis showed the involvement of an enzyme required for the synthesis of 
menaquinone41, an isoprenoid quinone compound that can participate in the transfer 
of electrons to low-potential electron acceptors, as occurs in photosynthesis. These 
small, mobile organic molecules, e.g. humic substances or quinones, may play a key 
role in this mechanism42.  Although the compound(s) responsible for electron 
shuttling in these studies remain to be identified, melanin was shown to serve as a 
soluble electron shuttle to promote Fe(III) oxide reduction in Shewanella algae43,44.  
Further evidence for Shewanella species reducing Fe(III) via soluble electron shuttles 
was provided by the observation that Fe(III) oxides can be reduced at locations that 
are at significant distances from where the cells are attached45.  The possible 
strategies for microbial reduction of Fe(III) in sedimentary environments are 
summarized in Figure 1. 
 
 
Figure 1. Strategies for Fe(III) oxide reduction. (A) The reduction of Fe(III) oxide via direct 
contact between an Fe(III)-reducing bacterium and the mineral. (B) Fe(III) reduction via 
electron shuttling with soluble humic substances. (C) Fe (III) reduction in the presence of 
soluble Fe(III). (D) Fe(III) reduction via electron shuttles produced by the bacterium. 
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3.2.2. MODEL FOR ELECTRON TRANSFER 
Electrons need to be transferred from the central metabolism to the site of reduction 
somewhere outside the inner membrane, whether soluble Fe(III), insoluble Fe(III) 
oxides or electron-shuttling quinones are reduced by dissimilatory Fe(III)-reducing 
microorganisms.  The reduction of Fe(III) is likely to take place either in the periplasm, 
for soluble Fe(III), or at the surface of the outer membrane.  Remarkably, 
phylogenetically distinct Fe(III) reducers appear to have different strategies for 
transferring electrons onto Fe(III) oxides.  In Geobacter and Shewanella species for 
example, the proteins involved in electron transfer to the periplasm and the outer 
membrane are similar in function, but not closely related.  This may suggest that 
strategies for dissimilatory Fe(III) reduction have evolved independently several 
times46.  It is generally considered that electron transfer proteins, or quinones in the 
inner membrane, transfer electrons to electron transfer proteins in the periplasm, 
primarily c-type cytochromes. The electrons are then passed on to other c-type 
cytochromes in the outer membrane, which transfer the electrons directly to Fe(III) or 
to soluble electron shuttling compounds.  There have been many detailed genetic 
investigations into specific proteins involved in Fe(III) reduction in Shewanella 
species.  However, in many studies it is difficult to assign the true role of these 
proteins in Fe(III) oxide reduction.  Shewanella species appear to be specially 
adapted to carry out the reduction of extracellular electron acceptors.  The specific 
localization of c-type cytochromes to the outer membrane in anaerobically grown 
cells47,48 and the localization of a Fe(III) reductase activity in the membrane 
fraction49,50 are striking examples.  The important components that were 
characterized in Shewanella species, in relation to Fe(III) reduction are summarized 
in Table 1. 
 
 
Table 1. Summary of Important Proteins from Shewanella oneidensis MR-1 Characterized and shown 
to be Involved in Fe(III) reduction 
Protein Structure/Location Function Comments 
CymA - a tetraheme c-type 
cytochrome (±21kDa) 
associated with the inner 
membrane and periplasmic 
fraction51,52 
 
- transfers electrons from the 
inner membrane to electron 
carriers or acceptors in the 
periplasm53,54 
 
- similar cytochrome 
present in S. 
frigidimarina55 
MtrA - a decaheme c-type 
cytochrome (32kDa) 
presumably located in the 
periplasm56,57 
- accepts electrons from CymA 
and transfers these electrons to 
an acceptor in the outer 
membrane or may directly 
reduce soluble Fe(III) entering 
the periplasm 
 
- part of an operon 
which includes mtrA, 
mtrB and mtrC 
cytochrome 
c3 
- periplasmic tetraheme c-
type cytochrome 
- reduction of soluble Fe(III) in S. 
frigidimarina58 
- may serve as an electron 
shuttle in periplasm 
- knock out mutants 
show reduced 
capacity for Fe(III) 
citrate reduction 
- similar cytochrome 
present in S. 
oneidensis59 
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Table 1. Continued. 
MtrB - outer membrane protein 
(76kDa) 60 
- apparent metal binding 
motif (CXXC) 
- requires the humic acid analog, 
anthraquinone-2,6-disulfonate, 
for the reduction of Fe(III)61 
- required for proper localization 
of OmcA and OmcB to the outer 
membrane62 
 
 
OmcA - decaheme c-type 
cytochrome (±83kDa) 
present in the outer 
membrane (83kDa)63 
-exposed to the outer 
surface64 
- mutant still able to reduce 
Fe(III) oxide but displays lower 
rate of Mn(IV) reduction65 
- overexpression of omcB 
compensates for the lower rate 
of reduction66 
 
- most abundant 
cytochrome in the 
outer membrane 
- contradictory 
statements in 
literature67 
OmcB - decaheme c-type 
cytochrome (±75kDa) 
present in the outer 
membrane 
- involved in electron transfer to 
Mn(IV) 
- role in Fe(III) uncertain 
- previously known 
as mtrC 
- contradictory 
statements in 
literature 
 
 
3.3. CONCLUSIONS 
Based on all available information, a model for the electron transfer mechanism can 
be constructed (Figure 2).  However, the model is still developing and far from 
complete.  For sure, quinones are intermediates that are reduced by a 
dehydrogenase and, in turn, CymA oxidizes the quinone pool.  Yet, from that point on, 
the further exact electron transfer pathway is not known.  Whether CymA 'presents' 
the electrons to electron shuttling proteins or periplasmic reductases and whether the 
interaction is temporarily or permanent, is still unclear.  The electrons are then 
transferred, from either the small cytochromes or periplasmic reductase, to the 
decahaem outer membrane cytochromes.  Again, the precise transfer of electrons is 
unknown and whether these proteins are terminal reductases and form an enzyme 
complex, as generally expected, remains to be established.  Moreover, the presence 
of 39 c-type cytochromes, of which 32 were previously unidentified as revealed by 
the recently published genome sequence68, shows the enormous task to unravel and 
pinpoint the function of every component in its electron-shuttling pathway.  Hence, 
further investigations on the role of these proteins, and detailed studies on the above 
described components, will certainly complete the developing model.  
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4. PROTEOMIC ANALYSIS OF SHEWANELLA ONEIDENSIS 
MR-1 
 
Note: This section has been adapted from the paper, entitled: " Proteomics of the dissimilatory iron-
reducing bacterium Shewanella oneidensis MR-1, using a matrix-assisted laser desorption/ionization 
tandem-time of flight mass spectrometer". Details on the experimental procedures are provided in 
appendix A.  (Proteomics 2003, 3, 2249-2257) 
 
4.1. INTRODUCTION  
In the last couple of years, much research has been focused on the role of the 
electron transport components involved in metal reduction in Shewanella species and 
also in other dissimilatory iron-reducing bacteria, such as Geobacter species.  As 
much of the attention went to the electron transfer pathway, it is not surprising that 
little is known about the regulation of anaerobic respiration in Shewanella species.   
The extraordinary wide array of anaerobic electron acceptors that can be utilized 
suggest a sophisticated regulatory network that modulates the expression of genes 
involved in their reduction.  
Notwithstanding little is known about regulation of anaerobic metabolism in S. 
oneidensis, it is clearly different from the Escherichia coli paradigm. Mutants lacking 
the cyclic AMP receptor protein in S. oneidensis are defective in utilizing several 
anaerobic electron acceptors, suggesting that this protein plays a role in regulating 
anaerobic respiration, but it is unclear whether this is a direct or indirect effect69. The 
possible involvement of the electron transport regulator EtrA, a homologue of Fnr 
(fumarate nitrate regulator) which is responsible for the regulation of gene expression 
under anaerobic conditions in Escherichia coli, was shown by mutational analysis, 
although no significant phenotype was apparent70,71. Another regulatory protein, the 
Figure 2. Summary of components suggested to be 
involved in electron transfer to Fe (III) oxides in 
Shewanella species. Adapted from reference 46. 
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ferric uptake regulator (Fur), has been reported to be involved in energy metabolism, 
transcriptional regulation, and oxidative stress72. The regulatory mechanism involved 
in trimethylamine N-oxide (TMAO) reduction in S. oneidensis MR-1 has also been 
described recently73. In the absence of oxygen, autophosphorylation of TorS results 
in the transphosphorylation of the DNA-binding protein TorR, inducing the synthesis 
of the TMAO reducing enzymes. This pathway of events may simultaneously be 
responsible for the down-regulation of proteins expressed in other respiratory 
processes, such as fumarate reductase74. Despite these efforts, many questions 
remain unanswered concerning the electron transport pathway and its regulation 
under different conditions.  
Proteomics is a useful tool to achieve a more comprehensive and accurate 
annotation of a genome sequence. For example, several parallel proteomic 
approaches have been used to experimentally evaluate the expression of annotated 
and hypothetical genes in Shewanella oneidensis MR-175,76. In a different study, the 
biochemical processes associated with Fe(III)-respiration were investigated77. The 
authors mainly focused on the differential analysis of aerobically versus anaerobically 
grown bacteria. 
In the present study, we attempted to analyze differential displayed proteins isolated 
from bacteria grown anaerobically on fumarate and on ferric oxide in order to identify 
proteins that are specifically expressed upon anaerobic growth on metals. A better 
understanding of how S. oneidensis MR-1 regulates the expression of its various 
respiratory systems will not only improve the insight of how bacteria adapt to 
changing environmental conditions, but has the potential to be useful in the design of 
appropriate strategies to stimulate its respiratory activity for the purpose of 
bioremediation.   
 
4.2. RESULTS AND DISCUSSION  
4.2.1. BACTERIAL GROWTH AND 2D-PAGE ANALYSIS  
In a preliminary study, we supplemented the growth medium with Fe(III)-citrate.  The 
2D-PAGE gels for Shewanella oneidensis MR-1 grown on a control medium and on 
ferric citrate are shown in Figure 3.  Although several differential displayed proteins 
were observed, the results we obtained by this approach were not reproducible.  In a 
later report78, it was suggested that the introduction of a chelator, such as citrate, 
changes the solubility and the accessibility of iron and that, therefore, this system can 
react unspecifically with any electron-accepting biological system. Moreover, 
chelated Fe(III) may enter the periplasm prior to reduction79,80 and thus be reduced 
by electron transfer components that are not directly involved in the reduction of 
Fe(III) oxides.  Besides this, most iron chelators are not present as such in the 
environment; hence, the choice of ferric citrate leads to somewhat artificial growth 
conditions. 
Since S. oneidensis MR-1 is able to reduce iron(III) oxides to soluble derivatives81, 
we added ferric oxide to the broth medium. The use of this insoluble compound 
results in a ‘biofilm’-like way of growth, aside to planktonic growth. To reduce the 
presence of the latter in both conditions, cultures were not shaken during growth in 
the anaerobic chamber. Cultures of S. oneidensis MR-1 were grown on fumarate or 
ferric oxide as electron acceptor. For statistical analysis, the experiment was 
repeated five times for both conditions. After centrifugation and protein extraction of 
each culture, a 2D-map of each condition was obtained. A typical 2D-gel pattern of 
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the soluble protein fraction obtained from both growth conditions, after CBB G-250 
staining, is presented in Figure 4. We detected approximately 350 to 400 proteins 
on each 2D-gel.  The reproducibility of the 2D-gels was high, although some 
variations were observed. All gels were matched with a similarity of more than 80%, 
as verified by scatter plots. A replicate group was created for each condition and 
the reliability was good, as shown by the mean coefficient of variations (CV, 20%). 
Spot lists, generated by the PDQuest software were compared. A comparison of 
the relative integrated densities averaged from three to five replicate gels was 
performed, and only proteins with at least a two-fold increase in density ratio and 
with statistical relevance (P < 0.05) were submitted for further analysis. These spots 
were numbered and are indicated in Figure 4 and listed in Table 2.  
 
 
 
 
 
 
 
Figure 3. (Upper left) 2D-PAGE obtained after lysis of Shewanella oneidensis MR-1 
cultures grown on a minimal medium supplemented with 20mM lactate and 20mM 
fumarate.  (Bottom left) Detailed picture of the 2D-PAGE gel from the region indicated by 
the box in the figure above. (Upper right) Similar as left, but Shewanella oneidensis MR-1 
cultures were grown on a minimal medium supplemented with 20mM lactate and 10mM 
Fe(III)-citrate as electron-acceptor. (Bottom right) Detailed picture of the 2D-PAGE gel 
from the region indicated by the box in the figure above.  The arrows point to examples of 
differentially displayed proteins. 
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Table 2A. Proteins Displaying Significant Increased Abundance upon Growth on Fumarate 
compared to Growth on Fe2O3. 
Spota Accession no.b Protein namec Mass 
(kDa) 
pI 
 
Density 
ratiod 
1e 24371815 EF-Tu 43.3 5.20 6.58 
2 24375418 Ribosomal Protein S6 15.0 5.34 3.88 
3 24371820 Ribosomal Protein L10 17.7 9.35 3.71 
4 24373064 Alcohol Dehydrogenase II 40.0 5.98 2.67 
5 24372557 Fumarate Reductase 62.4 7.73 4.31 
6 24372002 Thioredoxin 1 11.9 4.56 3.66 
7 24376191 Conserved Hypothetical Protein 29.3 6.90 4.45 
8 24373389 Conserved Hypothetical Protein 24.9 4.83 2.85 
9 24373389 Conserved Hypothetical Protein 24.9 4.83 3.48 
10 24375259 Conserved Hypothetical Protein 25.4 6.78 2.07 
Table 2B. Proteins Displaying Significant Increased Abundance upon Growth on Fe203 
compared to Growth on Fumarate. 
Spota Accession no.b Protein namec Mass 
(kDa) 
pI 
 
Density 
ratiod 
11 24375475 Aerobic Respiration Control 
Protein 
27.2 5.66 2.80 
12 24375475 Aerobic Respiration Control 
Protein 
27.2 5.66 2.16 
13 24376142 Enhancing Lycopene 
Biosynthesis 
23.1 6.16 3.71 
Figure 4. Coomassie G-250 stained 2D-PAGE gels of the soluble protein extract of cultures grown 
in: (A) LB medium and 20mM lactate and 20mM fumarate, or (B) LB medium supplemented with 
20 mM lactate and 1.6 g/L Fe2O3. Protein spots displaying significant quantitative differences 
(P<0.05) are numbered. 
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Table 2B. Continued. 
14 24375802 Agglutination Protein 52.3 5.21 3.72 
15 24375212 Oxygen-insensitive NAD(P)H 
Nitroreductase 
24.2 6.56 4.18 
16e 24373949 Ribosomal protein S1 61.2 4.94 15.22 
17e 24372709 Chaperone Protein DnaK 68.8 4.78 > 20 
18 24373892 Glyceraldehyde-3-Phosphate 
Dehydrogenase 
36.5 6.14 2.85 
19 24375619 Uridine Phosphorylase 26.8 5.34 2.49 
20 24373581 Adenylate Kinase 23.1 5.77 2.22 
      
a) The numbers refer to the spot numbers as given in Figure 4. 
b) Protein entry code of NCBI (National Center for Biotechnology Information): 
http://www.ncbi.nlm.nih.gov 
c) The sequence annotation was used as provided by The Institute of Genomic Research 
(http://www.tigr.org). 
d) The relative averaged integrated density values from three to five replicate 2D-PAGE gels 
were compared by determining the ratio of protein abundance under Fe(III)-reducing 
conditions to that upon growth on fumarate.  Only proteins with at least p < 0.05 were 
considered to differ significantly in abundance. 
e) Protein spots have been analyzed and identified using the nanoLC-MS/MS experimental 
setup. 
 
4.2.2. DIFFERENTIALLY DISPLAYED PROTEINS  
Proteins showing an increased abundance under fumarate respiring conditions 
compared to ferric oxide respiring counterparts are listed in Table 2A. They can be 
subdivided in three categories: those associated with protein translation, with 
fumarate respiration, and a number of conserved hypothetical proteins. The soluble 
flavoprotein fumarate reductase has been recognized as the major terminal electron 
acceptor for growth on fumarate in Shewanella species, and is well characterized at 
the enzymatic and structural level. This result is consistent with its generally accepted 
role as the terminal electron acceptor in fumarate respiration82. We identified also a 
thioredoxin homologous protein, a thiol-disulfide oxidoreductase that plays a role in 
the maintenance of the cellular redox balance. As to the set of conserved 
hypothetical proteins, it is at present impossible to assign a specific role for any of 
them. Only for the protein with accession number 24376191 (see Table 2A), a strong 
similarity with an existing protein family could be demonstrated. It belongs to the 
group of periplasmic ligand binding proteins and shows the highest similarity to an 
ABC-type molybdate transporter.  
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The proteins up-regulated upon growth on Fe2O3, compared to fumarate respiration, 
are listed in Table 2B. Increased protein synthesis was detected for ArcA (Figure 5), 
a highly conserved protein in Shewanella species83, and known in E. coli as a DNA 
binding protein with a function as global anaerobic regulator84. This regulatory protein 
participates in a two-component system, ArcA/ArcB85, which partially overlaps the 
FNR regulon86. The ArcB is the transmembrane sensor that detects the presence of 
a signal while ArcA is the response regulator that, once phosphorylated by ArcB87, 
becomes competent to bind DNA88,89. The ArcB protein belongs to the family of 
sensor histidine kinases. Phosphorylated ArcA has the capacity to influence 
transcription of many genes in E. coli, both positively and negatively, which has been 
the subject of several comprehensive bioinformatic and array-based approaches90-92. 
A similar two-component system, TorR/S, has been described in the reduction of 
trimethylamine N-oxide in E. coli93. In S. oneidensis MR-1, it could be demonstrated 
that the TorR/TorS two-component system, present in a three-gene cluster torSTR, 
similarly regulates the torECAD operon. The synergy between the Arc and Tor 
system suggests a possible role for ArcA in the regulation of anaerobic ferric iron 
respiration. The identification of not only one, but even two spots in the 2D-gel as the 
aerobic regulator protein ArcA might be due to the presence of the phosphorylated 
and non-phosphorylated forms. However, the shift in molecular weight is quiet large, 
and can not be solely due to phosphorylation.  At present, we were not able to 
identify post-translational modifications by MS because they were not detected in the 
peptide map, measured both in the positive and negative ion mode. It is remarkable 
that no ArcB has been annotated upon S. oneidensis MR-1 genome sequence 
analysis. A more profound similarity search using the full sequence of E. coli ArcB 
reveals at least 150 homologous proteins, of which 34 are annotated as sensory box 
or transduction kinases, but the real partner of ArcA in S. oneidensis MR-1 remains 
Figure 5. (A) Detailed picture of the 2D-PAGE gels given in Figure 4 
showing clearly an increased abundance for spot 11 and spot 20.  
The spots were respectively identified as ArcA and adenylate kinase. 
(B) 3D-plot of the 2D-gel region shown above, using the position (x-
and y-coordinate) and the relative intensity (z-coordinate).  
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to be verified experimentally.  Genetic and molecular techniques were recently used 
for characterization of the Arc system in S. oneidensis94.  The authors show that the 
locus, containing genes predicted to encode subunits of dimethyl sulfoxide reductase, 
is regulated by ArcA.  They also identified a small protein, homologous to the 
histidine phosphotransfer domain of ArcB from E. coli, that is able to activate ArcA.  
However, this protein alone was unable to compensate for the lack of ArcB in E. coli, 
indicating that other proteins are required for the activation of ArcA.  The authors 
conclude that the Arc system in S. oneidensis is similar to E. coli in that it uses a 
response regulator that is identical in function between the two organisms, but that 
the components involved in the activation of ArcA are different.   
The increased abundance of the enhancing lycopene biosynthesis protein is also 
noteworthy. A homologous protein of E. coli (55% identity and 69% similarity at the 
amino acid sequence level) has been shown to be involved in the early steps of 
isoprenoid biosynthesis95. An increase in quinone compounds might be a necessity 
upon growth on ferric oxide and, therefore, an increased protein production of an 
enhancing lycopene biosynthesis protein is a causative phenomenon. Isoprenoid 
quinones freely diffuse into membranes and serve as an electron shuttle in the 
respiratory chain. A previous report of a quinone-like molecule in S. oneidensis MR-1, 
having the function of an endogenous shuttle, hypothesizes an extracellular electron 
transfer mechanism during anaerobic ferric iron reduction96.  
Another remarkable identification is that of an agglutination protein. The protein 
already appeared in another differential analysis with respect to respiration, namely 
the study of the role of the ferric uptake regulator (Fur, an iron-responsive, 
transcriptional repressor) in the energy metabolism, using a knock-out mutant97. This 
suggested a possible involvement of this negative regulator in the production of the 
agglutination protein. Our finding of an increased protein synthesis for the 
agglutination protein points to a possible involvement in the reduction of ferric iron, 
and indeed indirectly suggests a role for Fur in dissimilative iron reduction. Another 
report demonstrates an increased protein synthesis of the agglutination protein under 
anaerobic versus aerobic circumstances98. However, no significant difference in 
abundance was detected with growth on fumarate and Fe(III)-citrate. This appears to 
be inconsistent with our results, but it should be stressed that we used an insoluble 
ferric substrate, which might be physiologically different from the citrate salt. The 
annotated biological function of the gene for the agglutination protein has not yet 
been verified experimentally and remains elusive. The protein is most closely related 
to a putative agglutination protein in Vibrio cholerae (40% identity and 61% similarity 
at the amino acid level) and to an agglutination protein in Pseudomonas putida (34% 
identity and 52% similarity at the amino acid level). The agglutination protein from P. 
putida is involved in the adherence of the bacterium to plant roots99. On the other 
hand, the agglutination protein from S. oneidensis MR-1 shows significant sequence 
similarity (Blast E-value = 4e-08) to the TolC domain of an outer membrane protein 
from the same organism. A protective role of TolC in the efflux of electron-shuttling 
molecules like anthraquinone-2,6-disulfonate, a humic substance analogue, has 
been previously reported100. Further research will be needed to investigate the nature 
of this protein and its specific role in dissimilatory iron-reducing bacteria.  
 
 
 
 
 
CHAPTER V                                                                   PROTEOMICS OF S. ONEIDENSIS MR-1 
 
79 
4.3. CONCLUSIONS 
In addition to playing an important role in the natural cycle of carbon and metals, 
Fe(III)-reducing microorganisms appear to be useful tools for the bioremediation of 
contaminated environments.  The understanding of the factors controlling the rate 
and extent of Fe(III) reduction in environments is currently rudimentary. 
In the present work, we investigated the proteins that are up-regulated upon growth 
of S. oneidensis MR-1 on ferric oxide, using a classical proteomic approach. 
Reproducible 2D-PAGE gels of soluble proteins from cells grown on fumarate and 
ferric oxide were obtained. It is important to note that the analysis was limited to a 
subset of the proteome of S. oneidensis MR-1, because only a small number of 
protein spots, approximately 400, were present on the 2D maps. For instance, not 
many proteins were visualized in the basic and acidic region of the 2D-PAGE gel.  
Proteins displaying altered protein production levels were successfully analyzed and 
identified by mass spectrometry. We detected an increased protein synthesis for the 
aerobic respiration control protein, known as a global transcriptional regulator in 
anaerobiosis in other species, growing S. oneidensis MR-1 on ferric oxide.  The up-
regulation of the enhancing lycopene biosynthesis protein and an agglutination 
protein are also apparent. The former protein is possibly involved in the synthesis of 
isoprenoid units, but the role of the latter remains obscure.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER V                                                                   PROTEOMICS OF S. ONEIDENSIS MR-1 
 
80 
5. REFERENCES  
1  Vargas, M.; Kashefi, K.; Blunt-Harris, E.L. et al. Microbiological evidence for Fe(III) reduction on 
early Earth. Nature 1998, 395, 65-67 
2  Lovley, D.R.; Phillips, E.J.P.; Lonergan, D.J. Hydrogen and formate oxidation coupled to 
dissimilatory reduction of iron or manganese by Alteromonas putrefaciens. Appl. Environ. 
Microbiol. 1989, 55, 700-706 
3  Lovley, D.R.; Stolz, J.F.; Nord, G.L. et al. Anaerobic production of magnetite by a dissimilatory 
iron-reducing microorganism. Nature 1987, 330, 252-254 
4  Myers, C.R.; Nealson, K.H. Bacterial manganese reduction and growth with manganese oxide as 
the sole electron-acceptor. Science 1988, 240, 1319-1321 
5  Nealson, K.H.; Little, B. Breathing manganese and iron: solid-state respiration. Adv. Applied 
Microbiol. 1997, 45, 213-239 
6  Collins, R.; Picardal, F. Enhanced anaerobic transformations of carbon tetrachloride by soil 
organic matter. Environm. Toxicol. Chem. 1999, 18, 2703-2710 
7  Ward, M.J.; Fu, Q.S.; Rhoads, K.R. et al. A derivative of the menaquinone precursor 1,4-
dihydroxy-2-naphthoate is involved in the reductive transformation of carbon tetrachloride by 
aerobically grown Shewanella oneidensis MR-1. Appl. Microbiol. Biotechnol. 2004, 63, 571-577 
8  Bagge, D.; Hjelm, M.; Johanson, C. et al. Shewanella putrefaciens adhesion and biofilm formation 
on food processing surfaces. Appl. Environ. Microbiol. 2001, 67, 2319-2325 
9  Little, B.; Wagner, P.; Hart, K. et al. The role of biomineralization in microbiologically influenced 
corrosion. Biodegradation 1998, 9, 1-10 
10  Potekhina, J.S.; Sherisheva, N.G.; Povetkina, L.P. et al. Role of microorganisms in corrosion 
inhibition of metals in aquatic habitats. Appl. Microbiol. Biotechnol. 1999, 52, 639-646 
11  Khashe, S.; Janda, J.M. Biochemical and pathogenic properties of Shewanella alga and 
Shewanella putrefaciens. J. Clin. Microbiol. 1998, 36, 783-787 
12  Chen, Y.S.; Liu, Y.; Yen, M. et al. Skin and soft-tissue manifestations of Shewanella putrefaciens 
infection. Clin. Infect. Dis. 1997, 25, 225-229 
13  Frazier, M.E.; Johnson, G.M.; Thomassen, D.G. et al. Realizing the potential of the genome 
revolution: The Genomes to Life program. Science 2003, 300, 290-293 
14  http://doegenomestolife.org 
15 http://www.shewanella.org 
16  Heidelberg, J.F.; Paulsen, I.T.; Nelson, K.E. et al. Genome sequence of the dissimilatory metal 
ion-reducing bacterium Shewanella oneidensis. Nat. Biotech. 2002, 20, 1118-1123 
17  Daraselia, N.; Dernovoy, D.; Tian, Y. et al. Reannotation of Shewanella oneidensis genome. 
OMICS 2003, 7, 171-175 
18  Serres, M.H.; Riley, M. Structural domains, protein modules, and sequence similarities enrich our 
understanding of the Shewanella oneidensis MR-1 proteome. OMICS 2004, 8, 306-321 
19  Kolker, E.; Picone, A.F.; Galperin, M.Y. et al. Global profiling of Shewanella oneidensis MR-1: 
expression of hypothetical genes and improved functional annotations. Proc. Natl. Acad. Sci. USA 
2005, 102, 2099-2104 
20  Kato, C.; Li, L.; Nogi, Y. Extremely barophilic bacteria isolated from the Mariana Trench, 
Challenger Deep, at a depth of 11.000 meters.  Appl. Environ. Microbiol. 1998, 64, 1510-1513 
21  Bowman, J.P.; McCammon, S.A.; Brown, M.V. et al. Diversity and association of psychrophilic 
bacteria in Antarctic sea ice. Appl. Environ. Microbiol. 1997, 63, 3068-3078 
22  Bowman, J.P.; McCammon, S.A.; Nichols, D.S. et al. Shewanella gelidimarina sp. nov. and 
Shewanella frigidimarina sp. nov., novel Antarctic species with the ability to produce 
CHAPTER V                                                                   PROTEOMICS OF S. ONEIDENSIS MR-1 
 
81 
eicosapentaenoic acid (20:5 omega 3) and grow anaerobically by dissimilatory Fe(III) reduction. 
Int. J. Syst. Bacteriol. 1997, 47, 1040-1047 
23  Brettar, I.; Moore, E.R.; Hofle, M.G. Phylogeny and abundance of novel denitrifying bacteria 
isolated from the water column of the Central Baltic Sea. Microb. Ecol. 2001, 42, 295-305 
24  Venkateswaran, K.; Dollhopf, M.E.; Aller, R. et al. Shewanella amazonensis sp. nov., a novel 
metal-reducing facultative anaerobe from Amazonian shelf muds. Int. J. Syst. Bacteriol. 1998, 48, 
965-972 
25  Derby, H.A.; Hammer, B.W. Bacteriology of butter.  Bacteriological studies of surface taint butter.  
Iowa Agric. Exp. Stn. Res. Bul. 1931, 145, 387-416 
26  Shewan, J.M. The bacteriology of fresh and spoiling fish and the biochemical changes induced by 
bacterial action.  Proceedings of the conference on handling, processing and marketing of tropical 
fish.  Tropical Products Institute, London 1977, pp. 51-66 
27  Lee, J.V.; Gibson, D.M.; Shewan, J.M. A numerical taxonomy study of some Pseudomonas-like 
marine bacteria. J. Gen. Microbiol. 1977, 98, 439-451 
28  MacDonell, M.T.; Colwell, R.R. Phylogeny of the Vibrionaceae and recommendation for two new 
genera, Listonella and Shewanella. Syst. Appl. Microbiol. 1985, 6, 171-182 
29  Venkateswaren, K.; Moser, D.P.; Dollhopf, M.E. et al. Polyphasic taxonomy of the genus 
Shewanella and description of Shewanella oneidensis sp.nov. Int. J. Syst. Bacteriol. 1999, 49, 
705-724 
30  Myers, C.R.; Nealson, K.H. Bacterial manganese reduction and growth with manganese oxide as 
the sole electron-acceptor. Science 1988, 240, 1319-1321 
31  Myers, C.R.; Nealson, K.H. Microbial reduction of manganese oxides - Interactions with iron and 
sulfur. Geochim. Cosmochim. Ac. 1988, 52, 2727-2732 
32  Nealson, K.H.; Saffarini, D.  Iron and manganese in anaerobic respiration: environmental, 
significance, physiology, and regulation. Annu. Rev. Microbiol. 1994, 48, 311-343 
33  Nealson, K.H.; Belz, A.; McKee, B. Breathing metals as a way of life: geobiology in action. Antonie 
van Leeuwenhoek 2002, 81, 215-222 
34  Myers, C.R.; Carstens, B.P.; Antholine, W.E.; et al. Chromium(VI) reductase activity is associated 
with the cytoplasmic membrane of anaerobically grown Shewanella putrefaciens MR-1. Appl. 
Microbiol. 2000, 88, 98-106 
35  Abdelouas, A.; Lu, Y.M.; Lutze, W. et al. Reduction of U(VI) to U(IV) by indigenous bacteria in 
contaminated ground water. J. Contam. Hydrol. 1998, 35, 217-233 
36  Nealson, K.H.; Scott, J. Ecophysiology of the genus Shewanella. (2003) In: Prokaryotes, Vol. 2004, 
Edited by Dworkin, M., New York, Springer-Verlag 
37  Blakeney, M.D.; Moulaei, T.; DiChristina, T.J. Fe(III)-reduction activity and cytochrome content of 
Shewanella putrefaciens grown on ten compounds as sole terminal electron acceptor.  Microbiol. 
Res. 2000, 155, 87-94 
38  Guerinot, M.L. Microbial iron transport. Annu. Rev. Microbiol. 1994, 48, 743-772 
39 Madigan, M.T.; Martinko, J.M.; Parker, J. Brock Biology of microorganisms. Prentice Hall 
International, 1997, pp. 501-502 
40  Nevin, K.P.; Lovley, D.R. Mechanisms for Fe(III) oxide reduction in sedimentary environments. J. 
Geomicrobiol. 2002, 19, 141-159 
41  Newman, D.K.; Kolter, R. A role for excreted quinones in extracellular electron transfer. Nature 
2000, 405, 94-97 
42  Hernandez, M.E.; Newman, D.K. Extracellular electron transfer. Cell. Mol. Life Sci. 2001, 58, 
1562-1571 
CHAPTER V                                                                   PROTEOMICS OF S. ONEIDENSIS MR-1 
 
82 
43  Turick, C.E.; Tisa, L.S.; Caccavo, F. Melanin production and use as a soluble electron shuttle for 
Fe(III) oxide reduction and as a terminal electron acceptor by Shewanella algae BrY. Appl. 
Environ. Microbiol. 2002, 68, 2436-2444 
44  Turick, C.E.; Caccavo, F.; Tisa, L.S. Electron transfer from Shewanella algae BrY to hydrous ferric 
oxide is mediated by cell-associated melanin. FEMS Microbiol. Lett. 2003, 220, 99-104 
45  Rosso, K.M.; Zachara, J.M.; Fredrickson, J.K. et al. Nonlocal bacterial electron transfer to 
hematite surfaces. Geochem. Cosmochim. Acta 2003, 67, 1081-1087 
46  Lovley, D.R.; Holmes, D.E.; Nevin, K.P. Dissimilatory Fe(III) and Mn(IV) reduction. Adv. Microbiol. 
Physiol. 2004, 49, 219-286 
47  Myers, C.R.; Myers, J.M. Localization of cytochromes to the outer membrane of anaerobically 
grown Shewanella putrefaciens MR-1. J. Bacteriol. 1992, 174, 3429-3438 
48  Myers, C.R.; Myers, J.M. Outer membrane cytochromes of Shewanella putrefaciens MR-1: 
spectral analysis and purification of the 83-kDa c-type cytochrome.  Biochim. Biophys. Acta 1997, 
1326, 307-318 
49  Myers, C.R.; Myers, J.M. Ferric reductase is associated with the membranes of anaerobically 
grown Shewanella putrefaciens MR-1. FEMS Microbiol. Lett. 1993, 108, 15-22 
50  Dobbin, P.S.; Powell, A.K.; McEwan, A.G. et al. The influence of chelating agents upon the 
dissimilatory reduction of Fe(III) by Shewanella putrefaciens. BioMetals 1995, 8, 163-173 
51  Myers, C.R.; Myers, J.M. Cloning and sequencing of cymA, a gene encoding a tetraheme 
cytochrome c required for reduction of iron(III), fumarate, and nitrate by Shewanella putrefaciens 
strain MR-1. J. Bacteriol. 1997, 179, 1143-1152 
52  Myers, J.M.; Myers, C.R. Role of the tetraheme cytochrome CymA in anaerobic electron transport 
in cells of Shewanella putrefaciens MR-1 with normal levels of menaquinone. J. Bacteriol. 2000, 
182, 67-75 
53  Myers, C.R.; Myers, J.M. Role of menaquinone in the reduction of fumarate, iron(III) and 
manganese(IV) by Shewanella putrefaciens MR-1. FEMS Microbiol. Lett. 1993, 114, 215-222 
54  Schwalb, C.; Chapman, S.K.; Reid, G.A. The tetraheme cytochrome CymA is required for 
anaerobic respiration with dimethyl sulfoxide and nitrite in Shewanella oneidensis. Biochemistry 
2003, 42, 9491-9497 
55  Field, S.J.; Dobbin, P.S.; Cheesmand, M.R. et al. Purification and magneto-optical spectroscopic 
characterization of cytoplasmic membrane and outer membrane multiheme c-type cytochromes 
from Shewanella frigidimarina NCIMB 400. J. Biol. Chem. 2000, 275, 8515-8522 
56  Beliaev, A.S.; Saffarini, D.A.; McLaughlin, J.L. et al. MtrC, an outer membrane decahaem c 
cytochrome required for metal reduction in Shewanella putrefaciens MR-1. Mol. Microbiol. 2001, 
39, 722-730 
57  Pitts, K.E.; Dobbin, P.S.; Reyes-Ramirez, F. et al. Characterization of the Shewanella oneidensis 
MR-1 decaheme cytochrome MtrA. J. Biol. Chem. 2003, 278, 27758-27765 
58  Gordon, E.H.; Pike, A.D.; Hil, A.E. et al. Isolation and characterization of a novel cytochrome c3 
from Shewanella frigidimarina that is involved in Fe(III) respiration. Biochem. J. 2000, 349, 153-
158 
59  Leys, D.; Meyer, T.E.; Tsapin, A.S. et al. Crystal structures at atomic resolution reveal the novel 
concept of "electron-harvesting" as a role for the small tetraheme cytrochome c. J. Biol. Chem. 
2002, 277, 35703-35711 
60  Beliaev, A.S.; Saffarini, D.A. Shewanella putrefaciens mtrB encodes an outer membrane protein 
required for Fe(III) and Mn(IV) reduction. J. Bacteriol. 1998, 180, 6292-6297 
CHAPTER V                                                                   PROTEOMICS OF S. ONEIDENSIS MR-1 
 
83 
61  Shyu, J.B.H.; Lies, D.P.; Newman, D.K. Protective role of tolC in efflux of the electron shuttle 
anthraquinone-2,6-disulfonate. J. Bacteriol. 2002, 184, 1806-1810 
62  Myers, C.R.; Myers, J.M. MrtB is required for proper incorporation of the cytochromes OmcA and 
OmcB in the outer membrane of Shewanella putrefaciens MR-1. Appl. Environ. Microbiol. 2002, 
68, 5585-5594 
63  Myers, J.M.; Myers, C.R. Isolation and sequence of omcA, a gene encoding a decaheme outer 
membrane cytochrome c of Shewanella putrefaciens MR-1, and detection of omcA homologs in 
other strains of S. putrefaciens. Biochim. Biophys. Acta 1998, 1373, 237-251 
64  Myers, C.R.; Myers, J.M. Cell surface exposure of the outer membrane cytochromes of 
Shewanella oneidensis MR-1. Lett. Appl. Microbiol. 2003, 37, 254-258 
65  Myers, J.M.; Myers, C.R. Role for outer membrane cytochromes OmcA and OmcB of Shewanella 
putrefaciens MR-1 in reduction of manganese dioxide. Appl. Environ. Microbiol. 2001, 67, 260-269 
66  Myers, J.M.; Myers, C.R. Overlapping role of the outer membrane cytochromes of Shewanella 
oneidensis MR-1 in the reduction of manganese(IV) oxide. Lett. Appl. Microbiol. 2003, 37, 21-25 
67  Beliaev, A.S.; Saffarini, D.A.; McLaughlin, J.L. et al. MtrC, an outer membrane decahaem c 
cytochrome required for metal reduction in Shewanella putrefaciens MR-1. Mol. Microbiol. 2001, 
39, 722-730 
68  Heidelberg, J.F.; Paulsen, I.T.; Nelson, K.E. et al. Genome sequence of the dissimilatory metal 
ion-reducing bacterium Shewanella oneidensis. Nat. Biotech. 2002, 20, 1118-1123 
69  Saffarini, D.A., Schultz, R.; Beliaev, A. Involvement of cyclic AMP (cAMP) and cAMP receptor 
protein in anaerobic respiration of Shewanella oneidensis. J. Bacteriol. 2003, 185, 3668–3671 
70  Maier, T.M.; Myers, C.R. Isolation and characterization of a Shewanella putrefaciens MR-1 
electron transport regulator etrA mutant: reassessment of the role of EtrA. J. Bacteriol. 2001, 183, 
4918-4926 
71  Beliaev, A.; Thompson, D.; Fields, M. et al. Microarray transcription profiling of a Shewanella 
oneidensis etrA mutant. J. Bacteriol. 2002, 184, 4612-4616 
72  Thompson, D.K.; Beliaev, A.S.; Giometti, C.S.  et al. Transcriptional and proteomic analysis of a 
ferric uptake regulator (fur) mutant of Shewanella oneidensis: Possible involvement of fur in 
energy metabolism, transcriptional regulation, and oxidative stress. Appl. Environ. Microbiol. 2002, 
68, 881-892 
73 Gon, S.; Patte, J.; Dos Santos, J. et al.  Reconstitution of the trimethylamine oxide reductase 
regulatory elements of Shewanella oneidensis in Escherichia coli. J. Bacteriol. 2002, 184, 1262-
1269 
74 Gordon, E.; Pealing, S.; Chapman, S. et al. Physiological function and regulation of 
flavocytochrome c(3), the soluble fumarate reductase from Shewanella putrefaciens NCIMB 400. 
Microbiology 1998, 144, 937-945 
75  VerBerkmoes, N.C.; Bundy, J.L.; Hauser, L. et al. Integrating "Top-down" and "Bottom-up" mass 
spectrometric approaches for proteomic analysis of Shewanella oneidensis. J. Prot. Research 
2002, 1, 239-252 
76  Kolker, E.; Picone, A.F.; Galperin, M.Y. et al. Global profiling of Shewanella oneidensis MR-1: 
expression of hypothetical genes and improved functional annotations. Proc. Natl. Acad. Sci. USA 
2005, 102, 2099-2104 
77  Beliaev, A.S.; Thompson, D.K.; Khare, T. et al. Gene and protein expression profiles of 
Shewanella oneidensis during anaerobic growth with different electron acceptors. OMICS 2002, 6, 
39-60 
CHAPTER V                                                                   PROTEOMICS OF S. ONEIDENSIS MR-1 
 
84 
78  Straub, K.L.; Benz, M.; Schink, B. Iron metabolism in anoxic environments at near neutral pH. 
FEMS Microbiol. Ecol. 2001, 34, 181-186 
79  Dobbin, P.S.; Powell, A.K.; McEwan, A.G. et al. The influence of chelating agents upon the 
dissimilatory reduction of Fe(III) by Shewanella putrefaciens. BioMetals 1995, 8, 163-173 
80  Dobbin, P.S.; Burmeister, L.M.R.; Heath, S.L. et al. The influence of chelating agents upon the 
dissimilatory reduction of Fe(III) by Shewanella putrefaciens. Part 2. Oxo-and hydroxo-bridged 
polynuclear Fe(III) complexes. BioMetals 1996, 9, 291-301 
81  Kostka, J.E.; Nealson, K.H. Dissolution and reduction of magnetite by bacteria. Environ. Sci. 
Technol. 1995, 29, 2535-2540 
82  Tsapin, A.I.; Vandenberghe, I.; Nealson, K.H. et al. Identification of a small tetraheme cytochrome 
c and a flavocytochrome c as two of the principal soluble cytochromes c in Shewanella oneidensis 
strain MR1. Appl. Environ. Microbiol. 2001, 67, 3236-3244 
83  Murray, A.E.; Lies, D.; Nealson, K. et al. DNA/DNA hybridization to microarrays reveals gene-
specific differences between closely related microbial genomes. Proc. Natl. Acad. Sci. USA 2001, 
98, 9853-9858 
84  Luchi, S.; Lin, E.C. ArcA (dye), a global regulatory gene in Escherichia coli mediating repression of 
enzymes in aerobic pathways. Proc. Natl. Acad. Sci. USA 1988,  85, 1888–1892 
85  Georgellis, D.; Kwon, O.; Lin, E.C.C. Quinones as the redox signal for the Arc two-component 
system of bacteria.  Science 2001, 292, 2314-2316 
86  Liu, X.; De Wulf, P. Probing the ArcA-P modulon of Escherichia coli by whole genome 
transcriptional analysis and sequence recognition profiling. J. Biol. Chem. 2004, 279, 12588–
12597 
87  Kwon, O.; Georgellis, D.; Lin, E.C. Phosphorelay as the sole physiological route of signal 
transmission by the arc two-component system of Escherichia coli. J. Bacteriol. 2000, 182, 3858–
3862 
88  Lynch, A.S.; Lin, E.C. Responses to molecular oxygen. In Escherichia coli and Salmonella: 
Cellular and Molecular Biology. Edited by: Neidhardt, F.C.; Curtiss, R.; Ingraham, J.L.; Lin, E.C.C.; 
Low, K.B.; Magasanik, B.; et al., Washington, DC: American Society for Microbiology 1996, pp. 
1526–1538 
89  Lynch, A.S.; Lin, E.C. Transcriptional control mediated by the ArcA two-component response 
regulator protein of Escherichia coli: characterization of DNA binding at target promoters. J. 
Bacteriol. 1996, 178, 6238–6249 
90  Lynch, A.S.; Lin, E.C. Transcriptional control mediated by the ArcA two-component response 
regulator protein of Escherichia coli: characterization of DNA binding at target promoters. J. 
Bacteriol. 1996, 178, 6238–6249 
91  Liu, X.; De Wulf, P. Probing the ArcA-P modulon of Escherichia coli by whole genome 
transcriptional analysis and sequence recognition profiling. J. Biol. Chem. 2004, 279, 12588–
12597 
92  McGuire, A.M.; Wulf, P.D.; Church, G.M. et al. A weight matrix for binding recognition by the redox 
response regulator ArcA-P of Escherichia coli. Mol. Microbiol. 1999, 32, 217–221 
93  Jourlin, C.; Bengrine, A.; Chippaux, M. et al. An unorthodox sensor protein (TorS) mediates the 
induction of the tor structural genes in response to trimethylamine N-oxide in Escherichia coli. Mol. 
Microbiol. 1996, 20, 1297-1306 
94  Gralnick, J.A.; Brown, C.T.; Newman, D.K. Anaerobic regulation by an atypical Arc system in 
Shewanella oneidensis. Mol. Microbiol. 2005, 56, 1347-1357 
CHAPTER V                                                                   PROTEOMICS OF S. ONEIDENSIS MR-1 
 
85 
95  Hemmi, H.; Ohnuma, S.; Nagaoka, K. et al. Identification of genes affecting lycopene formation in 
Escherichia coli transformed with carotenoid biosynthetic genes: Candidates for early genes in 
isoprenoid biosynthesis. J. Biochem. 1998, 123, 1088-1096 
96  Hernandez, M.E.; Newman, D.K. Extracellular electron transfer. Cell. Mol. Life Sci. 2001, 58, 
1562-1571 
97  Thompson, D.K.; Beliaev, A.S.; Giometti, C.S. et al. Transcriptional and proteomic analysis of a 
ferric uptake regulator (fur) mutant of Shewanella oneidensis: Possible involvement of fur in 
energy metabolism, transcriptional regulation, and oxidative stress. Appl. Environ. Microbiol. 2002, 
68, 881-892 
98  Beliaev, A.S.; Thompson, D.K.; Khare, T. et al. Gene and protein expression profiles of 
Shewanella oneidensis during anaerobic growth with different electron acceptors. OMICS 2002, 6, 
39-60 
99  Buell, C.; Anderson, A. Genetic analysis of the AggA locus involved in agglutination and 
adherence of Pseudomonas putida, a beneficial fluorescent Pseudomonad. Mol. Plant Microbe 
Interact. 1992, 5, 154-162 
100 Shyu, J.B.; Lies, D.P.; Newman, D.K. Protective role of tolC in efflux of the electron shuttle 
anthraquinone-2,6-disulfonate. J. Bacteriol. 2002, 184, 1806-1810 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
        CHAPTER VI
                                                                   
 
86 
 
CHAPTER VI 
 
HEAT SHOCK RESPONSE IN BARLEY SHOOTS 
 
 
 
The analysis of stress-responsiveness in plants is an important route to the discovery 
of genes conferring stress tolerance and their use in breeding programs.  High 
temperature is one of the environmental stress factors that can affect growth and 
quality characteristics of plants. We applied a differential display proteomic analysis 
to one of the most important crops in the world, barley, which is used in the malting 
industry and as feeding stuff.  The effect of heat shock on the protein pattern of 
stress-tolerant and stress-susceptible cultivars was investigated by 2D-PAGE and the 
proteins spots were identified by mass spectrometry. The results will be outlined in 
this chapter. 
 
 
Note: This chapter has been adapted from a paper, entitled: "Proteomic analysis of small heat shock 
protein isoforms in barley shoots". Details on the experimental procedures are provided in Appendix B. 
(Phytochemistry 2004, 65, 1853-1863)   
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1. INTRODUCTION 
Any living organism has to cope with conditions of stress. Specifically for plants, the 
possibilities to escape from stress are limited because plants are immobile1.  In 
general, a typical response to environmental stress conditions is established by the 
induction of a set of stress proteins that protects the organism from cellular damage.  
The yield and quality of cereals are severely affected by heat stress in many 
countries2.  Therefore, understanding the effect of high temperature on barley 
(Hordeum vulgare) is an important issue for the improvement of the quality of these 
crops in temperate and warm countries.  
In plants, a heat shock response is a ubiquitous phenomenon resulting in altered 
gene expression and protein translation. Most of the proteins produced are heat 
shock proteins (HSPs)3.  The HSPs have either high (80-100 kDa, HMW HSPs), 
intermediate (68-73 kDa IMW- HSPs), or small molecular masses (15-20 kDa, 
sHSPs). The latter are classified as gene products of six gene families based on 
DNA sequence similarity, immunological cross-reactivity and intracellular 
localization4-6. 
The evolutionary conservation of HSPs has suggested that these proteins are 
involved in fundamental cellular functions.  HSPs are associated with protein folding, 
protein translocation across membranes, assembly of oligomeric proteins, modulation 
of receptor activities, mRNA protection, prevention of enzyme- especially 
photosynthesizing- denaturation and their stress- induced aggregation, and with post-
stress ubiquitin and chaperonin-aided repair. Based on these functions, HSPs have 
been termed ‘molecular chaperones’7,8.  Apart from being synthesized as heat shock 
protein, HSPs are also accumulated in plants in response to a large number of other 
stress factors such as arsenite, ethanol, heavy metals, water stress, light, hormones,  
abscisic acid, wounding, excess NaCl, chilling, and anoxic conditions9-12. 
 
Proteomics is a very elegant approach for the understanding of cellular processes. 
This tool provides more fundamental insights into organism development and 
homeostatic control than provided by the genome sequence13. In a standard 
approach, two techniques, two-dimensional polyacrylamide gel electrophoresis (2D-
PAGE) and mass spectrometry are combined.  Electrophoresis is still the preferred 
separation technique of many researchers in a global, comparative analysis of 
proteins. In fact, the 2D-PAGE technique was established early on for barley14-16.  In 
a differential analysis setup, this method provides powerful insights into the stress-
responsiveness of genes17.  Mass spectrometry, implementing fingerprinting and 
partial sequencing is the method of choice for the identification of differentially 
displayed proteins. The mass spectrometric identification of proteins strongly relies 
on the presence of sequence information in the databases.  This is clearly a limitation 
for barley, for which the genome has not yet been sequenced.  However, a large, 
publicly available expressed sequence tag (EST) database, which comprises 
2028018 sequences to date, together with the genome sequence information of 
closely related organisms, such as rice (Oryza sativa), mainly circumvents this 
drawback. 
Several plant species, including barley, have already been investigated by a 
proteomic approach18-20.  In these proteome studies, several authors mainly focused 
either on a more descriptive overview of occurring proteins21,22 or they investigated 
the changes in protein synthesis during seed development23.  In other plant species, 
like wheat (Triticum aestivum), proteomics has already been applied to study the 
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effects of heat shock at the protein expression level during grain filling24.  These 
authors made a comparison between two cultivars (heat-susceptible and heat-
tolerant), the analysis revealing differential expression of several sHSPs. 
In the present study, we investigated the influence of short-term (2 hours) heat stress 
on the protein expression levels of barley.  We used a heat-tolerant and a heat-
susceptible cultivar and attempted to analyze the differentially displayed proteins 
after shock treatment of both cultivars, in order to identify proteins responsible for 
heat tolerance.  Such proteins are thought to be potential markers for heat tolerance 
of barley cultivars in breeding programs. 
 
2. RESULTS AND DISCUSSION 
2.1.  2D-GEL ELECTROPHORESIS AND IMAGE ANALYSIS 
The composition of the soluble protein fraction of an abiotic stress-tolerant 
(Mandolina) and an abiotic stress-susceptible (Jubilant) cultivar, grown under 
different temperature conditions, was compared.  Four barley batches of 25 
seedlings of the Mandolina genotype were grown five days at 24°C, with a heat 
shock (40°C) of two hours allowed to act upon two of those samples.  Concomitantly, 
a similar experiment was set up in which the abiotic stress-susceptible genotype was 
used.  A representative CBB G-250 stained 2D-gel pattern of the soluble protein 
fraction of the control state and of heat shock shoots from both cultivars is presented 
in Figure 1.   
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Figure 1. Coomassie G-250 stained 2D-PAGE gels of the soluble protein fractions of (A) the 
Mandolina cultivar, 24°C; (B) the Jubilant cultivar, 24°C; (C) the Mandolina cultivar, 40°C and 
(D) the Jubilant cultivar, 40°C. 
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Approximately 400 to 500 proteins were detected on each gel.  Two replicate groups 
were created for the Mandolina cultivar (24°C and 40°C) and two were created for 
the Jubilant cultivar (24°C and 40°C).  The reproducibility of the gel patterns was high 
as reflected by the figures for the scatter plot tool (> 80%) and the mean coefficient of 
variations (CV < 35%).  In a first analysis, the spot lists of the two genotypes at both 
temperatures were compared. Comparison of the proteomes at 24°C revealed one 
differential protein spot being present in the Mandolina cultivar, while comparison of 
the proteomes at 40°C revealed two proteins unique to the Jubilant cultivar.  Because 
we were mainly interested in the influence of a short term heat shock on barley and 
due to the small differences between the two genotypes, we continued with two 
replicate groups.  We created one replicate group for the 2D-images at 24°C and one 
group for the 2D-images at 40°C.  This approach slightly improved the mean 
coefficient of variations.  The spot lists of the two replicate groups were compared.  A 
comparison of the relative integrated densities averaged from three or four replicate 
gels was performed, and only proteins with at least a two-fold increase in density 
ratio and with a statistical relevance (p<0.05) were submitted to further mass 
spectrometric analysis.  The applied short term heat shock to both cultivars affected 
mainly the protein profile in the 15-30 kDa range and in the pH region of 4.0 to 8.5 
(Figure 2).  The spots were numbered, indicated in Figures 1 and 2 and listed in 
Table 1.
Figure 2. Detailed picture of the individual boxes in Figure 1. 
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Table 1. Summary of the Identified Protein Spots. 
Spot 
Nr.1 
Accession 
nr2 
Protein ID3 Organism Peptide 
mass 4 
Sequence5 Comments Method6 
Protein with increased abundance in the Mandolina cultivar compared to the Jubilant cultivar 
1469.73 TNMVMVFGEITTK  1 11895380 S-adenosyl 
methionine 
synthetase 
Oryza sativa 
2042.98 QVTVEYHNDNGAMVPIR  
LC-MS/MS 
Proteins showing an increased abundance after a short term heat shock 
2 18234603 Unknown protein Arabidopsis 
thaliana 
1410.88 ILIPTLSVLSLSR  LC-MS/MS 
974.52 FRLPEDAK  
1026.60 AEVKKPEVK  
1396.79 AGLENGVLTVTVPK  
1616.76 MDWKETPEAHVFK  
18213982 Small heat shock 
protein 16.9B 
Triticum 
aestivum 
1931.97 SIVPAISGGNSETAAFANAR  
LC-MS/MS 
21940839 Small heat shock 
protein 16.9B 
T. aestivum 1918.98 SIIPAISGNSETATFANAR  LC-MS/MS 
24238923 Small heat shock 
protein 16.9B 
T. aestivum 1056.62 TEVKKPEVK  LC-MS/MS 
21964213 Small heat shock 
protein 16.9B 
T. aestivum 1961.98 SIVPAISGSNSETAAFANAR  LC-MS/MS 
18212283 Small heat shock 
protein 16.9B 
T. aestivum 1908.93 SIVPAFSGNSETAAFANAR  LC-MS/MS 
3 
21195581 Small heat shock 
protein 16.9B 
T. aestivum 1888.96 SIIPAISGNSETAAFANAR  LC-MS/MS 
1979.97 SIFPAISGGNSETAAFANAR  
2225.04 SNVLDPFADLWADPFDTFR  
1824.04 AGLENGVLTVTVPKAEVK  
4 21968553 Small heat shock 
protein 16.9B 
T. aestivum 
1967.09 VDEVKAGLENGVLTVTVPK  
LC-MS/MS 
1153.54 TSSDTAAFAGAR  5 13091926 Heat shock protein, 
low molecular weight 
O. sativa 
1598.81 IDWKETPEAHVFK  
MALDI 
TOF/TOF 
1153.54 TSSDTAAFAGAR  6 13091926 Heat shock protein, 
low molecular weight 
O. sativa 
1198.54 TDTWHRVER  
MALDI 
TOF/TOF 
1296.56 TTDSETAAFAGAR  7 16292234 Heat shock protein, 
low molecular weight 
O. sativa 
1584.79 IDWKETPDAHVFK  
MALDI 
TOF/TOF 
1307.60 FVLPENADMEK Met ox 
989.49 AMAATPADVK Met ox 
1291.61 FVLPENADMEK  
1027.61 VLVISGERR  
1818.01 DGVLTVTVEKLPPPEPK  
8 16321745 Small heat shock 
protein 17.8 
T. aestivum 
2151.06 ELPGAYAFVVDMPGLGSGDIK Met ox 
LC-MS/MS 
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   3122.53 AMAATPADVKELPGAYAFVVDMGLGSGDIK 2 x Met ox  
2193.07 ELPDAFAFVVDMPGLGSGDIK Met ox 
3148.54 AMAAPADVKELPDAFAFVVDMPGLGSGDIK Met ox 
21967462 Small heat shock 
protein 17.8 
T. aestivum 
3164.54 AMAAPADVKELPDAFAFVVDMPGLGSGDIK 2 x Met ox 
LC-MS/MS 
1277.66 FVLPDNADMEK  
 
16321080 Small heat shock 
protein 17.8 
T. aestivum 
1293.59 FVLPDNADMEK Met ox 
LC-MS/MS 
9 Not identified 
10 Not identified 
11 Not identified 
Proteins showing decreased abundance, after a short-term heat shock 
1242.66 QYYSITVLTR  
1561.74 KNTDFVAYSGEGFK  
2083.02 TADGDEGGKHQLITATVADGK  
21146652 23 kDa oxygen 
evolving protein of 
photosystem II 
T. aestivum 
3048.51 KTITDYGSPEEFLSQVGFLLGQQSYGGK  
LC MS/MS 
1288.63 TNVSPEVAESTR  24963702 Triosephosphate 
isomerase 
T. aestivum 
1311.65 IIYGGSVTGASCK Carbamidomethyl 
LC MS/MS 
1262.69 VTFLDDAQVKK  16308176 Adenosine 
diphosphate glucose 
pyrophosphatase 
Hordeum 
vulgare 2504.07 LTQDFCVADLSCSDTPAGYPCK 3 x Carbamidomethyl 
LC MS/MS 
1201.68 IFSTFVTFLK  
12 
12036592 Dehydroascorbate 
reductase 
T. aestivum 
1826.84 AAVGHPDTLGDCPFSQR Carbamidomethyl 
LC MS/MS 
1087.58 TFPQQAGAIR  
1310.75 LPTDDVLLGQIK  
1419.70 CHFVAIDIFNGK Carbamidomethyl 
2216.06 KLEDIVPSSHNCDVPHVDR Carbamidomethyl 
13 18228088 Translation initiation 
factor 5A 
O. sativa 
2769.34 TGFADGKDLILSVMSAMGEEQICAVK Carbamidomethyl 
LC-MS/MS 
1059.56 SVGGITGDNLK  
1210.53 WDEGYDVTAR  
1318.74 LKAGYVAANWVK  
1778.87 DTNGIASTSGSTIELSAR  
14 9743953 Hypothetical protein H. vulgare 
2466.15 QVLSDASSFTWGIFNQPDPSDR  
LC MS/MS 
1.  Numbers refer to the spot numbers given in Figure 1. 
2.  Nucleotide entry code of the National Center for Biotechnology Information (NCBI):  http://ncbi.nlm.nih.gov. 
3.  Annotation of the protein sequence performed using the BLAST program (NCBI). 
4.  Theoretical molecular mass of the peptide. 
5.  Peptide sequence corresponding to the appropriate peptide mass.  Parts of the sequence, determined by mass spectrometry, could indisputably confirm the peptide. 
6.  Protein spots analyzed and identified using either MALDI-TOF/TOF MS or nano-HPLC Q-TRAP MS.  For detailed information, see appendix B and chapter IV. 
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2.2. MASS SPECTROMETRY 
Essential in a proteomic approach is the availability of sequence information from the 
organism.  Due to the lack of the genome sequence, we were forced to generate as 
much information as possible through our mass spectrometric analyses, since the 
data from peptide mass fingerprinting were not sufficient.  We therefore used two 
different, state-of-the-art mass spectrometers, a MALDI TOF/TOF instrument 
(Applied Biosystems) and a Q-TRAP LC-MS/MS system (Applied Biosystems).  Both 
instruments allow to obtain amino acid sequence information from peptides using 
their MS/MS capabilities.    In a first analysis step, the MALDI TOF/TOF spectrometer 
was used to investigate the peptide mixture, because a minimum of sample handling 
is inherent to this fast and sensitive ionization method.  Due to sample impurities, we 
were not able to unambiguously identify several protein spots by this analysis.  A 
second hyphenated strategy, an automated nano-HPLC coupled to a hybrid triple 
quadrupole/linear ion trap mass spectrometer, was therefore assayed, a method 
which allows to clean up the peptide mixture thoroughly.   
 
2.3. PROTEINS IDENTIFIED BY MASS SPECTROMETRY 
As mentioned under 2.1, we observed increased synthesis of spot 1 protein in the 
barley genotype Mandolina compared to Jubilant. The intensities of this spot at 24°C 
and 40°C were comparable. By means of the LC-MS/MS setup, several peptide 
sequences could be deduced (see Table 1) which identified the protein as S-
adenosylmethionine synthetase (SAM-S) on the basis of homology with a protein 
(93% identity and 95% similarity at the amino acid level) from rice (Oryza sativa).  
The enzyme catalyzes the conversion of ATP and L-methionine into S-adenosyl-L-
methionine (SAM or AdoMet). Within the cell, SAM-S is the major methyl group donor 
for numerous transmethylation reactions25. SAM-S has been proposed to play a role 
during drought-stress-induced betaine biosynthesis26. The high activity of the enzyme, 
combined with a high mRNA abundance during drought conditioning and after 
rewetting of the drought-conditioned seedlings, suggests that SAM-S may participate 
in reactions that enhance the ability of the seedling to survive prolonged drought 
stress27. Therefore, it is very likely that a reduced amount of SAM-S in the Jubilant 
cultivar contributes to heat suffering. 
Except for protein spot 2, the other proteins showing an increased abundance after 
heat shock treatment are sHSPs (Table 1).  They can be subdivided in three 
categories: proteins that are homologous to the 16.9 kDa sHSP from wheat, proteins 
that are homologous to the 17.8 kDa sHSP from the same organism, and those that 
are homologous to a low molecular weight HSP from rice.  In protein spot 3 we found 
six isoforms of the 16.9kDa HSP, differing by only a few amino acids.  Those six 
proteins were, in the current setup, not separated on the basis of their charge and 
molecular weight.  On the other hand, protein spot 4 is also an isoform of this protein 
that is nicely separated from protein spot 3 (Figure 2). Interestingly, this protein is 
only present in the Jubilant cultivar.  A specific correlation of the presence of this 
isoforms to heat susceptibility must be further investigated.  In a similar study in 
mature wheat grain28, one of those isoforms showed an increase in protein 
abundance in a heat tolerant cultivar. The authors determined this protein as a 
possible marker protein for heat-tolerance.   As revealed in the present work, the 
presence of multiple closely related isoforms shows the need for more refined 
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analysis of the specific species that are present in the different cultivars, before they 
can be used as heat-tolerance markers. 
Protein spots 5, 6 and 7 were identified and found to be homologous (> 65% identity) 
to a low molecular weight HSP from rice.   These three isoforms are nicely separated 
on the 2D gel (Figure 2).  It was possible to differentiate spot 7 from spots 5 and 6, 
but the latter two were indistinguishable.   Protein spot 7 is again unique in the 
stress-susceptible cultivar (cfr. spot 4).  
  
We also observed a decrease in abundance for three other proteins, listed in Table 1. 
In spot 12 we identified, besides other proteins, a 23kDa oxygen-evolving protein of 
photosystem II (98% identity).  The exposure of photosynthetic organisms to 
temperatures above the normal physiological range often results in an irreversible 
inactivation of photosynthesis. Photosystem II (PSII) is one of the most susceptible 
protein complexes to heat among various components of the photosynthetic 
apparatus. Previous studies have indicated that heat-related inhibition of PSII is often 
attributed to damage of the thylakoid-membrane proteins29. Preczewski et al30 
showed that the chloroplast small heat-shock protein referred to as ‘chip Hsp24’ 
protects photosystem II against heat stress, and that the phenotypic variation in the 
production of chip Hsp24 is positively related to PS II thermotolerance. 
Protein spot 13 was identified as being translation initiation factor 5A (eIF-5A).  The 
function of this protein is to promote the formation of the first peptide bond during 
protein synthesis. Takeuchi et al31 have suggested that loss of the active form of eIF-
5A upon 45 °C heat stress is an important factor in the irreversible process of heat 
stress-induced death of a human pancreatic cancer cell line, but similar behavior in 
plants has not been demonstrated before. 
 
3. CONCLUSIONS 
Our proteomic approach, high-resolution 2-D gel electrophoresis combined with 
mass spectrometry, proved to be a successful strategy in the study of heat shock 
associated proteins in different barley cultivars. The protein S-adenosylmethionine 
synthetase (SAM-S) displayed an increased protein synthesis in the stress-tolerant 
barley cultivar.  SAM-S is known to participate in surviving prolonged drought stress. 
Loss of resistance of the Jubilant cultivar against abiotic stress factors could be 
partially due to the absence of this protein.   
In the differential analysis of the heat-treated Jubilant and Mandolina barley shoots, 
we detected an increased protein abundance of several sHSPs.  One of them is 
highly homologous to the 16.9kDa HSP from wheat.  In a different study, this protein 
was referred to as a potential marker for heat-tolerance in wheat grains.  We showed 
the presence of several isoforms of this protein in barley.  We also found two proteins 
(protein spots 4 and 7, see Figures 1 and 2) unique to the stress-susceptible cultivar. 
An in-depth analysis of those proteins and of their isoforms will be necessary in order 
to better understand their role in relation to heat-tolerance and –susceptibility.  
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CHAPTER VII 
 
OXIDATIVE PHOSPHORYLATION: 
A PROTEOMIC APPROACH 
 
 
 
Blue-native polyacrylamide gel electrophoresis is an excellent technique for the 
separation of intact membrane protein complexes, such as the five multi-polypeptide 
complexes of the oxidative phosphorylation system.  This process provides energy to 
the cell, so that defects in genes coding for these proteins result in a reduced energy 
production and, concomitantly, in the dysfunction of energy-dependent tissue.  A 
proteomic approach, using BN-PAGE, can be clinically used to analyze mitochondrial 
diseases. However, in order to use this technique for conclusive and comprehensive 
diagnostic purposes and to link changes in protein expression with different forms of 
mitochondrial disorders, all of the proteins present in each of the complexes need to 
be identified. We present the results for the profiling of the different subunits of the 
oxidative phosphorylation system, obtained by a combination of blue-native 
polyacrylamide gel electrophoresis and mass spectrometry. 
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1. INTRODUCTION 
Mitochondria are the power 'stations' of the eukaryotic cell, i.e. they play a central 
role in cellular metabolism by providing the location for energy production in the cell.  
A typical eukaryotic cell can contain 100 to more than 1,000 mitochondria which differ 
in structure, shape and size depending on the tissue and the physiological status of 
the cell.  The cellular energy is generated as ATP through oxidative phosphorylation 
(OXPHOS). Four essential multi-enzyme complexes provide the proton gradient 
across the mitochondrial inner membrane during electron transport, while the fifth 
enzyme, ATP synthase, uses this gradient to drive the generation of ATP from ADP 
and phosphate.  
Defects in the genes coding for the OXPHOS enzymes and for associated proteins 
cause serious health problems. Children and adults who are unable to generate 
sufficient energy at the cellular level suffer from the malfunctioning of muscles, or 
other energy dependent tissues, classified as myopathies, encephalopathies or 
encephalo-myopathies.  There are many diverse forms of the diseases, which may 
appear at different ages.  The linkage between a specific mutation in mitochondrial 
DNA and a specific disease was first established in 19881,2. Since then, more 
diseases related to mutations and rearrangements of mitochondrial and nuclear DNA 
were found. While many typical diseases are already associated with a particular 
gene defect, most of them remain unexplained. 
An approach to screen for differences in gene expression in diseased cells is profiling 
proteomics3.  To study the protein components of the OXPHOS-system, we have 
separated the five intact membrane protein complexes by ‘blue-native polyacrylamide 
gel electrophoresis’ (BN-PAGE) followed by sodium dodecyl sulfate polyacrylamide 
gel electrophoresis, and identified the different subunits by mass spectrometry.  
Since the distribution of OXPHOS proteins is strongly tissue-dependent, especially of 
the complexes that are known to have tissue-specific isoforms, we analyzed human 
heart and liver tissue.  The results will be presented in this chapter, and in addition, 
the study of a patient who deceased from a mitochondrial disorder will be discussed.  
Prior to this discussion, we give a concise overview of the methodology used and the 
biochemical mechanisms of electron transport and oxidative phosphorylation.   
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2. THE MITOCHONDRION 
2.1. INTRODUCTION 
The mitochondrion is one of the most 
complex and important organelles found 
in eukaryotic cells. In addition to their 
central role in energy metabolism, 
mitochondria are involved in many cellular 
processes and mitochondrial dysfunctions 
have been associated with apoptosis, 
aging, and a number of pathological 
conditions4,5.  Mitochondria are 
characterized by the presence of two 
membranes (Figure 1). On the outside, 
the mitochondrion is surrounded by the 
mitochondrial envelope (outer membrane), 
while the inside of a mitochondrion 
contains an extensively invaginated inner 
membrane.  Two internal sub-compartments, namely the inter-membranous space 
and the mitochondrial matrix, are thus created.  The number of invaginations, called 
cristae, varies with the respiratory activity of the type of cell.  The matrix contains 
substrates, nucleotide cofactors, inorganic ions and soluble proteins, e.g. citric acid 
cycle enzymes.   
Mitochondria are peculiar in the sense that they are under control of two genomic 
systems: apart from the nuclear DNA, they have their own DNA.  The mammalian 
mitochondrial genome is a small, double stranded, circular DNA molecule of 
approximately 16,500 bp6 and encodes the 12S and 16S rRNAs, 22 tRNAs, and 13 
polypeptides, which are essential components of the respiratory chain. The genetics 
of mammalian mtDNA are characterized by the following unique features: (i) maternal 
inheritance, (ii) high mutation rate, and (iii) polyploidy. The low complexity of the 
mitochondrial genome implicates that the majority of the mitochondrial proteins 
(estimated to be 1500) are encoded by the nuclear genome7.  These proteins have to 
be transported into the mitochondria, and this is a complex system involving 
chaperones, receptors and other proteins8,9.  
 
2.2. THE ELECTRON TRANSPORT CHAIN  
The protein components of the respiratory chain are oligomeric complexes located in 
the inner mitochondrial membrane of mitochondria and are referred to as the multi-
subunit electron transport complexes I, II, III, and IV10,11. The mitochondrial oxidative 
phosphorylation system is composed of these complexes along with ATP synthase. 
The respiratory process in mitochondria involves the donation of electrons by low-
redox-potential electron donors, such as NADH and FADH2, and is followed by 
electron transfer through a range of protein-bound redox centers.  Finally, the 
process ends in the reduction of the high-redox-potential acceptor, oxygen (Figure 2).  
The free energy of electron transfer is coupled to ATP synthesis. 
Figure 1. Schematic picture of a 
mitochondrion.  They are typically ellipsoids 
of ~0.5 µm diameter and 1 µm length (about 
the size of a bacterium). 
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Complex I (NADH - coenzyme Q reductase) 
The first complex is the largest respiratory complex (>900 kDa) and contains at least 
45 polypeptides in mammals12-14. It catalyzes electron transfer from NADH to quinone 
through a series of redox centers that include a flavin mononucleotide (FMN) moiety, 
Fe-S centers and hydrophobic protein fractions 15-18.  Seven complex I subunits are 
encoded by the mtDNA, while the remaining are encoded by nuclear genes19-21.  
Simultaneous to electron transfer, protons are translocated across the mitochondrial 
inner membrane. From electron microscopic analysis, there is evidence that complex 
I exhibits an overall L shape, with one arm facing into the mitochondrial matrix and 
the other arm being associated with the inner mitochondrial membrane22,23.  An X-ray 
structure of this complex is not yet available.   
 
Complex II (Succinate - coenzyme Q reductase) 
Complex II, a component of the Krebs cycle, is localized on the inner face of the 
mitochondrial inner membrane, and consists of four polypeptides, which are encoded 
by nuclear DNA24. Complex II contains FAD and several Fe-S centers. The 
conversion of succinate to fumarate in the citric acid cycle, with concomitant 
production of FADH2, is coupled to the transfer of electrons from FADH2 to the 
ubiquinone pool. 
 
Complex III (Coenzyme Q - cytochrome c reductase or cytochrome bc1)  
Cytochrome bc1 (complex III), the best understood of the respiratory enzymes, 
consists of 11 subunits, only one being encoded by mtDNA.  The key subunits are 
cytochrome b, a membrane-anchored Fe-S protein carrying a Rieske type center 
(Fe2S2), and a membrane-anchored cytochrome c1. The transmembrane 
arrangement25,26 of complex III is involved in the transfer of electrons between the 
two mobile electron carriers, CoQ and cytochrome c27.  It couples this redox reaction 
to the generation of a proton gradient across the membrane by a mechanism known 
as the Q cycle. 
 
Figure 2.  A diagram of the mitochondrial electron-transport chain indicating the pathway of electron 
transfer (black) and proton pumping (red).  Electrons are transferred between complexes I and III by 
CoQ and between complexes III and IV by cytochrome c.  Complex II (not shown) transfers electrons 
from succinate to CoQ. (Ref. 11) 
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Complex IV (Cytochrome c oxidase) 
The final member of the mitochondrial electron transport chain generating a 
transmembrane proton gradient is the terminal cytochrome oxidase (~200 kDa).  In 
mammals this enzyme consists of 13 polypeptides, three of which are encoded by 
mtDNA28-31 and has four redox metal centers,  CuA, heme a, heme a3, and CuB.  
Electrons are first transferred from cytochrome c to CuA, subsequently to cytochrome 
a, and finally to the binuclear center a3 CuB ,  where they reduce oxygen to two water 
molecules. 
 
Complex V (ATP synthase) 
The final component of the oxidative phosphorylation system, F1F0 ATPase, is made 
up of 16 different proteins in mammals32 (>500 kDa), two of them are coded by 
mtDNA33. The process of ATP synthesis, the catalytic activity, is located in the F1 
segment.  The F0 contains a specific channel for passive movement of protons back 
into the mitochondrial matrix segment, and spans the mitochondrial inner 
membrane34,35.  
 
2.3. OXIDATIVE PHOSPORYLATION 
ATP, the universal ‘energy currency’ of the living cell, is produced in mitochondria as 
a result of oxidative phosphorylation.  Although the chemiosmotic theory proposed by 
Mitchell36 in 1961 remained controversial until the mid-1970s, it appears to be the 
model most consistent with the experimental evidence37.  It postulates that transport 
of electrons (generated by oxidation of substrates) through the respiratory chain is 
coupled to translocation of protons from the matrix into the intermembrane space, 
presumably at the level of complex I, III, and IV, so as to create an electrochemical 
proton gradient across the inner mitochondrial membrane.  The electrochemical 
potential of this gradient is harnessed to synthesize ATP. This chemiosmotic 
hypothesis explains several observations.  For example, oxidative phosphorylation 
requires an intact membrane and a measurable electrochemical gradient across the 
inner mitochondrial membrane is created.  The free energy sequestered by the 
resulting electrochemical gradient, drives the synthesis of ATP from ADP and Pi by 
complex V. Assuming 100% efficient coupling of respiration and phosphorylation, 
oxidation of one mole of NADH will generate three moles of ATP. Because one 
proton translocation site is bypassed in the oxidation of FADH2 (i.e. complex I), one 
mole of FADH2 will generate only two moles of ATP instead of three. However, in vivo, 
coupling of respiration and phosphorylation is not entirely efficient, because the 
mitochondrial inner membrane has a proton leak, so that a proportion of the protons 
translocated by the respiratory chain return via this leak rather than driving ATP 
synthesis38-40. 
 
3. BN-PAGE 
Blue-native polyacrylamide gel electrophoresis (BN-PAGE) is an electrophoretic 
method able to resolve native hydrophobic proteins and membrane protein 
complexes. In this technique, membranes are first suspended in an aminocaproic 
acid buffer, which keeps the protein complexes intact upon solubilization and 
electrophoresis. Protein complexes are then solubilized using a mild detergent, e.g. 
dodecyl maltoside41 or Triton X-10042; afterwards the dye Coomassie Brilliant Blue G-
250 is added, exchanging for the initial detergent. The Coomassie introduces a 
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negative charge-shift that enhances the migration of the proteins in a 'native' 
discontinuous electrophoretic system. After the first electrophoretic step, the protein 
complexes can be denatured using SDS, and the subunits become resolved 
according to their molecular mass by SDS-PAGE in the second dimension.  This 
strategy provides information on the functional membrane protein complexes and 
proved to be superior to 2D-PAGE for the solubilization of hydrophobic proteins.  The 
method allows resolving large protein complexes, and is thus an excellent separation 
tool for intact membrane protein complexes43,44.  
BN-PAGE has been mainly used for the separation and isolation of the five multi-
enzyme complexes responsible for oxidative phosphorylation (OXPHOS), the 
energy-gaining pathway executed in mitochondria. Catalytic activity of the enzymes 
is partially maintained45. The designers of the method already indicated the intrinsic 
capacity of the method in the study of protein defects in inborn mitochondrial 
myopathies. Zerbetto et al46 applied histochemical staining on BN-PAGE separated 
OXPHOS complexes to quantify enzyme function and showed that it can be used to 
demonstrate deficient complex I activity in patients. Activity staining in the gel can 
also be used for visualization of the complexes II, IV and V47. This method was used 
as a diagnostic tool in the investigation of deficiencies of individual OXPHOS 
complexes, associated with different clinical phenotypes, such as early infantile 
encephalo-cardiomyopathy and Leigh syndrome.  
Combining BN-PAGE with SDS-PAGE reveals a two-dimensional pattern showing 
the individual subunits of the five OXPHOS complexes. In patients with defects in 
structural proteins, or with mutations of a gene resulting in a wrong assembly of an 
OXPHOS complex, this will be visualized by a different migration in the first 
dimension, while the altered subunit composition can be evaluated in the second 
dimension. The approach allows screening for the presence or absence of these 
subunits in patients, as was first shown by Klement et al48 in cultured human 
fibroblasts, and later by Bentlage et al49 who applied the technique in a study of 
patients with different forms of mitochondrial encephalomyopathies. Houstek et al50 
used the method for the diagnosis of cytochrome c oxidase deficiency at the prenatal 
level, showing a significant decrease of all complex IV subunits. Others applied the 
method in the analysis of patients with diseases that are now generally accepted to 
be caused by mitochondrial defects, such as Parkinson’s disease51,52. In order to use 
two-dimensional BN-PAGE as routine clinical diagnostic tool, it is essential to reveal 
unambiguously the identity of the individual bands. The molecular weights of some of 
the subunits are too similar for complete separation, and irregular migration during 
SDS-PAGE is possible, which limits the reliability of the molecular weight estimation 
on the basis of protein standards. Although proteins can be stained and analyzed by 
Western blotting after the first53 or second dimension54, antibodies are available 
against only a limited number of subunits, so that detection by Western blotting is 
only partially useful. Moreover, the sample preparation methods that are routinely 
used are rather limited, so that co-migration with other mitochondrial membrane 
proteins, and even matrix proteins, is likely to occur.  On the other hand, mass 
spectrometry is a powerful tool for the identification of gel separated proteins.  
Recently, proteomic studies on plant mitochondria (Arabidopsis) were published in 
which a few BN-PAGE spots were identified using mass spectrometry55,56. 
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4. PROFILING OF THE OXPHOS COMPLEXES 
4.1. HUMAN HEART TISSUE 
 
Note: This section has been adapted from the paper, entitled: "Mass spectrometric identification of 
mitochondrial oxidative phosphorylation subunits separated by two-dimensional blue-native 
polyacrylamide gel electrophoresis". Details on 
the experimental procedures are provided in 
Appendix C.  (Electrophoresis 2002, 23, 2525-
2533) 
 
The two-dimensional BN-PAGE gel of 
human heart mitochondria used for this 
study is shown in Figure 3. The 
individual protein bands that were 
excised and subsequently submitted to 
tryptic digestion and mass 
spectrometric characterization were 
labeled as shown in the figure. 
 
Tables 1A-E list the identified proteins 
from the bands. Sixty percent of the 
known OXPHOS proteins were 
identified from the selected bands. 
From only four bands we could not 
identify the corresponding protein(s). 
This is a very good result, given the 
difficulties generally encountered to 
characterize membrane proteins, the major constituents of OXPHOS complexes, 
using either mass spectrometric or electrophoretic techniques. As expected, several 
bands were not pure and contained multiple OXPHOS subunits. On some occasion, 
subunits were found in a lane derived from a different complex. Migration of complex 
subunits in the direction of lower-molecular-weight complexes may be due to the 
presence of incompletely assembled enzymes that co-migrate with other complexes, 
or that are due to loss of weakly bonded subunits.  Different migration of incompletely 
assembled enzymes has previously been reported, and this phenomenon can even 
be used to study the biosynthesis of these large multi-subunit enzymes, as shown in 
the study of the synthesis of cytochrome c oxidase57.  
 
 
 
 
 
 
 
Figure 3. BN-PAGE of human heart 
mitochondrial extracts.  The labels indicate the 
bands that were excised for identification with 
mass spectrometric analysis methods. 
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Table 1A. Identification of the Bands Corresponding to Complex I lane 
Nr ID  SWISS-PROT MS protocol Origin if different from OXPHOS I 
1 NADH-ubiquinone oxidoreductase, 75 kDa subunit  P28331 PMF  
2 NADH-ubiquinone oxidoreductase, 75 kDa subunit 
Acyl-CoA dehydrogenase, very long chain specific 
Monoamine oxidase B, flavin containing  
Keratin 1 
P28331 
P49748 
P27338 
PST 
PST 
PST 
PST 
 
β-Oxidation 
Mitochondrial outer membrane protein 
Contamination 
3 NADH-ubiquinone oxidoreductase, 49 kDa subunit 
NADH-ubiquinone oxidoreductase, 51 kDa subunit 
O75306 
P49821 
PMF 
PMF 
 
4 ATP synthase, α-chain  
α-Actin  
3-Ketoacyl-CoA thiolase  
Microsomal glutathione transferase  
P25705 
P04270 
P42765 
O14880 
PST 
PST 
PST 
PST 
OXPHOS V 
Contamination 
β-Oxidation 
Contamination 
5 NADH-ubiquinone oxidoreductase, 42 kDa subunit  
ATP synthase, β-chain  
Keratin II 
O95299 
P06576 
PMF 
PMF 
PMF 
 
OXPHOS V 
Contamination 
6 NADH-ubiquinone oxidoreductase, 39 kDa subunit  Q16795 PMF  
7 B-cell receptor associated protein (d-prohibitin) 
Phosphate carrier protein  
Voltage dependent anion selective channel protein 1  
Q99623 
Q00325 
P21796 
PST 
PST 
PST 
Mitochondrial protein chaperone 
Mitochondrial inner membrane protein 
Mitochondrial outer membrane protein 
8 ADP, ATP carrier protein  
NADH-ubiquinone oxidoreductase, 49 kDa subunit 
ATP synthase, α-chain  
P12235 
O75306 
P25705 
PST 
PST 
PST 
 
 
OXPHOS V 
9 NADH-ubiquinone oxidoreductase, 30 kDa subunit  O75489 PST  
10 NADH-ubiquinone oxidoreductase, PDSW subunit  
NADH-ubiquinone oxidoreductase, 24 kDa subunit  
O96000 
P19404 
PMF 
PMF 
 
11 NADH-ubiquinone oxidoreductase, 23 kDa subunit  O00217 PMF  
12 NADH-ubiquinone oxidoreductase, ASHI subunit  O95169 PMF  
13 NADH-ubiquinone oxidoreductase, 18 kDa subunit  O43181 PMF  
14 NADH-ubiquinone oxidoreductase, B17 subunit  
NADH-ubiquinone oxidoreductase, SGDH subunit 
Cytochrome oxidase subunit IV  
O95139 
O43674 
P13073 
PMF 
PMF 
PMF 
 
 
OXPHOS IV 
15 Cell-death regulatory protein GRIM 19 Q9pOJ0 PST ? 
16 NADH-ubiquinone oxidoreductase, B14 subunit  P56566 PMF  
17 NADH-ubiquinone oxidoreductase, B15 subunit  095168 PMF  
18 Keratin   Contamination 
19 NADH-ubiquinone oxidoreductase, B14.5B subunit  O95298 PMF  
20 NADH-ubiquinone oxidoreductase, 13 kDa-A subunit  075380 PMF  
21 NADH-ubiquinone oxidoreductase, B8 subunit  O43678 PMF  
22 NADH-ubiquinone oxidoreductase, B9 subunit  095167 PST  
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23 NADH-ubiquinone oxidoreductase, B9 subunit  095167 PST  
24 Similar to upregulated during skeletal muscle growth  AAH07087 PST ? 
25 NADH-ubiquinone oxidoreductase, MNLL subunit  075438 PMF  
26 Not identified    
27 Cytochrome oxidase subunit VIIa heart 
Keratin 
 
 PST 
 
OXPHOS IV 
Contamination 
Table 1B. Identification of Bands Corresponding to Complex II lane 
Nr ID  SWISS-PROT MS protocol Origin if different from OXPHOS II 
1 Succinate dehydrogenase (ubiquinone) flavoprotein subunit  P31040 PST  
2 2,4-Dienoyl CoA reductase  Q16698 PST β-Oxidation 
3 Succinate dehydrogenase (ubiquinone) iron-sulfur protein subunit  P21912 PST  
4 Succinate dehydrogenase (ubiquinone) cytochrome b560 subunit  Q99643 PST  
5 Not identified 
 
   
 Table 1C. Identification of Bands Corresponding to Complex III lane 
Nr ID  SWISS-PROT MS protocol Origin if different from OXPHOS III 
1 Ubiquinol-cytochrome c reductase complex core protein 1  P31930 PST  
2 Ubiquinol-cytochrome c reductase complex core protein 2  P22695 PST  
3 Ubiquinol-cytochrome c reductase complex core protein 2  P22695 PST  
4 Ubiquinol-cytochrome c reductase complex heme protein  P08574 PST  
5 Ubiquinol-cytochrome c reductase complex iron-sulfur subunit  P47985 PST  
6 Ubiquinol-cytochrome c reductase complex iron-sulfur subunit  P47985 PMF  
7 Ubiquinol-cytochrome c reductase complex 6.4 kDa protein   
ATP synthase F chain  
O14957 
P56134 
PST  
OXPHOS V 
8 ATP synthase G chain  075964 PST OXPHOS V 
9 Ubiquinol-cytochrome c reductase complex 11 kDa protein  P07919 PST  
10 Ubiquinol-cytochrome c reductase complex iron-sulfur subunit  
Ubiquinol-cytochrome c reductase complex 14 kDa protein  
P47985 
P14927 
PST 
PST 
 
11 Not identified    
12 Ubiquinol-cytochrome c reductase complex 7.2 kDa protein   
 
Q9UDW1 PST  
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Table 1D.Identification of Bands Corresponding to Complex IV lane 
Nr ID  SWISS-PROT MS protocol Origin if different from OXPHOS IV 
1 Monoamine oxidase B, flavin containing  
Programmed cell death protein 8, AIF  
P27338 
O95831 
PST 
PST 
Mitochondrial outer membrane protein 
Mitochondrial intermembrane 
2 Pyruvate dehydrogenase E1 component alpha subunit  
Cytochrome c oxidase polypeptide I  
P08559 
P00395 
PST 
PST 
Mitochondrial matrix 
3 Cytochrome c oxidase polypeptide II  P00403 PST  
4 Cytochrome c oxidase polypeptide II  P00403 PST  
5 Cytochrome c oxidase polypeptide IV 
Ubiquinol-cytochrome c reductase 14 kDa protein  
NADH-ubiquinone oxidoreductase, 15 kDa subunit  
P13073 
P14927 
O43920 
PST 
PST 
PST 
 
OXPHOS III 
OXPHOS I 
6 Cytochrome c oxidase polypeptide Va  
Cytochrome c oxidase polypeptide Vb  
P20674 
P10606 
PST 
PST 
 
7 Cytochrome c oxidase polypeptide VIc  P09669 PST  
8 Cytochrome c oxidase polypeptide VIIa  P24713 PST  
9 Cytochrome c oxidase polypeptide VIIa  
 
P24713 PST  
 Table 1E.Identification of Bands Corresponding to Complex V lane 
Nr ID  SWISS-PROT MS protocol Origin if different from OXPHOS V 
1 ATP synthase, α-chain  P25705 PMF  
2 ATP synthase, β-chain  P06576 PMF  
3 ATP synthase, γ-chain  P36542 PMF  
4 ATP synthase, B chain  P24539 PMF  
5 ATP synthase, oligomycin sensitivity conferral protein  P48047 PMF  
6 ATP synthase, D-chain  
ATP synthase, A-chain  
O75947 
P00846 
PMF 
PST 
 
7 Cytochrome c oxidase polypeptide IV P13073 PST OXPHOS IV 
8 ATP synthase, δ-chain  P30049 PST  
9 Ubiquinol-cytochrome c reductase 14 kDa protein  
NADH-ubiquinone oxidoreductase 15 kDa subunit  
P14927 
O43920 
PST 
PST 
OXPHOS III 
OXPHOS I 
10 ATP synthase F subunit  P56134 PMF  
11 ATP synthase F subunit  P56134 PMF  
12 ATP synthase G subunit  O75964 PMF  
13 ATP synthase E subunit  P56385 PMF  
14 Not identified    
15 ATP synthase, ε-chain  P56381 PMF  
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In the present work, some subunits were detected in lanes corresponding to higher-
molecular-weight complexes. Some of these, like the ATP synthase α- and β-chains 
in the complex I lane, are reflecting the relatively low resolution in the first dimension, 
as the separation of complex I and V was generally incomplete. The detection of 
traces of complex IV subunits in the lane of complex I was more surprising, since 
complex I and IV normally migrate relatively distinctly in the BN-PAGE gel. Traces of 
subunit 4 of complex IV, for example, were detected in spot 14 of lane I, which is 
located at the same position as band 5 of the complex IV lane. This can be explained 
by the effect of streaking, due to aggregation and/or partial precipitation of the 
complex during the first dimension of the separation. From the current experiments it 
was impossible to quantify the degree of cross-contamination of the lower molecular 
weight complexes in the lane corresponding to complex I. The tailing was also 
observed using histochemical staining methods on one-dimensional BN-PAGE 
separations58.  
 
Apart from the identification of the major constituents of the OXPHOS complexes, we 
made observations that deserve to be mentioned. Among the peptides identified, we 
discovered a new variant of the cytochrome c oxidase VIc subunit that results from a 
change of Glu40 to an Asp residue (Figure 4). The occurrence of polymorphisms in 
several subunits has been reported in the literature, amongst others in the subunits 
IV59 and VIIa. A point mutation of the latter subunit has been associated with 
mitochondrial myophathies60. The variant of the cytochrome c oxidase subunit 
demonstrated here was caused by a neutral mutation with probably no effect on the 
function of this subunit, since the samples used in our study were from a patient in 
whom no OXPHOS deficiency was found.  
We obviously detected proteins that are not a constituent part of OXPHOS 
complexes. The sample preparation was apparently not restricted to the five 
OXPHOS complexes. The detection of keratins and actin was not totally unexpected 
as these are ubiquitous contaminants. Other non-OXPHOS proteins that were 
identified belong to different mitochondrial enzyme systems, such as the β-oxidation 
enzymes that are expected to be abundantly present in mitochondria. Examples of 
such proteins were the very long chain acyl-CoA dehydrogenase (VLCAD), 3-
ketoacyl-CoA synthase, and also some membrane channel proteins like the 
Figure 4. MS/MS of the doubly charged ion with m/z 805.1 of a peptide eluting from the 
nanoLC run of the in situ digest of the lane containing complex IV, band 7.  The deduced 
sequence corresponds to an E40D variant in the sequence of COX subunit VIc. 
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ADP/ATP carrier and the phosphate carrier protein. It is expected that the abundance 
of these proteins is strongly tissue-dependent. BN-PAGE profiles from liver tissue, for 
example, look much less resolved than those from heart61, and indicate relatively 
higher amounts of proteins from different metabolic pathways (see below 4.2.).  
We also detected D-prohibitin, reportedly found to be a chaperone for the 
stabilization of mitochondrial proteins, and to co-elute with BAP-37 (not detected here) 
forming a molecular complex of 1 MDa62. In our study, the fact that it co-migrated 
with the 750 kDa complex I may reflect the size of the protein complex to which it 
belongs. For other proteins, the origin of the co-migration with complex I is at present 
much less clear. VLCAD, for example, is said to form a 120 kDa homodimer63, and 
reports on larger heterocomplexes are not available. We assume that, under the 
native conditions used in BN-PAGE, this and other membrane proteins form 
aggregates that co-migrate with the largest OXPHOS complex. Anyway, it is 
apparent from these results that the migration behavior of proteins under BN-PAGE 
conditions is less predictable than in IEF-SDS-PAGE, and identification, e.g. using 
mass spectrometric methods or specific antibodies, is necessary for the 
unambiguous localization of a particular OXPHOS-component on a two-dimensional 
BN-PAGE gel.  
Surprisingly, we detected proteins associated with the process of cell death, a 
phenomenon in which mitochondria and cytochrome c in particular are known to play 
a central role: the programmed cell death protein 864 and the cell-death regulatory 
protein GRIM 1965. The former is a ubiquitous flavoprotein identified as a caspase-
independent apoptosis inducing factor66,67. GRIM 19 is one of the proteins involved in 
tumor cell death, upon induction using a combination of β-interferon and retinoic acid. 
A recent report suggested that this protein is a subunit of bovine complex I, since it 
was found as a band during a SDS-PAGE separation of the hydrophilic arm of the 
enzyme68. Our observation supports this finding. The MS/MS spectra that prove the 
presence of this protein are given in Figure 5.  
Several subunits could not be identified from this gel (Table 2). It is of concern that 
almost half of the subunits of complex I were absent. Some subunits may be missing 
because the appropriate band was not cut from the gel. Bands were selected on the 
basis of the expected molecular weight of the subunits, but some of these may 
migrate anomalously upon SDS-PAGE. Moreover, several subunits in this complex 
have similar molecular weights and they are not separated during SDS-PAGE. This 
Figure 5. MS/MS spectrum of a 
doubly charged ion with m/z 727.1 
of a peptide eluting from the 
nanoLC run of the in situ digest of 
the lane corresponding to complex 
I, band 15.  The deduced 
sequence and the mass data 
revealed that the peptide is from 
GRIM 19, a programmed cell death 
associated protein. 
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may cause problems to detect specific subunits, especially using an automated PMF 
approach which not always succeeds in identifying all of the proteins in a complex 
mixture. Currently, many new software tools are being developed to overcome this 
problem. Last but not least, most of the missing proteins are either extremely 
hydrophobic (the membrane spanning subunits) or small (less than 10 kDa). In both 
cases, the proteins contain few tryptic cleavage sites, generating only a limited 
number of peptides in the mass range that can be used for PMF and peptide 
sequencing (1000–3500 kDa) and which, therefore, are difficult to detect by 
automated MS approaches. This is particularly true when such proteins are present 
in a band that contains multiple species. A more directed search, specifically looking 
for expected masses, should overcome the problem of detecting the small subunits.  
 
 
The difficulties associated with proteomics of proteins smaller than 150 residues 
have been discussed by Rudd et al69. Membrane spanning proteins in particular  are 
Table 2. List of Missing Subunits. 
Complex Name Mw 
(kDa) 
Explanation 
I Acyl carrier protein 9.6 < 10 kDa 
 NADH-ubiquinone oxidoreductase subunit B14.5A 12.4  
 NADH-ubiquinone oxidoreductase subunit B17.2 17.1  
 NADH-ubiquinone oxidoreductase subunit B12 11.3  
 NADH-ubiquinone oxidoreductase subunit B18 16.3  
 NADH-ubiquinone oxidoreductase subunit B22 21.7  
 NADH-ubiquinone oxidoreductase AGGGsubunit 8.6 < 10 kDa 
 NADH-ubiquinone oxidoreductase KFYI 5.9 < 10 kDa 
 NADH-ubiquinone oxidoreductase MWFE 8.1 < 10 kDa 
 NADH-ubiquinone oxidoreductase chain 1 36 Extremely hydrophobic 
 NADH-ubiquinone oxidoreductase chain 2 39 Extremely hydrophobic 
 NADH-ubiquinone oxidoreductase chain 3 13.2 Hydrophobic 
 NADH-ubiquinone oxidoreductase chain 4 51.6 Hydrophobic 
 NADH-ubiquinone oxidoreductase chain 5 67 Hydrophobic 
 NADH-ubiquinone oxidoreductase chain 6 18.6 Large peptides, hydrophobic 
 NADH-ubiquinone oxidoreductase 13 kDa subunit B 13.3  
 NADH-ubiquinone oxidoreductase 20 kDa subunit 19.7  
 NADH-ubiquinone oxidoreductase chain 4L 10.7 Only 1 trypsin cleavage site 
 NADH-ubiquinone oxidoreductase MLRQ 9.4 < 10 kDa 
 NADH-ubiquinone oxidoreductase 9 kDa  8.5 < 10 kDa 
 NADH-ubiquinone oxidoreductase 19 kDa subunit 
 
19.9  
II Succinate dehydrogenase cytochrome b small subunit 
 
10.9 Limited number of peptides 
III Ubiquinol-cytochrome c reductase complex 
ubiquinone binding protein 
11.2 Limited number of peptides 
 cytochrome b 
 
42.7 Hydrophobic, large peptides 
IV Cytochrome c oxidase polypeptide 3 30 Limited number of peptides, 
hydrophobic 
 Cytochrome c oxidase polypeptide VIa 9.5 < 10 kDa 
 Cytochrome c oxidase polypeptide VIb 10 < 10 kDa 
 Cytochrome c oxidase polypeptide VIIb 6.3 < 10 kDa 
 Cytochrome c oxidase polypeptide VIIc 5.4 < 10 kDa 
 Cytochrome c oxidase polypeptide VIII 
 
4.9 < 10 kDa 
V ATP synthase lipid binding protein (proteolipid 
P1=P2=P3) 
7.6 < 10 kDa 
 ATP synthase protein 8 8.0 < 10 kDa 
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giving problems, because most of their tryptic peptides are expected to be in the 
mass range in which PMF or peptide sequence tag (PST) cannot generally be 
applied. Moreover, many of these peptides may be lost prior and during LC-MS, due 
to hydrophobicity70. Figure 6 displays a schematic overview of the subunits of 
complex V identified in this analysis. 
 
4.2. HUMAN LIVER TISSUE 
 
Note: This section has been adapted from a book chapter, entitled: "Automated nanoflow liquid 
chromatography/tandem mass spectrometric identification of liver mitochondrial proteins". 
Experimental procedures (sample preparation, electrophoresis and mass spectrometric analyses) 
were similar to that for the heart mitochondrial analysis and therefore, we also refer to Appendix C.  
Important changes are mentioned throughout the text. (Handbook of Proteomic Methods 2003, pp. 
181-191) 
 
The effect of genetic deficiencies in the OXPHOS- and related genes is often tissue-
dependent, and for some subunits, even tissue-specific isoforms exist72.  Therefore, 
we also attempted to analyze the liver OXPHOS proteome. The mitochondrial 
proteome map of this tissue is shown in Figure 7.  All the labeled protein spots from 
the map were excised from the gel, digested with trypsin, and the resulting digestion 
mixtures analyzed by mass spectrometry. The results are summarized in Table 3. 
Figure 6. Identified subunits from ATP synthase, complex V.  The model approximates the 
precise positioning of the subunits in the complex.  The identified subunits are highlighted in 
yellow, while the subunits in pink were not identified. Note that only a few, mainly the 
transmembrane subunits, were not detected. Adapted from ref. 71 
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Table 3. Identification of the Excised Bands from the Human Liver Mitochondrial Proteome Map 
Nr. Protein ID Mw (kDa) pI SWISS-PROT 
1 Not identified - - - 
2 Prohibitin 29.80 5.57 P35232 
3 ATP synthase α-chain 55.21 8.28 P25705 
4 ATP synthase β-chain 51.77 5.00 P06576 
5 ATP synthase γ-chain 30.17 9.02 P36542 
6 ATP synthase B-chain 24.63 9.10 P24539 
7 ATP synthase α-chain 
ATP synthase O subunit 
55.21 
20.88 
8.28 
9.81 
P25705 
P48047 
8 ATP synthase A-chain  
ATP synthase D-chain  
24.82 
18.36 
10.09 
5.22 
P00846 
O75947 
9 Not identified - - - 
10 ATP synthase E chain 7.80 9.35 P56385 
11 60 kDa Heat shock protein 
Ubiquinol-cytochrome c reductase complex core protein 2 
57.96 
46.78 
5.24 
7.74 
P10809 
P22695 
12 ADP/ATP carrier protein 
2,4-dienoyl-coA isomerase 
35.38 
32.15 
9.86 
8.79 
Q59EI9 
Q16698 
13 Cytochrome c1 27.35 6.49 P08574 
14 Superoxide dismutase [Mn] 22.20 6.86 P04179 
15 Cytochrome c oxidase polypeptide Va 
Cytochrome c oxidase polypeptide Vb 
Dopachrome tautomerase 
12.51 
10.61 
56.69 
4.88 
6.33 
6.59 
P20674 
P10606 
P40126 
16 Cytochrome c oxidase polypeptide VIIa-L 6.72 6.44 P14406 
17 Catalase 
60 kDa Heat shock protein 
Liver Carboxylesterase 1 
59.62 
57.96 
62.52 
6.95 
5.24 
6.15 
P04040 
P10809 
P23141 
18 Glutamate dehydrogenase 56.01 6.71 P00367 
19 Hemoglobin β-chain 15.87 6.81 P02023 
20 Glutamate dehydrogenase 56.01 6.71 P00367 
21 Aldehyde dehydrogenase 54.44 5.69 P05091 
22 Electron transfer flavoprotein α-subunit 35.08 8.62 P13804 
23 Electron transfer flavoprotein β-subunit  
Enoyl-coA hydratase 
27.84 
28.34 
8.25 
5.88 
P38117 
P30084 
24 Aldehyde dehydrogenase 54.44 5.69 P05091 
25 Electron transfer flavoprotein α-subunit 35.08 8.62 P13804 
26 Electron transfer flavoprotein β-subunit  27.84 8.25 P38117 
27 Cytochrome c oxidase polypeptide II 25.57 4.67 P00403 
Figure 7| BN-PAGE of human liver 
mitochondrial extracts; 900 µg of 
protein extract was loaded.  The labels 
indicate the bands that were excised 
for identification by mass spectrometric 
analysis methods. 
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Table 3. Continued. 
28 Microsomal glutathione S-transferase 1 
ATP synthase δ-chain 
17.60 
15.02 
9.41 
4.53 
P10620 
P30049 
29 Not identified - - - 
30 Not identified - - - 
31 Propionyl-coA carboxylase α-chain 75.00 6.26 P05165 
32 3-Ketoacyl-coA thiolase  41.92 8.32 P42765 
33 Acyl-coA dehydrogenase 41.72 6.15 P16219 
34 2,4-Dienoyl-coA reductase 32.15 8.79 Q16698 
35 Enoyl-coA hydratase 31.35 8.50 P30084 
36 Cytochrome b5 
Cytochrome c oxidase polypeptide IV 
15.20 
17.20 
4.88 
9.16 
P00167 
P13073 
37 Thioredoxin dependent peroxide reductase 27.69 7.68 P30048 
38 NADH-ubiquinone oxidoreductase MLRQ subunit 9.37 9.42 O00483 
 
 
Although the main pattern is similar, the BN-2D-PAGE of liver mitochondria displays 
some differences compared with that of heart.   Therefore, we also focused on those 
proteins of which the bands were outside the OXPHOS lane to make a global 
analysis of the liver BN-2D-PAGE map and in order to have more information on the 
presence of other, potentially interesting, mitochondrial protein complexes.   As the 
relatively poor resolution of the BN-PAGE technique generates spots that very often 
contain mixtures of multiple proteins, and because some of the proteins are very 
small or membranar and have a limited number of tryptic peptides, MS/MS data is 
mostly needed for unambiguous protein identification.  By way of example, the 
identification of spot 31 by nanoLC-MS/MS is shown in Figure 8. The top part of the 
figure shows the total ion current chromatogram. From each peak, a MS spectrum, 
and a MS/MS spectrum has been taken, the latter on condition that the MS signal 
intensity reached a particular value. The MS spectrum of the labeled peak is shown 
in Figure 8B and the MS/MS spectrum in Figure 8C. 
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Figure 8. Identification of a protein by nanoLC-MS/MS (spot 31 on the liver BN-2D-PAGE gel). (A) The total ion current chromatogram, displaying the 
intensities of the mass spectral signal in function of time.  The peak labels show the masses of the precursor ions selected for fragmentation. (B) The 
peak labeled 749.9 corresponds to the signal of the fragment ions from the doubly charged ion with a mass-to-charge ratio of 749.90. (C) The 
corresponding MS/MS spectrum, from which the sequence [L/I]NMDA[L/I] is easily deduced. (Note that this type of fragmentation does not distinguish 
between Leu and Ile.) The protein is identified as propionyl-coA carboxylase (α-chain). 
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We also focused on proteins that were different from the earlier published heart BN-
PAGE. A striking example of the power of LC-MS/MS analysis was the ability to 
distinguish between the tissue-specific isoforms of subunit VIIa of the cytochrome c 
oxidase complex. On the heart proteome map, both the liver/heart and heart isoform 
were detected, while in the liver map (spot 16) exclusively the first isoform was 
detected. Figure 9 shows the MS/MS spectra that distinguishes these forms.  
Compared to the heart proteome map, we could identify one extra subunit (spot 
38), the MLRQ subunit of complex I (Figure 10). This spot is far out of the lane 
corresponding to the entire complex, and it is likely that it dissociated from the 
complex, unlike the other subunits.  
Apart from the OXPHOS-proteins, we detected several subunits from other 
mitochondrial complexes, such as the tri-functional enzyme (spot 25, α- subunit and 
spot 26, β-subunit). We expected these proteins to appear in the gel pattern, since 
liver samples contain relatively more enzymes of other metabolic pathways, 
particularly from the ß-oxidation of fatty acids. Further research will be needed to 
investigate the reproducibility of the presence and localization of these proteins in the 
2D pattern and, therefore, to see whether the method is suitable for investigating a 
wider range of mitochondrial proteins in the study of non-OXPHOS related diseases. 
Figure 9. Distinguishing between the isoforms of complex IV, subunit VIIa. (A)The spectrum of a 
peptide of the liver/heart-type isoform (sequence LFQEDDEIPLYLK). (B) The heart isoform 
(sequence LFQEDNDIPLYLK), differing by only two amino acids. 
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4.3. A QUALITATIVE COMPARATIVE ANALYSIS 
As we mentioned above, several diseases are known to originate from mutations in 
the enzymes from the oxidative phosphorylation, or from defects in the assembly 
genes necessary to construct the large multienzyme complexes correctly73, some of 
them being even lethal at very young age.  We used the reference map of liver tissue 
in the study of a patient who deceased, at the age of only one month, from a 
mitochondrial disorder. Acidosis and increased blood lactate concentrations were 
apparent in this patient.  Although the activities of the OXPHOS complexes were 
normal in fibroblast, skeletal muscle and heart muscle and although mtDNA analysis 
did not reveal any abnormality, a severe combined deficiency of complexes I, III, IV 
and V from the liver were found spectrophotometrically. Catalytic staining in the blue 
native gel confirmed these observations; the procedure is comprehensively described 
in Smet et al74.  The BN-2D-PAGE gel is shown in Figure 11.  All labeled protein 
bands were excised and submitted to mass spectrometric analysis.  The results are 
summarized in Table 4. 
 
 
 
 
 
Figure 10| The MS/MS spectrum that allowed us to identify the complex I MLRQ 
subunit by BN-2D-PAGE of the liver. 
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Table 4. Identification of the Excised Bands from the Liver BN-2D-PAGE Map of  the Patient 
Nr. Protein ID Mw (kDa) pI SWISS-PROT 
1 Not identified - - - 
2 Prohibitin 29.80 5.57 P35232 
3 ATP synthase α-chain 55.21 8.28 P25705 
3a ATP synthase α-chain 
UTP-Glucose-1-phosphate uridylyltransferase 
δ-1-Pyrroline-5-carboxylate dehydrogenase 
55.21 
56.82 
59.03 
8.28 
7.67 
6.96 
P25705 
Q07131 
P30038 
4 ATP synthase β-chain 51.77 5.00 P06576 
5 ATP synthase γ-chain 30.17 9.02 P36542 
6 ATP synthase B-chain 
Superoxide dismutase [Mn] 
24.63 
22.20 
9.10 
6.86 
P24539 
P04179 
7 ATP synthase α-chain  
ATP synthase β-chain  
ATP synthase D-chain 
55.21 
51.77 
18.36 
8.28 
5.00 
5.22 
P25705 
P06576 
O75947 
8 ATP synthase α-chain  55.21 8.28 P25705 
9 ATP synthase α-chain 
ATP synthase F chain 
55.21 
10.79 
8.28 
9.70 
P25705 
P56134 
10 ATP synthase E chain 7.80 9.35 P56385 
11 Trifunctional enzyme β-subunit 47.48 9.24 P55084 
14 Superoxide dismutase [Mn] 
ATP synthase D chain 
22.20 
18.36 
6.86 
5.22 
P04179 
P56385 
15 ATP synthase F chain  
Ubiquinol-cytochrome C reductase complex 14 kDa protein 
10.79 
13.40 
9.70 
8.75 
P56134 
P14927 
17 Catalase 
60 kDa Heat shock protein 
Liver Carboxylesterase 1 
59.62 
57.96 
62.52 
6.95 
5.24 
6.15 
P04040 
P10809 
P23141 
17a Glutamate dehydrogenase  
Aldehyde dehydrogenase 
56.01 
54.44 
6.71 
5.69 
P00367 
P05091 
18 Glutamate dehydrogenase 1, mitochondrial 56.01 6.71 P00367 
19 Hemoglobin β-chain 15.87 6.81 P68871 
19a Glutamate dehydrogenase 56.01 6.71 P00367 
20 Glutamate dehydrogenase 56.01 6.71 P00367 
21 Aldehyde dehydrogenase 54.44 5.69 P05091 
23 Electron transfer flavoprotein β-subunit 27.84 8.25 P38117 
24 Aldehyde dehydrogenase 
Fumarate hydratase 
54.44 
50.08 
5.69 
6.99 
P05091 
P07954 
25 Electron transfer flavoprotein α-subunit 35.08 8.62 P13804 
Figure 11. (A) BN-PAGE of human 
liver mitochondrial extracts from an one 
month old patient.  The labels indicate 
the bands that were excised for 
identification by mass spectrometric 
analyses.  
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Table 4. Continued. 
26 Electron transfer flavoprotein β-subunit  
Aldehyde dehydrogenase 
27.84 
54.44 
8.25 
5.69 
P38117 
P05091 
30 3-Ketoacyl-coA thiolase  
Carbamoyl-phosphate synthase 
41.92 
160.55 
8.32 
5.92 
P42765 
P31327 
32 3-Ketoacyl-coA thiolase  41.92 8.32 P42765 
33 Acyl-coA dehydrogenase 41.72 6.15 P16219 
34 2,4-Dienoyl-coA reductase 
Enoyl-coA hydratase 
32.15 
28.34 
8.79 
5.88 
Q16698 
P30084 
35 Enoyl-coA hydratase 31.35 8.50 P30084 
36 Cytochrome B5 15.20 4.88 P00167 
37 Thioredoxin-dependent peroxide reductase 27.69 7.68 P30048 
38 Chaperonin 10 10.80 8.91 P61604 
A ATP synthase β-chain 
4-aminobutyrate aminotransferase 
60 kDa Heat shock protein 
51.77 
53.27 
57.96 
5.00 
7.19 
5.24 
P06576 
P80404 
P10809 
B Ferritin light chain 
ATP synthase α-chain 
60 kDa Heat shock protein 
Trifunctional enzyme α-subunit 
19.89 
55.21 
57.96 
79.01 
5.51 
8.28 
5.24 
8.98 
P02792 
P25705 
P10809 
P40939 
C Electron transfer flavoprotein α-subunit  
Ornithine carbamoyltransferase 
Peroxisomal bifunctional enzyme 
35.08 
36.35 
79.21 
8.62 
7.24 
9.22 
P13804 
P00480 
Q08426 
 
Comparison of the protein pattern of the patient with the reference map clearly shows 
the absence of subunits from complex IV.  In agreement with this, no single subunit 
was found from this complex, although some subunits could be identified in the 
reference map.  Furthermore, one extra band was present on the BN-2-D-PAGE gel 
(Figure 12), and ATP synthase α subunit was identified in it. In addition, multiple 
'forms' of the α and β subunits of ATP synthase were found all over the gel (Table 4).  
For example, the ATP synthase β subunit was identified by MALDI TOF-TOF MS in 
spot A, which is definitely not its proper position (Figure 13). These observations may 
be, speculatively, due to truncation or misfolding of the ATP synthase α and β 
subunits. The abnormal subunit composition of complex V was also confirmed by 
immunoblotting, using antibodies against complex V subunits. 
 
 
 
 
Figure 12. (left) Detail of the upper left region of the human 
liver reference map (see Figure 7). (right) Detail of the 
picture provided in Figure 11 (upper left). 
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Figure 13. (A) A typical MS spectrum obtained with the MALDI TOF-TOF mass spectrometer from 
the tryptic digest of spot A in Figure 11.  Using peptide mass fingerprint analysis, we could identify 
this protein as ATP synthase, β subunit.  All the indicated masses match the theoretical values 
within 50 ppm. (B) MALDI TOF/TOF CID spectrum, obtained in the 1 kV mode, of the peak 1921.97 
Da , labeled (*) in (A).  Numerous ion fragments are present and the complete amino acid sequence 
(nl. DQEGQDVLLFIDNIFR) can be deduced from this spectrum.  Logically, a MS/MS ion search 
(Mascot) identified this protein unambiguously as ATP synthase, β subunit. (Inset): Detail of the 
MS/MS spectrum in the 1kV (upper trace) and in the 2kV mode (lower trace) from the peak labeled 
in (A).  Due to the higher energy used in 2kV mode, more high-energy side-chain fragmentation ions 
are present, allowing to distinguish isobaric amino acids.  
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Finally, the ubiquinol cytochrome c reductase core protein 2 was not detected in the 
gel, while this protein was well detected, and at the right position, in the reference 
map.  Again, immunoblotting against this subunit clearly showed a decrease in 
abundance for the patient and, therefore, confirmed our result.  In conclusion, the 
BN-2-D-PAGE liver proteome map of this patient reveals some indications on the 
deficiency in the oxidative phosphorylation. 
 
4.4. CONCLUSIONS 
The technique of blue native polyacrylamide gel electrophoresis uses specific 
detergents, and has shown to be powerful in the analysis of membrane proteins. We 
identified a large number of the OXPHOS-related proteins by this technique, 
combined in a two-dimensional approach with SDS-PAGE, of the human heart 
mitochondrial proteome. On the other hand, the BN-2D-PAGE of liver mitochondria 
showed some differences compared with that of heart.  We could profile less 
subunits of the OXPHOS system, possibly due to the presence of several other 
mitochondrial proteins involved in different metabolic pathways, such as the ß-
oxidation of fatty acids.   
The reference map from human heart and liver are of considerable use for further 
analysis of post mortem material or bioptic samples, and can be used for the 
diagnosis of mitochondrial diseases due to defects in OXPHOS complexes or to 
proteins closely linked to these complexes. The fingerprints displayed by this 
technique rapidly show the absence of individual subunits, or even of complete shifts, 
in the pattern.  For example, the map of human heart that we presented in our paper 
has been successfully utilized by others as a reference for the analysis of the 
mitochondrial proteome in response to chronic ethanol abuse75.  We also used this 
approach for a qualitative comparative analysis of a patient, displaying a severe 
mitochondrial defect.  Serious defects in the oxidative phosphorylation were revealed 
by comparison of the proteome maps, control and patient, from liver tissue. Further 
research will be needed to investigate the underlying biochemical cause(s) of this 
particular mitochondrial disorder. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER VII                                         MS OF BN-PAGE SEPARATED OXPHOS PROTEINS 
 121 
5. REFERENCES 
 
1  Holt, I.J.; Harding, A.E.; Morgan Hughes, J.A. Deletions of muscle mitochondrial DNA in patients 
with mitochondrial myopathies. Nature 1988, 331, 717-719 
2  Wallace, D.C.; Singh, G.; Lott, M.T. et al. Mitochondrial DNA mutation associated with Leber’s 
hereditary optic neuropathy. Science 1988, 242, 1427-1430 
3  Anderson, N.L.; Matheson, A.D.; Steiner, S. Proteomics: applications in basic and applied biology. 
Curr. Opin. Biotech. 2000, 11, 408-412 
4  McDonald, T.G.; Van Eyk, J.E. Mitochondrial proteomics: undercover in the lipid bilayer. Basic 
Res. Cardiol. 2003, 98, 219-227 
5  Lopez, M.F.; Melov, S. Applied Proteomics: mitochondrial proteins and effect on functions. Circ. 
Res. 2002, 90, 380-389 
6  Anderson, S.; Bankier, A.T.; Barrell, B.G. et al. Sequence and organization of the human 
mitochondrial genome. Nature 1981, 290, 457-465 
7  Westermann, B.; Neupart, W. ‘Omimics of the mitochondrion’: two complementary proteomics 
approaches promise to move us closer to definition of the complete complement of proteins that 
make up a mitochondrion. Nat. Biotechnol. 2003, 21, 239-240 
8  Taylor, R.D.; Pfanner, N. The protein import and assembly machinery of the mitochondrial outer 
membrane. Biochim. Biophys. Acta 2004, 1658, 37-43 
9  Truscott, K.N.; Brandner, K.; Pfanner, N. Mechanisms of protein import into mitochondria. Curr. 
Biol. 2003, 13, R326-337 
10  Saraste, M. Oxidative phosphorylation at the fin de siecle. Science 1999, 283, 1488–1493 
11  Voet, D.; Voet, J.G. Biochemistry, 2nd edition, Wiley & Sons, Inc. 1995, pp. 563-598  
12  Walker, J.E.; Skehel, J.M.; Buchanan, S.K. Structural analysis of NADH:ubiquinone 
oxidoreductase from bovine heart mitochondria. Methods Enzymol. 1995, 260, 14-34 
13  Skehel, J.M.; Fearnley, I.M.; Walker, J.E. NADH: ubiquinone oxidoreductase from bovine heart 
mitochondria: sequence of a novel 17.2-kDa subunit. FEBS Lett. 1998, 438, 301-305 
14  Carroll, J.; Shannon, R.J.; Fearnley, I.M. et al. Definition of the nuclear encoded protein 
composition of bovine heart mitochondrial complex I - Identification of two new subunits. J. Biol. 
Chem. 2002, 277, 50311–50317 
15  Hatefi, Y. The mitochondrial electron transport and oxidative phosphorylation system. Annu. Rev. 
Biochem. 1985, 34, 1015-1069 
16  Ohnishi, T. Iron-sulfur clusters/semiquinones in complex I. Biochim. Biophys. Acta 1998, 1364, 
186–206 
17  Friedrich, T.; Scheide, D. The respiratory complex I of bacteria, archaea and eukarya and its 
module common with membrane-bound multi-subunit hydrogenases. FEBS Lett. 2000, 479, 1–5 
18  Yano, T.; Magnitsky, S.; Ohnishi, T. Characterization of the complex I-associated ubisemiquinone 
species: toward the understanding of their functional roles in the electron/proton transfer reaction. 
Biochim. Biophys. Acta 2000, 1459, 299–304 
19  Schuelke, M.; Loeffen, J.; Mariman, E. et al. Cloning of the human mitochondrial 51 kDa subunit 
(NDUFV1) reveals a 100% antisense homology of its 3’UTR with the 5’UTR of the α-interferon 
inducible protein (IP-30) precursor: is this a link between mitochondrial myopathy and 
inflammation? Biochem. Biophys. Res. Commun. 1998, 245, 599-606 
20  Loeffen, J.; van den Heuvel, L.; Smeets, R. et al. cDNA sequence and chromosomal localization 
of the remaining three human nuclear encoded iron sulphur protein (IP) subunits of complex I: the 
human IP fraction is completed. Biochem. Biophys. Res. Commun. 1998, 247, 751-758 
CHAPTER VII                                         MS OF BN-PAGE SEPARATED OXPHOS PROTEINS 
 122 
21  Loeffen, J.; Triepels, R.H.; van den Heuvel, L.P. et al. cDNA of eight nuclear encoded subunits of 
NADH:ubiquinone oxidoreductase: human complex I cDNA characterization completed. Biochem. 
Biophys. Res. Commun. 1998, 253, 415-422 
22  Grigorieff N. Three-dimensional structure of bovine NADH : Ubiquinone oxidoreductase (Complex 
I) at 22 angstrom in ice. J. Mol. Biol. 1998, 277, 1033–1046 
23  Guenebaut, V.; Schlitt, A.; Weiss, H.; Friedrich, T. Consistent structure between bacterial and 
mitochondrial NADH : ubiquinone oxidoreductase (complex I). J. Mol. Biol. 1998, 276, 105–112 
24  Kadenbach, B.; Scheneyder, B.; Mell, O. et al. Respiratory chain proteins. Rev. Neurol. 1991, 147, 
436-442 
25  Trumpower, B.L.; Gennis, R.B. Energy transduction by cytochrome complexes in mitochondrial 
and bacterial respiration - the enzymology of coupling electron-transfer reactions to 
transmembrane proton translocation. Annu. Rev. Biochem. 1994, 63, 675–716 
26  Berry, E.A.; Guergova-Kurus, M.; Huang, L. et al. Structure and function of cytochrome bc 
complexes. Annu. Rev. Biochem. 2000, 69, 1005–75 
27  Mathews, C.K.; Van Holde, K.E. Biological oxidations, electron transport, and oxidative 
phosphorylation. In: Biochemistry, 2nd edition. Edited by: Scanlan-Rohrer, A.; Parlante, S.; With, 
L., Melon Park, Benjamin/Cummings, Inc. 1996, pp. 520-553 
28  Yoshikawa, S.; Shinzawa-Itoh, K.; Tsukihara, T. X-ray structure and the reaction mechanism of 
bovine heart cytochrome c oxidase. J. Inorg. Biochem. 2000, 82, 1–7 
29  Ludwig, B.; Bender, E.; Arnold, S. et al. Cytochrome c oxidase and the regulation of oxidative 
phosphorylation. Chembiochem. 2001, 2, 392–403 
30  Takamiya, S.; Lindorfer, M.A.; Capaldi, R.A. Purification of all thirteen polypeptides of bovine heart 
cytochrome c oxidase from one aliquot of enzyme. FEBS Lett. 1987, 218, 277-282 
31  Buse, G.; Meinecke, L.; Bruch, B. The protein formula of beef heart cytochrome c oxidase. J. Inorg. 
Biochem. 1985, 23, 149-153 
32  Lutter, R.; Saraste, M.; Vanwalraven, H.S. et al. F1F0-ATP synthase from bovine heart 
mitochondria - development of the purification of a monodisperse oligomycin-sensitive ATPase. 
Biochem. J. 1993, 295, 799–806 
33  Kadenbach, B.; Scheneyder, B.; Mell, O. et al. Respiratory chain proteins. Rev. Neurol. 1991, 147, 
436-442 
34  Walker, J.E.; Collinson, I.R.; van Raaij, M.J. et al. Structural analysis of ATP synthase from bovine 
heart mitochondria. Methods Enzymol. 1995, 260, 163-190 
35  Walker, J.E. Determination of the structures of respiratory enzyme complexes from mammalian 
mitochondria. Biochim. Biophys. Acta 1995, 1271, 221-227 
36  Mitchell, P. Vectorial chemistry and the molecular mechanics of chemiosmotic coupling: power 
transmission by proticity. Biochem. Soc. Trans. 1976, 4, 398-430 
37  Rottenberg, H. Decoupling of oxidative phosphorylation and photophosphorylation. Biochim. 
Biophys. Acta 1990, 1018, 1-17 
38  Brown G.C. Control of respiration and ATP synthesis in mammalian mitochondria and cells. 
Biochem. J. 1992, 284, 1-13 
39  Rolfe, D.F.; Brand, M.D. Contribution of mitochondrial proton leak to skeletal muscle respiration 
and to standard metabolic rate. Am. J. Physiol. 1996, 271, C1380-1389 
40  Rolfe, D.F.; Newman, J.M.; Buckingham, J.A. et al. Contribution of mitochondrial proton leak to 
respiration rate in working skeletal muscle and liver and to SMR. Am. J. Physiol. 1999, 276, C692-
699 
CHAPTER VII                                         MS OF BN-PAGE SEPARATED OXPHOS PROTEINS 
 123 
41  Schägger, H.; von Jagow, G. Blue native electrophoresis for isolation of membrane protein 
complexes in enzymatically active form. Anal. Biochem. 1991, 199, 223-331 
42  Poetsch, A.; Neff, D.; Seelert, H. et al. Dye removal, catalytic activity and 2D crystallization of 
chloroplast H+-ATP synthase purified by blue native electrophoresis. Biochim. Biophys. Acta 2000, 
1466, 339-349 
43  Heazlewood, J.L.; Howell, K.A.; Whelan, J. et al. Towards an analysis of the rice mitochondrial 
proteome. Plant Physiol. 2003, 132, 230-242 
44  Schägger, H.; von Jagow, G. Blue native electrophoresis for isolation of membrane protein 
complexes in enzymatically active form. Anal. Biochem. 1991, 199, 223-331 
45  Schägger, H.; Cramer, W.A.; von Jagow, G. Analysis of molecular masses and oligomeric states 
of protein complexes by blue native electrophoresis and isolation of membrane protein complexes 
by two-dimensional native electrophoresis. Anal. Biochem. 1994, 217, 220-230 
46  Zerbetto, E.; Vergani, L.; Dabbeni-Sala, F. Quantification of muscle mitochondrial oxidative 
phosphorylation enzymes via histochemical staining of blue native polyacrylamide gels. 
Electrophoresis 1997, 18, 2059-2064 
47  Van Coster, R.; Smet, J.; George, E. et al. Blue native polyacrylamide gel electrophoresis: a 
powerful tool in diagnosis of oxidative phosphorylation defects. Pediatric Res. 2001, 50, 658-665 
48  Klement, P.; Nijtmans, L.G.; Van den Bogert, C. et al. Analysis of oxidative-phosphorylation 
complexes in cultured human fibroblasts and amniocytes by blue-native-electrophoresis using 
mitoplasts isolated with the help of digitonin. Anal. Biochem. 1995, 231, 218-224 
49  Bentlage, H.; De Coo, R.; ter Laak, H. et al. Human-diseases with defects in oxidative-
phosphorylation: decreased amounts of assembled oxidative-phosphorylation complexes in 
mitochondrial encephalomyopathies. Eur. J. Biochem. 1995, 227, 909-915 
50  Houstek, J.; Klement, P.; Hermanska, J. et al. Complex approach to prenatal diagnosis of 
cytochrome c oxidase deficiencies. Prenat. Diagn. 1999, 19, 552-558 
51  Schägger, H. Quantification of oxidative phosphorylation enzymes after blue native 
electrophoresis and two-dimensional resolution: Normal complex I protein amounts in Parkinson's 
disease conflict with reduced catalytic activity.  Electrophoresis 1995, 16, 763-770 
52  Schägger, H.; Ohm, T.G. Human diseases with defects in oxidative phosphorylation: F1F0 ATP-
synthase defects in Alzheimer disease revealed by blue native polyacrylamide gel electrophoresis. 
Eur. J. Biochem. 1995, 227, 916-923 
53  Culvenor, J.G.; Ilaya, N.T.; Ryan, M.T. et al. Characterization of presinilin complexes from mouse 
and human brain using Blue Native gel electrophoresis reveals high expression in embryonic brain 
and minimal change in complex mobility with pathogenic presinilin mutations. Eur. J. Biochem. 
2004, 271, 375-385 
54  Rasmusson, A.G.; Agius, S.C. Rotenone-insensitive NAD(P)H dehydrogenases in plants: 
immuno-detection and distribution of native proteins in mitochondria. Plant Physiol. Biochem. 2001, 
39, 1057-1066 
55  Kruft, V.; Eubel, H.; Jänsch, L. et al. Proteomic approach to identify novel mitochondrial proteins in 
Arabidopsis. Plant Physiol. 2001, 127, 1694-1710 
56  Millar, H.; Sweetlove, L.; Giege, P. et al. Analysis of the Arabidopsis mitochondrial proteome.  
Plant Physiol. 2001, 127, 1711-1727 
57  Nijtmans, L.G.J.; Taanman, J.W.; Muijsers, A.O. et al. Assembly of cytochrome-c oxidase in 
cultured human cells. Eur. J. Biochem. 1998, 254, 389-394 
58  Van Coster, R.; Smet, J.; George, E. et al. Blue native polyacrylamide gel electrophoresis: a 
powerful tool in diagnosis of oxidative phosphorylation defects. Pediatric Res. 2001, 50, 658-665 
CHAPTER VII                                         MS OF BN-PAGE SEPARATED OXPHOS PROTEINS 
 124 
59  Van Kuilenburg, A.B.P.; Van Beeumen, J.J.; Demol, H. et al. Subunit IV of human cytochrome c 
oxidase, polymorphism and a putative isoform. Biochim. Biophys. Acta 1992, 1119, 218-224 
60  Van Beeumen, J.J.; Van Kuilenburg, A.B.P.; Van Bun, S. et al. Demonstration of 2 isoforms of 
subunit VIIa of cytochrome c oxidase from human skeletal muscle: implications for mitochondrial 
myopathies. FEBS Lett. 1990, 263, 213-216 
61  Schägger, H. Quantification of oxidative phosphorylation enzymes after blue native 
electrophoresis and two-dimensional resolution: Normal complex I protein amounts in Parkinson's 
disease conflict with reduced catalytic activity.  Electrophoresis 1995, 16, 763-770 
62  Nijtmans, L.G.J.; de Jong, L.; Sanz, M.A. et al. Prohibitins act as a membrane-bound chaperone 
for the stabilization of mitochondrial proteins. EMBO J. 2000, 19, 2444-2451 
63  Souri, M.; Aoyama, T.; Hoganson, G. et al. Very-long-chain acyl-CoA dehydrogenase subunit 
assembles to the dimer form on mitochondrial inner membrane. FEBS Lett. 1998, 426, 187-190 
64  Susin, S.A.; Lorenzo, H.K.; Zamzami, N. et al. Molecular characterization of mitochondrial 
apoptosis-inducing factor.  Nature 1999, 397, 441-446 
65  Angell, J.E.; Lindner, D.J.; Shapiro, P.S. et al. Identification of GRIM-19, a novel cell death-
regulatory gene induced by the interferon-beta and retinoic acid combination, using a genetic 
approach. J. Biol. Chem. 2000, 275, 33416-33426 
66  Daugas, E.; Nochy, D.; Ravagnan, L. et al. Apoptosis-inducing factor (AIF): a ubiquitous 
mitochondrial oxidoreductase involved in apoptosis. FEBS Lett. 2000, 476, 118-123 
67  Lorenzo, H.K.; Susin, S.A. Mitochondrial effectors in caspase-independent cell death. FEBS Lett. 
2004, 557,14-20 
68  Fearnley, I.M.; Carroll, J.; Shannon, R.J. et al. GRIM-19, a cell death regulatory gene product, is a 
subunit of bovine mitochondrial NADH : Ubiquinone oxidoreductase (complex I). J. Biol. Chem. 
2001, 276, 38345-38348 
69  Rudd, K.E.; Humphery-Smith, I.; Wasinger, V.C. et al. Low molecular weight proteins: A challenge 
for post-genomic research. Electrophoresis 1998, 19, 536-544 
70  van Montfort, B.A.; Canas, B.; Duurkens, R. et al. Improved in-gel approaches to generate peptide 
maps of integral membrane proteins with matrix-assisted laser desorption/ionization time-of-flight 
mass spectrometry. J. Mass Spec. 2002, 37, 322–330 
71  Patton, W.F.; Schulenberg, B.; Steinberg, T.H. Two-dimensional gel electrophoresis; better than a 
poke in the ICAT? Curr. Opin. Biotechnol. 2002, 13, 321-328 
72  Van Kuilenburg, A.B.P.; Van Beeumen, J.J.; Van der Meer, N.M. et al. Subunits VIIa,b,c of human 
cytochrome c oxidase.  Identification of both 'heart-type' and 'liver-type' isoforms of subunit VIIa in 
human heart. Eur. J. Biochem. 1992, 203, 193-199 
73  Schoffner, J.M. An introduction: oxidative phosphorylation diseases. Semin. Neurol. 2001, 21, 
237-250 
74  Smet, J.; Devreese, B.; Van Beeumen, J. et al. Non-denaturing polyacrylamide gel electrophoresis 
as a method for studying protein interactions: applications in the analysis of mitochondrial 
oxidative phosphorylation complexes. Cell Biology 2005, pp. 259-264 
75  Venkatraman, A.; Landar, A.; Davis, A.J. et al. Modification of the Mitochondrial Proteome in 
Response to the Stress of Ethanol-dependent Hepatotoxicity. J. Biol. Chem. 2004, 279, 22092-
22101 
 
 
 
 
      CHAPTER VIII
                                           
 125 
 
CHAPTER VIII 
 
PROTEIN PROFILING OF 
THE MYELIN SHEATH 
 
 
 
Multi-dimensional liquid chromatography has been shown to be successful in the 
analysis of membrane proteins and highly basic proteins.  We have applied this 
strategy for profiling the protein composition of the myelin sheath.  This specialized 
membrane contains a specific selection of proteins and, moreover, is overwhelmingly 
dominated by just two types of protein, the myelin basic protein and proteolipid 
protein.  The identification and characterization of the other proteins, in this context, 
is thus a real challenge.  In this chapter, we will present and discuss the results from 
our proteomic approach, using multi-dimensional liquid chromatography in 
combination with MALDI TOF-TOF mass spectrometry.  A comparison between this 
strategy and a classical approach, i.e. two-dimensional gel electrophoresis and mass 
spectrometry, is given and discussed.  
 
 
 
Note: This chapter has been adapted from the paper, entitled: "Profiling of myelin proteins by 2D-gel 
electrophoresis and multidimensional liquid chromatography coupled to MALDI TOF-TOF mass 
spectrometry". Details on the experimental procedures are provided in appendix D. (Journal of 
Proteome Research 2005, in press) 
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1. INTRODUCTION 
The myelin sheath is formed by oligodendrocytes in the central nervous system (CNS) 
that wrap layer upon layer of their own membrane (up to a hundred times) around an 
axon in a tight spiral, thereby forming an electrically insulating sheath1 (Figure 1). 
This sheath plays a key role in the function of the nervous system by allowing fast 
saltatory conduction of nerve pulses.  Serious neurological disorders can occur due 
to loss, or damage, of this specialized membrane2. Multiple sclerosis, for example, is 
a frequently occurring disease in adults, characterized by plaques of demyelination in 
the CNS3. More generalized demyelination is seen in several diseases, affecting 
mainly children, due to congenital defects in lysosomal and peroxisomal proteins4. 
Much less defined is the large group of dysmyelinating diseases where the myelin is 
not degraded but has never been well formed. A defect has been found in only one of 
these diseases; it turned out to be located in the proteolipid protein (PLP)5.   
The myelin sheath is a specialized membrane containing very little water, high 
amounts of lipids (~70%) and a specific selection of proteins (~30%). The protein 
fraction is dominated by a few major proteins, including myelin basic protein (MBP), 
proteolipid protein (PLP) and its alternatively spliced isoforms (DM-20), which 
account for most of the protein mass (~30% and ~50%, respectively)6.  However, the 
identity and function of many minor proteins are beginning to be revealed.  The 
protein composition of the myelin sheath has already been investigated by several 
proteomic strategies7-9.  In these studies, proteins were separated by two-
dimensional gel electrophoresis (2D-PAGE), using different experimental conditions, 
followed by identifications using Western blotting.  Recently, Taylor and co-workers10 
reported the first proteome map of the myelin sheath, namely that of mice.  In that 
study, 98 unique proteins were identified using 2D-PAGE, followed by mass 
spectrometry (MS) and/or 2D-immunoblotting.   
To date, the most widely used strategy in proteomics is still 2D-PAGE, followed by 
enzymatic digestion and MS analysis11.   Although the resolving power is excellent, 
2D-PAGE suffers from some major drawbacks12,13.  The dynamic range of the 
technique is limited, which makes the analysis of low abundant proteins difficult.  This 
is particularly the case for myelin, given the before mentioned dominance of MBP 
and PLP. Moreover, myelin consists mainly of membrane proteins and basic proteins, 
two classes of proteins rarely represented in a 2D-gel14,15.  Some of these important 
Figure 1. Detail of the myelin sheath. Action potentials propagate via saltatory 
conduction in myelinated nerves. Action potentials are generated at the initial 
segment and propagate to and are refreshed at the nodes of Ranvier, the periodic 
interruptions between myelin segments. 
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shortcomings can be overcome by using chromatography coupled to MS detection.  
In this alternative approach, commonly referred to as 'shotgun proteomics', the 
proteins are digested and the generated peptides are separated by multidimensional 
liquid chromatography (MDLC).  The peptides are then further identified by MS.   The 
combination of various chromatographic techniques has already been successfully 
applied in a variety of proteomic approaches.  The different orthogonal strategies are 
discussed and reviewed in two references16,17.  In particular, the combination of SCX 
chromatography in the first dimension and RP chromatography in the second 
dimension is the most frequently used approach for the separation of complex 
peptide mixtures17.   For example, Yates and co-workers18 analyzed the proteome of 
Saccharomyces cerevisiae via the Multidimensional Protein Identification Technology 
(MudPIT) using a biphasic column.  Approximately 1500 proteins of the yeast 
proteome could be identified using this approach.  In other applications, the SCX 
chromatographic and RP chromatographic steps are carried out using two distinct 
columns.  The peptides are thereby eluted stepwise by plugs of increasing salt 
concentrations or by applying a semi-continuous gradient, are 'on-line' trapped on a 
short enrichment column, and are further separated on a nano-RP column19,20.  The 
peak capacity of a two-dimensional liquid chromatography (2D-LC) system can be 
significantly increased in an 'off-line' 2D-LC setup21-23.  In this strategy, the peptide 
mixture is eluted by applying a linear salt gradient followed by collection of the 
fractions.  The fractions are then subjected to RP chromatography.  This off-line 
setup appeared to be more flexible and superior to on-line variants22. 
In shotgun proteomics, electrospray ionization (ESI) is usually the interface of choice 
between the column effluent and the mass spectrometer.  However, the 
chromatographic separation limits the analysis time, and not all peptides in a 
complex sample are amenable to tandem mass spectrometry (MS/MS).  Several 
experimental schemes, such as peak parking24 and the use of exclusion lists, have 
been developed to circumvent this problem.  Although these efforts increase the total 
number of peptides analyzed, many of them remain unidentified.  This is especially 
true for low abundance species coeluting with more abundant ones.  On the other 
hand, the use of MALDI in shotgun proteomics offers several advantages compared 
to ESI25,26.  The sample analysis can be performed independently from the 
separation, and immobilization of the column effluent enables archiving of the sample.  
In addition, the number of peaks analyzed by MS/MS in a given spot is theoretically 
almost unlimited and precursor selection can be done in a result-dependent manner.  
By also analyzing the minor components, eventually co-eluting with more abundant 
ones, the sample coverage can be comprehensively improved.   
In the present study, we evaluate a bottom-up shotgun proteomic approach and 
compare the results with those obtained by a classical 2D-PAGE approach.  In the 
electrophoretic based strategy, proteins were separated by 2D-PAGE and identified 
by either MALDI TOF-TOF or nanoLC-MS/MS.  In the 2D-LC MALDI TOF-TOF setup, 
the isolated myelin proteins were proteolytically digested, separated by strong cation 
exchange (SCX) chromatography and fractionated.  The fractions were then further 
analyzed by reversed-phase (RP) chromatography. The column effluent was spotted 
'on-line' onto a MALDI target and further analyzed by MALDI TOF-TOF MS.   
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2. RESULTS AND DISCUSSION 
2.1. 2D-ELECTROPHORESIS 
The 2D-PAGE image of the extracted myelin fraction from C57bl6 mice is depicted in 
Figure 2. More than 150 protein spots were visualized and a total of 80 protein spots 
were manually excised and subjected to mass spectrometric analyses.  Via this 
approach, we could identify 57 spots, corresponding to 38 unique proteins.  An 
overview of the identified spots is provided in Table 1.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1. Proteins Identified in the Myelin Fraction by Mass Spectrometry after Separation by 2D-PAGE. 
Spot 
Nr 
Protein Name Accession 
Nr.a 
Mw pI Localizationb Experimentc Methodd 
          Myelin formation and/or maintenance 
1-10 Myelin basic protein 387419 21.50 11.24  MDLC MALDI 
& 
LC/MS 
          Cell growth and/or maintenance 
11 Actin, cytoplasmic 1 P60710 41.74 5.29  MDLC-T LC/MS 
12 Tubulin beta 4 Q62364 49.55 4.78  MDLC LC/MS 
13 Neurofilament, light 
polypeptide 
P08551 61.45 4.63  * LC/MS 
14 Tubulin alpha-2 chain P05213 50.15 4.94  MDLC-T LC/MS 
15 Cofilin 1 P18760 18.43 8.26  MDLC-T LC/MS 
16 Tubulin alpha-2 chain P05213 50.15 4.94  MDLC-T LC/MS 
17 Tubulin alpha-2 chain P05213 50.15 4.94  MDLC-T LC/MS 
18 Gelsolin P13020 85.94 5.83  T LC/MS 
19 Neurofilament-66 P46660 55.87 5.16  T LC/MS 
20 Sirtuin 2 Q8VDQ8 43.26 5.23  MDLC-T LC/MS 
21 Dynactin subunit 2 
 
 
Q99KJ8 43.99 5.14  * LC/MS 
Figure 2. Coomassie brilliant blue G-250 stained 2D-gel 
of the isolated myelin fraction from C57/bl6 mice. 
Numbered spots refer to identified proteins (Table 1). 
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Table 1. Continued. 
          Signal transduction 
22 Calmodulin P62204 16.71 4.09  MDLC MALDI 
23 Rho GDP dissociation 
inhibitor 
Q99PT1 23.41 5.12  T LC/MS 
24 Guanine nucleotide-
binding protein, beta 
subunit 2 
P62880 37.33 5.60 M MDLC LC/MS 
25 Guanine nucleotide-
binding protein, beta 
subunit 1 
P62874 37.38 5.60 M MDLC-T MALDI 
26 14-3-3 protein P61982 - -  T LC/MS 
          Vesicle /Synapse 
27 Synaptosomal-associated 
protein 25 
P60879 23.32 4.66 M MDLC LC/MS 
28 Septin-8 Q8CHH9 49.81 5.68  MDLC-T LC/MS 
29 Dihydropyrimidinase 
related protein-2 
O08553 62.17 5.95  MDLC-T LC/MS 
30 Dihydropyrimidinase 
related protein-2 
O08553 62.17 5.95  MDLC-T LC/MS 
          Metabolism 
31 Creatine kinase, ubiquitous P30275 47.00 8.39  T LC/MS 
32 Glutamine synthetase P15105 42.15 6.47  MDLC-T MALDI 
33 Creatine kinase, brain Q04447 42.71 5.40  MDLC-T LC/MS 
34 Enolase 1, alpha P17182 47.01 6.36  MDLC-T LC/MS 
35 Enolase 1, alpha P17182 47.01 6.36  MDLC-T LC/MS 
36 Aldolase 1, A isoform P05064 39.22 8.40  MDLC-T LC/MS 
37 Creatine kinase, brain Q04447 42.71 5.40  MDLC-T LC/MS 
38 Enolase 2, gamma 
neuronal 
P17183 47.17 4.99  MDLC-T LC/MS 
39 Glutamine synthetase P15105 42.15 6.47  MDLC-T LC/MS 
40 Phosphoglycerate kinase 1 P09411 44.41 7.52  MDLC-T LC/MS 
41 Glyceraldehyde-3-
phosphate dehydrogenase 
P16858 35.68 8.45  MDLC-T LC/MS 
42 Malate dehydrogenase 1, 
NAD 
P14152 36.35 6.16  MDLC-T LC/MS 
43 Pyruvate kinase, isozyme 
M2 
P52480 57.76 7.42  MDLC-T LC/MS 
          Respiration 
44 ATP synthase beta chain P46480 56.30 5.19 M MDLC-T MALDI 
45 ATP synthase alpha chain Q03265 59.75 9.22 M MDLC-T LC/MS 
46 ATP synthase beta chain P46480 56.30 5.19 M MDLC-T LC/MS 
          Oxidative Stress 
47 Peroxiredoxin 2 Q61171 21.78 5.20  * LC/MS 
48 Peroxiredoxin 1 P35700 22.18 8.26  T LC/MS 
49 Glutathione S-transferase 
P1 
P19157 23.48 8.13  MDLC LC/MS 
50 Peroxiredoxin 1 P35700 22.18 8.26  T LC/MS 
          Folding 
51 Heat shock 70kDa protein P63017 70.87 5.37  MDLC-T LC/MS 
52 Peptidyl-prolyl cis-trans 
isomerase A 
P17742 17.84 7.88  MDLC LC/MS 
53 Heat shock 60kDa protein, 
mitochondrial precursor 
P63038 60.96 5.91  T LC/MS 
54 Peptidyl-prolyl cis-trans 
isomerase A 
P17742 17.84 7.88  MDLC MALDI 
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Table 1. Continued. 
         Other 
55 Phosphatidylethanolamine-
binding protein 
P70296 20.70 5.19  * LC/MS 
56 N-myc downstream 
regulated 1 
Q62433 43.01 5.69  MDLC-T LC/MS 
57 N-myc downstream 
regulated 1 
Q62433 43.01 5.69  MDLC-T LC/MS 
a) Swiss-Prot accession numbers begin with a letter (http://us.expasy.org).  The other accession numbers 
are retrieved from the NCBI (http://www.ncbi.nlm.nih.gov). 
b) Transmembrane or membrane-associated proteins are denoted by the letter M. 
c)  Comparison of the identified proteins with two other proteomic analyses.  MDLC refers to the identified 
proteins by shotgun proteomics performed in this study, while T refers to the study conducted by Taylor et 
al. (ref 10). Proteins not detected in these analyses are indicated by an asterisk. 
d)  Protein spots analyzed and identified using either MALDI TOF-TOF MS or nanoLC Q-TRAP MS.  For 
more detailed information, see Appendix D. 
 
The spots were nicely resolved in the 2D pattern, although some horizontal streaking 
from the basic to the acidic end at the bottom of the gel is present.  The spots (1-10) 
identified in this area contained the myelin basic protein (MBP).  This highly basic 
protein probably precipitates at the acidic end, leading to incomplete focusing in the 
first dimension. Other causes of this streaking may be due to its high concentration 
(about 30% of total protein in the myelin sheath) and its numerous post-translational 
modifications27. Moreover, several MBP isoforms exist as a result of different splicing 
of the coding gene.  For some medium-intensity spots, no useful MS data could be 
obtained and are therefore not discussed.   
A previous proteomic investigation of the myelin sheath by 2D-PAGE (pI 3-10) 
identified 130 protein spots, corresponding to 98 unique proteins10.  In that study, 
protein spots were visualized by silver staining and identified by mass spectrometry 
(MS), or detected by the sensitive technique of 2D-immunoblotting.  The proteomic 
analysis was also extended by the use of zoom gels (pI 4-7; pI 6-9) during 2D-PAGE.   
However, the most striking difference with our work is that the authors used the 
zwitterionic detergent amidosulfobetain-14 (ASB-14) for the solubilization of the 
isolated myelin fraction prior to 2D-PAGE.  The use of specific detergents for different 
samples and their effects on the separation in 2D-PAGE have already been 
profoundly investigated18.  As a general rule, the choice of detergent and of the 
sample preparation protocol has to be empirically determined.  For example, a 
proteomic analysis of rat brain tissue by 2D-electrophoresis using CHAPS and ASB-
14 as zwitterionic detergents showed a slight preference for CHAPS in solubilizing 
cytosolic and membrane proteins28.  Taylor et al. 9, on the contrary, found that the 
analysis of myelin by 2D-PAGE gave a better recovery of membrane proteins using 
ASB-14 as detergent.  In particular, some transmembrane proteins, e.g. PLP/DM-20, 
and glycosylphosphatidylinositol-anchored myelin proteins, e.g. contactin, were 
focused by 2D-PAGE with ASB-14, while they were not detected by Western blotting 
using CHAPS. However, the transmembrane polypeptides myelin-associated 
glycoprotein (MAG) and the myelin-oligodendrocyte glycoprotein (MOG) were still 
poorly resolved in this study.  We recovered few membrane or membrane-associated 
proteins in our 2D-analysis. Yet, we identified 11 proteins (Table 1) that were 
previously not reported.  For example, MBP, one of the major constituents of myelin 
was detected in several spots.  This fact encouraged us to investigate our samples 
by MDLC, and to explore the capabilities of this technique.  The usefulness of this 
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approach, with a better dynamic range, has already been shown in the analysis of 
proteomic samples rich in peripheral or integral membrane proteins25. 
 
2.2. MULTI-DIMENSIONAL CHROMATOGRAPHY 
The experimental setup of the off-line 2D-LC system is schematically presented in 
Figure 3.  The isolated myelin fraction was proteolytically digested and the resulting 
peptides were separated by SCX chromatography with fraction collection (2 min 
interval).  Each fraction (n=25) was automatically injected and further analyzed by 
nano-RP chromatography.  The column effluent was spotted 'on-line' on the MALDI 
target and the peptides were analyzed with the 4700 Proteomics Analyzer.    
 
The analysis of fraction 18 is shown in Figure 4 by way of an example.  Figure 4A 
shows the UV chromatogram (214 nm) and the collected fractions from the SCX 
chromatographic separation, while Figure 4B shows the UV chromatogram obtained 
after nano-RP chromatography of fraction 18.  The acquired MS spectrum 
(time=31.5-32 min) is depicted in Figure 4C and a representative MS/MS spectrum 
(m/z 1518.69 Da) originating from the oligodendrocyte specific protein (OSP), is 
given in Figure 4D.  The power of coupling LC to MALDI is immediately obvious from 
the fact that no less than 5 peptides could be identified within a spotting frequency 
window of 30s (MS/MS data of the other peptides not shown). 
 
 
 
Figure 3. Scheme of the off-line 2D-LC MALDI TOF-TOF setup.    
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Figure 4. Large-scale analysis of the myelin fraction by 2D-LC MALDI TOF-TOF. (A) Elution profile of the digested myelin fraction obtained after SCX 
chromatography (214 nm).  Fractions were collected every 2 min.  The inset plots the number of identified peptides, after MALDI TOF-TOF analysis, 
against each collected fraction. (B)  UV-chromatogram (214 nm) obtained after nanoLC-analysis of SCX fraction 18. The column effluent was spotted on-
line onto the MALDI target.  (C) MALDI TOF-TOF MS spectrum of the spotted effluent at time 31.5-32 min, during nanoLC-analysis.  The five peptides 
identified after MS/MS analysis are indicated by •.  (D) The MS/MS spectrum of precursor ion m/z 1518.69, labeled in Figure 3C, is given as an example.  
This spectrum matches the amino acid sequence of the peptide shown; some of the b- and y-ions are indicated.  The sequence led to the identification of 
the oligodendrocyte-specific protein.      
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The spotting frequency was chosen with care, considering factors such as (i) sample 
complexity, (ii) chromatographic run time and, probably most importantly (iii) 
conservation of chromatographic resolution.  For a given peak width, the analyte will 
be distributed in multiple spots if the spot time is decreased.  On the other hand, if 
the spot frequency is too slow, separated analytes will be re-pooled and the MS 
sensitivity will be affected by ion suppression effects.   To optimize the spotting 
frequency, we used four standard peptides (des-Arg-bradykinin; angiotensin I; Glu-
fibrino-peptide B, and adrenocorticotropic hormone (ACTH), clip (1-17)).  The 
peptides were separated by nano-RP chromatography and spotted on the target, 
using the 30 s spotting frequency.  Figure 5 shows the extracted ion chromatogram 
for the four components.  The data show this the spotting frequency (Figure 5B) was 
appropriate and in good correlation with the UV data (Figure 5A).  Moreover, no loss 
of chromatographic resolution or carry-over is observed in the MALDI-analysis.  
Carry-over from peptides from one spot to the other can indeed be expected by direct 
contact of the capillary to the target.  However, the column effluent contacting the 
target plate dissolves the dried matrix, which adsorbs the peptides, and afterward 
recrystallizes.  By doing so, the spot is dissolved starting from the middle to the edge, 
where almost all sample gets concentrated.  To make a nice homogeneous 
microcrystalline layer, we therefore applied 0.1 µL of matrix solution containing 20% 
ethanol to recrystallize the spot. 
Figure 5. Preservation of chromatographic resolution during LC/MALDI. (A) UV-trace (214 
nm) of 4 standard peptides, des-Arg-Bradykinin; Angiotensin I; Glu-Fibrino-peptide B and 
Adrenocorticotropic hormone (ACTH), clip (1-17), after nanoLC-analysis. (B) Extracted ion 
chromatogram of the 4 peptides detected by MALDI TOF-TOF MS.  The X-axis shows as 
the spot number as well as the time of collection. 
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The coupling of MALDI TOF-TOF with the off-line 2D-LC system resulted in the 
automated acquisition of more than 3000 MS/MS spectra of which 812 could be 
assigned to a peptide using our local MASCOT server.  Analysis and manual 
validation of the MS/MS spectra were facilitated by the GPS explorer v2.0 software.  
In total, 377 unique peptides were identified, corresponding to the identification of 93 
proteins.  These results are summarized in Table 2. 
 
 
Table 2. Identified Proteins by the Shotgun Proteomic Analysis. 
Protein Name Accession 
Nr.a 
Mw pI Localizationb Experimentc 
Myelin formation and/or maintenance 
Myelin proteolipid protein P60202 29.95 8.72 M T 
Myelin basic proteind 387419 21.50 11.24  2D 
Myelin-oligodendrocyte glycoprotein Q61885 28.27 8.16 M * 
Myelin-associated glycoprotein P20917 69.26 5.03 M * 
Myelin-associated oligodendrocytic 
basic protein 
7330691 19.17 11.15  * 
      
Cell growth and/or maintenance 
     
Cofilin 1 P18760 18.43 8.26  2D-PAGE&T 
Actind P60710 41.74 5.29  2D-PAGE&T 
Tubulin alphad P05213 50.15 4.94  2D-PAGE&T 
Tubulin beta 2 P68372 49.83 4.79  T 
Tubulin beta 4 Q62364 49.55 4.78  2D 
MARCKS-related protein P28667 20.03 4.63 M * 
Sirtuin 2 Q8VDQ8 43.26 5.23  2D-PAGE&T 
Contactin 1 P12960 113.39 5.80 M T 
Protein CGI-38 homolog Q9CRB6 18.97 9.18  * 
      
Signal transduction 
     
2',3'-cyclic-nucleotide 3'-
phosphodiesterase IId 
P16330 
 
47.12 9.08 M T 
Calmodulin P62204 16.71 4.09  2D 
Guanine nucleotide-binding protein 
G(O), alpha subunit 1d 
P18872 39.95 5.34 M T 
 
Guanine nucleotide-binding protein, 
beta subunit 1d 
P62874 37.38 
 
5.60 M 2D-PAGE&T  
Guanine nucleotide-binding protein 
G(S), alpha subunit 
P63094 45.66 5.69 M * 
Rab GDP dissociation inhibitor αd P50396 50.52 4.95  T 
Ras related protein Rap-1A P62835 20.99 6.39 M T 
p21-Rac1 P63001 21.45 8.77 M * 
Ras related protein Rab-10d P61027 22.54 8.58  * 
Visinin-like 1 P62761 22.01 5.01 M * 
Neurocalcin delta Q91X97 22.11 5.23 M * 
Visinin-like 3 P62748 22.21 5.32  * 
Limbic system-associated membrane 
protein precursor 
Q8BLK3 38.09 6.21 M * 
14-3-3 zeta/delta P63101 27.77 4.73  * 
14-3-3 epsilon P62259 29.17 4.63  * 
Macrophage inhibitory factor P34884 12.37 7.28  * 
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Table 2. Continued. 
     
Cell adhesion      
Oligodendrocyte-specific protein Q60771 22.11 8.23 M T 
Neural cell adhesion molecule 1 P13595 119.35 4.73 M T 
Thy-1 membrane glycoprotein 
precursor 
P01831 18.08 9.16 M * 
Junctional adhesion molecule C Q9D8B7 34.84 6.60 M * 
Membrane 
glycoprotein/immunoglobulin 
superfamily member 4C 
19068139 42.70 5.92 M * 
Membrane 
glycoprotein/immunoglobulin 
superfamily member 4B 
19068137 42.94 5.50 M * 
Immunoglobulin superfamily member 
8 
32189434 64.97 7.96 M * 
Vesicle /Synapse 
     
Synaptosomal-associated protein 25 P60879 23.32 4.66 M 2D 
Syntaxin 1B P61264 33.24 5.25 M * 
Dihydropyrimidinase related protein-2 O08553 62.17 5.95  2D-PAGE&T 
Septin-7 O55131 50.55 8.73  T 
Septin-2 P42208 41.53 6.10  T 
Septin-8 Q8CHH9 49.81 5.68  2D-PAGE&T 
EH-domain containing 1d Q9WVK4 60.60 6.35  T 
      
Metabolism 
     
Aldolase 1, A isoform P05064 39.22 8.40  2D-PAGE&T 
Enolase 1, alpha P17182 47.01 6.36  2D-PAGE&T 
Enolase 2, gamma neuronal P17183 47.17 4.99  2D-PAGE&T 
Glutamine synthetase P15105 42.15 6.47  2D-PAGE&T 
Isocitrate dehydrogenase 3 alpha 
subunit 
Q9D6R2 39.64 6.27  * 
Isocitrate dehydrogenase 3 beta 
subunit 
Q91VA7 42.19 8.76  * 
Malate dehydrogenase 1 P14152 36.35 6.16  2D-PAGE&T 
Malate dehydrogenase 2 P08249 35.60 8.82  T 
Phosphoglycerate mutase 1 Q9DBJ1 28.70 6.75  T 
Phosphoglycerate kinase 1 P09411 44.41 7.52  2D-PAGE&T 
Triosephosphate isomerase P17751 26.58 7.09  * 
Pyruvate kinase, isozyme M2 P52480 57.76 7.42  2D-PAGE&T 
Creatine kinase, B chain Q04447 42.71 5.40  2D-PAGE&T 
Glyceraldehyde-3-phosphate 
dehydrogenase 
P16858 35.68 8.45  2D-PAGE&T 
Transketolase P40142 67.63 7.23  T 
Carbonic anhydrase II P00920 28.96 6.52  T 
Nucleoside diphosphate kinase A P15532 17.21 6.84  T 
Nucleoside diphosphate kinase B Q01768 17.36 6.97  T 
Adenine nucleotide translocase 1 P48962 32.77 9.73 M * 
Aspartate aminotransferase P05202 47.11 9.13  * 
Ectonucleotide 
pyrophosphatase/phosphodiesterase 
6 
Q8B6N3 50.62 6.87 M * 
Elongation factor 1-alpha 1 P10126 50.11 9.10  * 
      
Respiration 
     
Sodium/potassium-transporting 
ATPase alpha-1 chain 
Q8VDN2 112.98 5.30 M * 
Sodium/potassium-transporting 
ATPase beta-1 chain 
P14094 35.19 8.83 M * 
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Table 2. Continued. 
     
ATP synthase alpha chain Q03265 59.75 9.22 M 2D-PAGE&T 
ATP synthase beta chain P46480 56.30 5.19 M 2D-PAGE&T 
ATP synthase gamma chain Q91VR2 32.89 9.06 M * 
Ubiquinol cytochrome c reductase 
complex 14 kDa protein 
Q9D855 13.40 9.10 M * 
Ubiquinol cytochrome c reductase 
core protein 2 
Q9DB77 48.23 9.26 M * 
Cytochrome c oxidase, subunit IV P19783 19.53 9.25 M * 
Cytochrome c oxidase, subunit VIb P56391 9.94 8.97 M * 
Cytochrome c oxidase, subunit VIIa P48771 9.29 10.28 M * 
Cytochrome c oxidase, subunit VIIc P17665 7.33 11.00 M * 
Cytochrome c P62897 11.47 9.61  * 
      
Oxidative Stress and Oxygen transport 
Hemoglobin alpha P01942 14.95 8.08  * 
Hemoglobin beta P02088 15.71 7.26  * 
Peroxiredoxin 5 P99029 21.90 9.10  * 
Glutathione S-transferase P1 P19157 23.48 8.13  2D 
Manganese superoxide dismutase P09671 24.60 8.80  T 
Cu/Zn-superoxide dismutase P08228 15.81 6.03  * 
      
Folding 
     
Peptidyl-prolyl cis-trans isomerase A P17742 17.84 7.88  2D 
FK506-binding protein 1A P26883 11.79 8.08  * 
Heat shock 70kD protein 8 P63017 70.87 5.37  2D-PAGE&T 
Alpha crystallin B chain P23927 20.07 6.76  T 
      
Other 
     
N-myc downstream regulated 1 Q62433 43.01 5.69  2D-PAGE&T 
Neuronal axonal membrane protein 
NAP-22 
Q91XV3 21.96 4.50 M * 
ADP-ribosylation factor 1d P84078 20.57 6.36 M T 
Ubc protein Q922B0 22.72 9.15  * 
Unnamed protein product 
 
12843458 50.61 6.22  * 
a) Swiss-Prot accession numbers begin with a letter (http://us.expasy.org).  The other accession 
numbers are retrieved from the NCBI (http://www.ncbi.nlm.nih.gov). The entries from the NCBI 
database were only used when a Swiss-Prot entry was not available. 
b) Transmembrane or membrane-associated proteins are denoted by the letter M. 
c)  Comparison of the identified proteins with two other proteomic analyses.  2D-PAGE refers to the 
identified proteins in the electrophoretic based strategy used in this study, while T refers to the study 
conducted by Taylor et al (ref 10).  Proteins not detected in these analyses are indicated by an 
asterisk. 
d) MS/MS data matched to several protein entries (see Supplemental Table/Appendix E). 
 
2.3. CHARACTERISTICS OF THE DETECTED PEPTIDES AND THE 
IDENTIFIED PROTEINS 
As mentioned previously, the myelin proteome contains several basic, hydrophobic 
and integral or peripheral membrane proteins.  In addition, there are differences of 
orders of magnitude in abundance of each protein within the mixture compared with 
the dominant proteins PLP/DM-20 and MBP.  This results in the fact that many 
important proteins, reported to be present in myelin, were not represented or not 
efficiently resolved by our 2D-PAGE analysis.  For example, principal basic 
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constituents of the membrane 2’,3’-cyclic-nucleotide 3’-phosphodiesterase (CNP), 
PLP, MOG and OSP (all having a pI around 8-9), could not be found.  Actually, we 
detected only 2 proteins with a pI value >9 (Table 1).  Yamaguchi et al. 8 were able to 
resolve and properly detect this class of proteins by immunoblotting using a different 
electrophoretic technique, i.e., nonequilibrium pH gradient electrophoresis 
(NEPHGE-2D-PAGE).  We, on the contrary, identified a lot more basic proteins, 
reflected by the 18 identifications (~19,1%) of proteins with a calculated pI value >9 
in the 2D-LC-analysis (Table 2). 
Another important class of polypeptides, that of the integral or membrane-associated 
proteins, is underrepresented (only six protein spots) in our electrophoretic analysis.  
This class is well-presented in the 2D-LC strategy, apparent from the 38 protein 
identifications (~40,4 %) which reveal either transmembrane or membrane-
associated proteins (Table 2).  Taylor et al.10 were able to identify a substantial 
number of membrane proteins by 2D-PAGE using the detergent ASB-14, which 
definitely recovers more membrane proteins during isoelectric focusing.  However, 
key myelin membrane proteins, like MOG and MAG, as well as important basic 
proteins, e.g., MBP and MOBP, were not detected in their analysis, whereas they 
were detected in our 2D-LC analysis.  This clearly demonstrates that our shotgun 
proteomic approach can definitely be employed for profiling the myelin proteins, 
especially for the analysis of highly basic and membrane proteins. Moreover, worth 
mentioning that only ± 40 µg of sample was required in the 2D-LC analysis, while 
more sample (200-400 µg) was required in the electrophoretic based strategies. 
In shotgun proteomics, the detection of a membrane protein is largely due to the 
detection of peptides from the soluble domain of the protein25.  This was also the 
case in our system.  By way of example, the 26-28 kDa myelin/oligodendrocyte 
glycoprotein, only accounting for about 0.05% of total CNS myelin protein29,30, 
contains an extracellular immunoglobulin-like domain and two hydrophobic domains31 
(Figure 6A).   The first hydrophobic domain appears to be transmembranar, while the 
latter is probably associated with the membrane.  Although this protein is reported to 
be low abundant in myelin, we identified 11 different peptides from it, but none of the 
peptides was from the transmembrane or membrane-associated region.  Similar 
results were obtained for the extremely abundant protein PLP (± 30 kDa), an integral 
Figure 6. Amino acid sequences of the myelin-
oligodendrocyte protein (A) and the myelin proteolipid 
protein (B).  The transmembrane or membrane-
associated regions are shaded in gray.  The identified 
peptides, all from the soluble domains of these 
proteins, are underlined. TM = transmembrane 
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membrane protein that contains four transmembrane domains32 (TM) (Figure 6B), 
two soluble extracellular loops (between TM1-TM2 and TM3-TM4) and one large 
soluble cytoplasmic domain (TM2-TM3).  We identified six peptides belonging to one 
of these soluble domains, but we could not distinguish PLP from its spliced variant 
DM-20.   
In general, bottom-up shotgun proteomics may underestimate the complexity of a 
sample33.  For example, we detected two peptides unique to PLP and four peptides 
common between PLP and the DM-20 splice variant.  PLP is definitely present, due 
to the detection of the unique peptides, but the common peptides can as well be from 
PLP as from the DM-20 splice variant.  Proteins that share common peptides with the 
proteins listed in Table 2, but from which no unique peptide has been discovered are 
not listed.  On the contrary, where the MS/MS data matched several protein entries in 
the database and no unique peptide could be detected, a single representative 
protein entry for this set of identified peptides is given in Table 2. The complete list of 
derived peptide sequences is given in the Supplemental Table, provided in Appendix 
E. 
A Venn diagram comparing the number of identified proteins in our two proteomic 
approaches (2D-PAGE/MS and MDLC) and those of the previous study is given in 
Figure 7.  A few proteins identified in our 2D-PAGE/MS analysis were not observed 
in the 2D-LC experiment.  The lack of identification of these proteins can have 
several causes.  The peptides can be missed either due to ionization efficiency, 
because they are too hydrophobic or because of their size.  Compared to the 
previous published proteome map of myelin, 46 proteins were not detected via MDLC.  
As mentioned, different solubilization agents were used. Notwithstanding this 
difference, we confirmed 53.1% of this proteomic map in our study, lending increased 
confidence to these identifications.  It is obvious that several methods and the use of 
several detergents are required to tackle this complex protein mixture and unravel 
the myelin proteome. 
 
 
Figure 7. Venn diagram comparing the 
number of proteins identified in the 
present study and those previously 
reported (ref 10).  2D-PAGE/MS and 
MDLC refer to the proteomic strategies 
based on electrophoresis and 
multidimensional liquid 
chromatography respectively.  (*) 
Guanine nucleotide-binding protein α1 
and α 2, Rab GDP dissociation 
inhibitor α en β2, PLP/DM20 and CNP 
I/CNP II, identified as unique proteins 
in the previous study, could not be 
distinguished in the shotgun proteomic 
approach (see Supplemental Table).  
These proteins were classified in the 
overlap 'MDLC/previous study'.  By 
analogy with this, we classified the 
guanine nucleotide-binding protein β2 
in the overlap 'MDLC/2D-PAGE/MS'. 
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2.4. BIOLOGICAL RELEVANCE OF THE IDENTIFIED PROTEINS 
Via shotgun proteomics, we extended the myelin proteome map by the identification 
of several known myelin proteins, previously not detected in other proteomic 
analyses.  For example, myelin-associated oligodendrocytic basic protein (MOBP), a 
major component of the CNS myelin34, has never been reported in any proteomic 
analysis.  The identification of all these known myelin proteins in a single analysis 
offers unique possibilities for comparative studies in white matter disorders.  Although 
our shotgun proteomic analysis was not quantitative, our experimental setup can be 
easily extended by various labeling strategies that allow quantification of these 
proteins.  Reagents such as ICAT and iTRAQ have already proven their utility in the 
study of protein expression profiles35,36. Certainly, detection and quantitation of the 
myelin proteins is essential, since many are involved in various demyelinating and 
dysmyelinating diseases. 
Among the new identified proteins, we detected several mitochondrial proteins (Table 
2).  Early electron microscopy revealed the presence of mitochondria in the myelin of 
the peripheral nervous system37, and mitochondrial proteins were also found in the 
proteome map of CNS myelin10. Mitochondria are involved in various 
neurodegenerative diseases where demyelination is observed38, showing the 
importance of detection and profiling of this class of proteins.   Furthermore, the 
proteome map was expanded by the identification of a variety of proteins involved in 
actin (re)organization, protein trafficking, vesicular transport and membrane 
biogenesis.    
Myelin contains a high lipid to protein ratio and the isolation of this membrane is 
based on the ability to float to a characteristic density in a sucrose gradient. However, 
myelin is closely associated with the axolemmal membrane through adhesive protein 
complexes and it has been shown that significant bidirectional signaling occurs 
between the myelin and the axon39,40.  Menon et al. 41 investigated the distribution, 
due to these high-affinity interactions, of specific myelin proteins in the different 
regions of the sucrose gradient and tried to obtain 'pure myelin'.  In fact, specific 
myelin and axolemmal proteins were enriched in different regions of the sucrose 
gradient.  However, the high-affinity interactions seem to persist, despite rigorous 
homogenization, high-salt shocks and several sucrose density centrifugation steps.  
The authors suggest that the isolated fraction is an interacting unit, the myelin-
axolemmal complex, and conclude that it is difficult, if not impossible, to purify the 
myelin membrane to homogeneity.  Therefore, the exact localization of some of the 
identified proteins in our proteomic analyses should be further examined by other 
techniques, e.g. immunofluorescence microscopy.  In this respect, the new identified 
membrane proteins as well as three membrane glycoproteins with immunoglobulin-
like domains are of interest.  Additional experiments will be needed to establish the 
role and function of these proteins in the myelin-axolemmal complex. 
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3. CONCLUSIONS 
The protein composition of myelin in C57/bl6 mice was investigated by two different 
proteomic strategies.  A classical proteomic approach, 2D-PAGE followed by MS, 
identified 38 unique proteins.  However, myelin contains many tissue specific basic 
and membrane proteins and only few of these have been detected.  Therefore, the 
sample was further investigated by a shotgun proteomic approach.  Here, sample 
was digested and the resultant peptides were separated by an off-line 2D-LC setup.  
The resolved peptides were spotted on-line onto a MALDI target.  The method 
proved to be reliable and no less than 812 peptides could be successfully identified, 
accounting for the detection of 93 unique proteins.  Highly basic proteins and 
membrane proteins were all present.  Moreover, many known proteins, such as MOG, 
MAG, CNP, MBP, PLP, and MOBP were all detected in this analysis.  Previous 
proteomic strategies failed in the detection of these proteins in a single analysis.  
Moreover, a limited amount of sample was required in our shotgun proteomic 
approach.  Further development, like implementation of labeling strategies, can result 
in the quantification of these important myelin proteins.  In time, this approach can be 
the key to comparative studies and applications associated with white matter 
disorders.  A proteome map of myelin using 2D-PAGE and MS was previously 
published by Taylor et al.10.  Although a different zwitterionic detergent was used, we 
confirmed more than 50% of the proteins by our proteomic analyses.  On the other 
hand, we could add a substantial number of proteins to the myelin proteome.  A 
comprehensive profile of the proteins present in myelin is unmistakably essential in 
order to better understand the biological role of this membrane and the many 
diseases that are associated with it.       
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Profiling proteomics is widely applied to analyze global protein synthesis as an 
indicator of gene expression. This tool is helpful in the understanding of an 
organism's metabolism, as outlined in Part I.  However, no single analytical 
separation technique is able to solve the diversity and extent of proteome complexity. 
While the separation strategies may still vary, the identification technique of choice in 
profiling proteomics is mass spectrometry.  Developments in mass spectrometry 
have made efforts to improve performance and produce new capabilities.  This has 
resulted in improved mass accuracy and resolution, speed and new types of 
instruments.  The implementation of these and future instruments into proteomic 
strategies will definitely result into improved capabilities.   
 
Two-dimensional gel electrophoresis and mass spectrometry is an established, 
powerful strategy for the analysis of quantitative and qualitative differences in two or 
more samples, and is particularly well suited for differential quantitative analysis of 
metabolic processes such as protein synthesis and stress response. In Chapter V, 
we discussed a differential display study from Shewanella oneidensis MR-1 in 
relation to its growth on ferric oxide, while the effect of a short term heat shock on 
barley was outlined in Chapter VI.  To be able to identify these gel separated proteins, 
we coupled nanoLC to ESI-Q-TOF and ESI-Q-TRAP MS (Chapter IV).  These 
methods are robust, reliable and clearly allowed unambiguous protein identification. 
In addition, sample throughput and automatization were obtained and opened up 
ways for 'high throughput' proteomic research. Furthermore, the very good signal-to-
noise ratio in the spectra, and the observation that many spectra are strongly 
dominated by y”-ion series makes manual interpretation feasible.  The nice quality of 
the spectra very often enables to deduce a peptide sequence of significant length 
that can be used in similarity search programs such as FASTA or BLAST. This 
permits proteins to be identified of which little database information is available 
(homology searching).   
 
Any proteomic approach largely depends on the accessibility of genome sequence 
information.  The characterized genome sequence of Shewanella oneidensis MR-1 
allowed us to successfully identify the differential displayed proteins in our study. Due 
to the presence of this information, different appropriate genome-scale physiological 
studies can now be performed and this will greatly expand the understanding of the 
physiology of the organism under different environmental conditions in the future.  
The result will be a more complete picture of the electron transport and metabolic 
capacities of this bacterium.  On the other hand, the barley genome is not yet 
available and, therefore, we relied on expressed sequence tag databases and 
genome sequence information of closely related organisms. However, we were able 
to identify most of the proteins displaying differential protein synthesis.  This is largely 
due to the improvements, sensitivity and MS/MS capabilities in the mass 
spectrometric analyses, enabling to perform 'de novo sequencing' and, consequently, 
to identify more protein spots. The strength of the hyphenation of nanoLC and mass 
spectrometry is also shown by the identification of no less than six isoforms of a small 
heat shock protein in one single spot.  In conclusion, the hyphenated setup proved to 
be very useful, in particular for the analysis of protein spots for which limited genome 
sequence information was available.   
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2D-PAGE is still superior to other techniques when it comes to high resolution 
separation of several proteins, especially when quantitative data rather than 
qualitative data are needed. The results presented of the two differential display 
studies also revealed the major limitation of this approach, i.e. only the relative 
abundance of a subset of cellular, soluble proteins can be investigated.  Although 
these 'small-scale' methods only provide the clue to a small part of the big puzzle, 
they open the way for the identification of both regulatory and structural genes critical 
to specific metabolic pathways. For example, the ArcA protein of Shewanella 
oneidensis MR-1 was shown to be involved in dissimilatory iron reduction. Such 
studies can then be pursued via specific mutagenesis and physiological analyses. 
Therefore, these approaches will remain to be important and crucial for the 
elucidation of complex biochemical pathways in the future. 
 
As two-dimensional gel electrophoresis is less suited for the analysis of certain 
classes of proteins, such as membrane and low abundant proteins, alternative tools 
are needed. The separation of membrane proteins, as opposed to water-soluble 
cytosolic proteins, is problematic because they often precipitate in the isoelectric 
focusing step, due to the formation of aggregates, even in the presence of detergents. 
However, membrane proteins can comprise a large fraction of the total gene product 
population, and proteomics of this type of proteins is therefore essential for the 
understanding of cellular function. We applied two alternative proteomic strategies, 
gel and non-gel based, for profiling of membrane proteins in mammalian systems. 
The different components of the oxidative phosphorylation were investigated by an 
electrophoretic based strategy, i.e. BN-2D-PAGE in combination with mass 
spectrometry (Chapter VII). The implementation of nanoLC hyphenated to ESI-Q-
TOF MS again proved its efficacy, and proteome maps of the OXPHOS components 
from human heart and liver were obtained.  These reference maps can be further 
used in comparative analyses.  We made a qualitative comparison between the 
control and the OXPHOS liver map of a patient who was diagnosed with a 
mitochondrial disorder, revealing serious defects in the oxidative phosphorylation 
system.  
A different approach, multi-dimensional liquid chromatography, was used for the 
profiling of membrane proteins present in the myelin sheath (Chapter VIII).  This 
'hydrophobic' proteome contains a specific selection of proteins and is dominated by 
only a few of them.  We successfully coupled nanoLC to MALDI TOF-TOF MS, as the 
experimental setup proved to be reproducible and reliable. This bottom-up shotgun 
proteomic approach identified a substantial number of additional, but in quantity 
minor, proteins compared with the 2D-PAGE/MS strategy.   
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De grootste uitdaging binnen de bio-wetenschappen is het streven naar een volledig 
begrip van hoe een cel op moleculair niveau functioneert. Een belangrijke 
verwezenlijking in dit fundamenteel onderzoek is ongetwijfeld de opheldering van de 
totale genoomsequentie van diverse organismen, dankzij de ontwikkeling van 
automatische DNA-sequentietechnieken. De opheldering van de eerste volledige 
genoomsequentie, van Haemophilus influenzae in 1995, is één van de mijlpalen in 
de moleculaire microbiologie. Sindsdien werden meer dan 200 genomen 
opgehelderd en de snelheid waarmee dit gebeurt stijgt stelselmatig. Recent werd 
zelfs het volledige menselijke genoom gesequeneerd. De toenemende 
informatiestroom op DNA-niveau heeft er voor gezorgd dat veel biologische 
experimenten nu op een grotere schaal uitgevoerd worden. De technieken die hierbij 
gebruikt worden hebben tot doel de biologische processen in een cel of organisme 
beter te begrijpen en een antwoord te bieden op één van de volgende drie vragen. 
Ten eerste, wat is de ‘inhoud’ van het biologische systeem? Ten tweede, hoe werken 
elk van deze individuele componenten, en tenslotte, hoe werken deze individuele 
componenten samen? 
 
In dit werk werden methodes voor de scheiding en identificatie van eiwitten 
ontwikkeld, gebaseerd op elektroforese, nano-vloeistofchromatografie en 
massaspectrometrie. De ontwikkelde strategieën werden gebruikt om de eiwit- 
inhoud van specifieke bacteriële, planten- en zoogdiersystemen te onderzoeken. Het 
werk bestaat uit drie grote delen. In Deel I, opgedeeld in drie hoofdstukken, wordt de 
huidige status van grootschalige methodes voor analyse van biologische systemen 
behandeld. In Hoofdstuk I worden de disciplines ‘genomics’, ‘transcriptomics’ en 
‘proteomics’ toegelicht en wordt de noodzaak van proteoomanalyses (‘proteomics’) 
aangetoond. Proteomics is een middel om genoominformatie in verband te brengen 
met functionaliteit en is in essentie de studie van de eigenschappen van eiwitten 
(expressieniveaus, post-translationele modificaties, interacties, ...) om een globaal, 
geïntegreerd zicht te krijgen op ziekteprocessen, cellulaire processen, .... op 
eiwitniveau.  In Hoofdstuk II maakt de lezer kennis met de drie hoofddisciplines 
binnen proteomics: ‘profiling’, functionele, en structurele ‘proteomics’.  Er wordt een 
overzicht gegeven van de voornaamste technologieën die heden gebruikt worden in 
functionele en structurele proteoomanalyses, terwijl de verscheidene mogelijkheden 
om eiwitten te ‘mappen’, profiling proteomics, worden besproken in Hoofdstuk III.  
Laatstgenoemde discipline is een belangrijk onderdeel van proteomics en probeert 
systematisch elk eiwit in een cel, weefsel of organisme te identificeren, samen met 
de bepaling van andere relevante eigenschappen, zoals o.m. abundantie.  In het 
hoofdstuk worden de verschillende mogelijkheden om eiwitten te scheiden, te 
analyseren en te identificeren m.b.v. massaspectrometrie uitvoerig beschreven. 
 
Deel II is eveneens opgebouwd uit drie hoofdstukken en behandelt de analyse van 
cytosolische eiwitten gescheiden via tweedimensionale gelelektroforese en 
geïdentificeerd via massaspectrometrie (2D-PAGE/MS).  Deze strategie is binnen de 
discipline profiling proteomics, een krachtige analysetechniek om kwalitatieve en 
kwantitatieve verschillen in twee of meerdere stalen te onderzoeken. In het bijzonder 
is het uitermate geschikt om wijzigingen in metabolische processen, zoals 
eiwitsynthese, te onderzoeken via een differentiële kwantitatieve analyse. In 
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Hoofdstuk IV worden de verschillende massaspectrometrische technieken 
beschreven die gebruikt werden voor de identificatie van gel-gescheiden eiwitten. In 
het hoofdstuk wordt voornamelijk de experimentele set-up, dit is de koppeling van 
nano-vloeistofchromatografie en massaspectrometrie, toegelicht.  Om de eiwitten te 
identificeren uit gel werd een nanoLC-systeem gekoppeld aan ofwel een ESI-Q-TOF 
of een ESI-Q-TRAP massaspectrometer. De koppeling is robuust en betrouwbaar en 
is bovendien volledig automatisch, wat de snelheid van de analyses merkelijk 
verhoogt. De ontwikkelde methodes werden verder gebruikt in verschillende 
proteoomanalyses (Hoofdstukken V en VI).  
Eerst wordt een differentiële kwantitatieve analyse besproken van Shewanella 
oneidensis MR-1 (Hoofdstuk V).  Deze gram-negatieve facultatief aërobe bacterie is 
in staat om tal van elektronen-acceptoren te gebruiken, en opmerkelijk hierbij is de 
reductie van metalen. De interesse komt niet alleen van het belang van deze bacterie 
in het domein van de geochemie, maar ook van praktische toepassen, zoals het 
‘biologisch opruimen’ (bioremediatie) van gecontamineerde milieus. Ondanks 
uitgebreid onderzoek is de kennis van deze respiratoire processen in Shewanella 
echter nog vaag. In het hoofdstuk wordt metaalreductie besproken en worden de 
resultaten voorgesteld van een proteoomanalyse van Shewanella oneidensis MR-1 
met betrekking tot groei op ijzeroxide.  
De analyse van de respons op de toestand van stress van planten is belangrijk om 
genen te ontdekken met betrekking tot stress-tolerantie. Eén van de factoren die de 
groei en kwaliteit van planten sterk kan beïnvloeden is temperatuur. In Hoofdstuk VI 
wordt het effect van een korte hitte-schok op gerst besproken. De resultaten van een 
differentiële proteoomanalyse, 2D-PAGE/MS, van één van de meest belangrijke 
gewassen in de wereld worden voorgesteld. Daarnaast wordt de kracht van de 
koppeling van nanoLC en massaspectrometrie nogmaals benadrukt door de 
identificatie van niet minder dan zes isovormen van een klein 'heat shock’ eiwit in één 
enkele spot.   
Tweedimensionale gelelektroforese is een uitgelezen techniek wanneer een hoge 
resolutie voor de scheiding van verschillende eiwitten noodzakelijk is, en zeker 
wanneer eerder kwantitatieve dan kwalitatieve data vereist zijn. De besproken 
resultaten van de twee differentiële proteoomanalyses toonden echter ook de 
grootste beperking van deze techniek aan. Enkel specifieke cellulaire, goed 
oplosbare, eiwitten konden worden onderzocht. Deze strategie reveleert m.a.w. 
slechts een klein deel van de (soms) grote puzzel. Anderzijds kunnen regulatorische 
en structurele eiwitten geïdentificeerd worden die belangrijk zijn in welbepaalde 
metabolische processen. Zo werd bijvoorbeeld aangetoond dat het ArcA eiwit van 
Shewanella oneidensis MR-1 betrokken is in het proces van dissimilatorische ijzer 
reductie.  Dergelijke studies kunnen dan opgevolgd worden door specifieke 
mutagenese en fysiologische experimenten en zullen daarom in de toekomst 
belangrijk en cruciaal blijven in de opheldering van complexe biochemische 
processen. 
 
In Deel III worden alternatieve strategieën voorgesteld en toegepast in het gebied 
van profiling proteomics. Vermits tweedimensionale gelelektroforese minder geschikt 
is voor de analyse van bepaalde klassen van eiwitten, zoals membranaire en laag 
abundante eiwitten, zijn alternatieve strategieën vereist. De scheiding van 
membraaneiwitten met behulp van de techniek van iso-elektrische focussering wordt, 
bijvoorbeeld, bemoeilijkt doordat eiwitten door vorming van aggregaten neerslaan, 
zelfs in aanwezigheid van detergenten. Membraaneiwitten kunnen echter een groot 
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deel uitmaken van de totale eiwitpopulatie en een proteoomanalyse van deze 
eiwitten is daarom essentieel teneinde bepaalde cellulaire functies beter te kunnen 
begrijpen. Wij hebben twee alternatieve proteoomanalyses toegepast, gel en niet-gel 
gebaseerd, voor het profileren van membraanproteïnen.  
Ten eerste werden de verschillende componenten van de oxidatieve fosforylatie 
geanalyseerd via de techniek van ‘blue-native’ polyacrylamide gelelektroforese in 
combinatie met massaspectrometrie (Hoofdstuk VII). Een proteoommap van de 
verschillende subeenheden van deze complexen, zowel van menselijk hart- als 
leverweefsel, wordt voorgesteld en besproken. De referentie-proteoommappen 
kunnen verder gebruikt worden in vergelijkende proteoomanalyses, en een 
vergelijkende analyse van leverweefsel werd uitgevoerd tussen een controle en een 
patiënt die een sterk verstoord mitochondriaal metabolisme vertoonde tijdens een 
doktersdiagnose. De bekomen resultaten van de vergelijkende proteoomanalyse 
worden besproken in het hoofdstuk. 
In een tweede, alternatieve strategie wordt multidimensionale vloeistofchromatografie 
gebruikt voor de analyse van membraaneiwitten in de myelineschede (Hoofdstuk 
VIII). Dit ‘hydrofoob’ proteoom bestaat uit een specifieke selectie van eiwitten en 
wordt bovendien qua kwantiteit gedomineerd door slechts enkele eiwitten. Na de 
scheiding werden de eiwitten geïdentificeerd m.b.v. massaspectrometrie.  Hiervoor 
werd nano-vloeistofchromatografie gekoppeld met MALDI TOF-TOF MS.  In dit 
hoofdstuk wordt de experimentele set-up uitvoerig beschreven en de resultaten van 
deze ‘bottom-up’ proteoomanalyse worden vergeleken met de ‘klassieke’ 2D-
PAGE/MS aanpak. 
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BACTERIAL GROWTH AND PREPARATION OF EXTRACTS:  
Shewanella oneidensis MR-1 was grown aerobically in 20 ml Luria-Bertani (LB) 
medium in a rotary shaker at a speed of 200 rpm and at 28°C up to the exponential 
phase (OD600 =± 1). From these cultures, 1 ml was used to inoculate 200 ml of 
anaerobically prepared LB broth supplemented with lactic acid (20 mM) as electron 
donor and either one of the electron acceptors, 20 mM sodium fumarate or 1.6 g/L 
ferric oxide (Fe2O3). The medium was adjusted to pH 7. Five cultures of each of 
these were grown in an anaerobic chamber (Coy Laboratory Products) at 28°C for 16 
h, and then harvested. Analytical test strips (Merck) were used to detect the 
formation of ferrous iron.  After washing twice using a 50 mM Tris-HCl solution, pH 8, 
bacteria were placed in an ultrasonic bath on ice for 2 x 30 s, followed by protein 
extraction in 9 M urea, 4% CHAPS, 1% DTT and 1 mM PMSF. After centrifugation at 
14 000 rpm (4°C) for 20 min, the supernatant containing the soluble protein fraction 
was recovered.  
 
TWO-DIMENSIONAL GEL ELECTROPHORESIS AND ANALYSIS:  
After determination of the protein concentration using the Protein Assay Kit (Bio-Rad), 
approximately 300 µg of protein of each culture was applied on an IPG strip (pH 3–10 
L) via a 7 h passive in-gel rehydration protocol1. The IEF was performed in a 
Multiphor II system (Amersham Biosciences) running a standard program provided 
by the manufacturer. The temperature was kept at 18°C. After completion of the 
program, the IPG strips were equilibrated for 10 min in a 50 mM Tris-HCl solution, pH 
8.8, containing 6 M urea, 30% glycerol, 2% SDS and with 1% DTT, after which the 
solution was replaced by the same solution, but DTT was now being replaced by 
2.5% iodoacetamide. The strips were then placed on vertical SDS-PAGE gels cast 
in-house (12.5%T and 2.6%C), and subjected to electrophoresis in a Protean Plus 
Dodeca Cell system (Bio-Rad) at 10 mA/gel for 15 min, followed by a ± 5 h run at 20 
mA/gel, until the bromophenol blue front reached the bottom of the gel. Staining was 
performed using CBB G-250, according to Anderson et al.2. 
The 2D gel images were digitized with a 12-bit GS-710 calibrated densitometer (Bio-
Rad) and analyzed with the accompanying PDQuest 7.1 software (Bio-Rad). After 
spot detection, the 2D maps were automatically aligned, followed by manual 
optimization. Landmark spots were manually defined and spot editing was carried out 
to increase the correlation between the different 2D maps. Statistical analysis of the 
relative abundance of each matched protein spot was accomplished by using a two-
tailed t-test, as described3. Proteins displaying quantitative differences with a P-value 
of at least < 0.05 were considered to differ significantly in abundance.  
 
IN-GEL DIGESTION:  
In-gel digestion was performed according to Rosenfeld et al.4, with minor 
modifications. Briefly, the spots were excised from the gels and washed twice with 
200 mM ammonium bicarbonate in 50% acetonitrile/water (20 min at 30°C), and 
where then allowed to dry at room temperature. The tubes were chilled on ice and 8 
µl of digestion buffer (50mM ammonium bicarbonate, pH 7.8) containing 150 ng 
modified trypsin (Promega) were added. The samples were kept on ice for 45 min to 
allow the enzyme to enter the gel piece. A volume of 15 µl digestion buffer was then 
added and the samples were incubated overnight at 37°C. The supernatant was 
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recovered, and the remaining peptides were extracted from the gel piece by washing 
twice with 60% acetonitrile/0.1% formic acid in water. The extracts were combined 
and the samples were dried in a Speedvac. The samples were dissolved in 10 µl of 
0.1% formic acid.  
 
PROTEIN IDENTIFICATION AND MASS SPECTROMETRY:  
The peptide mixture was measured on a 4700 Proteomics Analyzer, a MALDI TOF-
TOF mass spectrometer (Applied Biosystems), equipped with a Nd:YAG laser set at 
a Hz rate of 200.  The digest mixture (1 µl) was co-crystallized with an equal volume 
of matrix solution (7mg/ml α-cyano-4-hydroxycinnamic acid, dissolved in 50% v/v 
acetonitrile/0.1% TFA in water) and applied on the MALDI target.  Prior to analysis, 
the mass spectrometer was externally calibrated with a standard mixture (angiotensin 
I, Glu-fibrino-peptide B, adenocorticotropic hormone (ACTH) (clip 1–17) and ACTH 
(clip 18–39)) as outlined by the manufacturer. For MS/MS experiments, the 
instrument was externally calibrated with fragments of Glu-fibrino-peptide. In the MS 
mode, a total of 2000 shots were typically collected (40 sub-spectra accumulated 
from 50 laser shots each). After MS data acquisition, peptides were selected and 
subjected to MS/MS analysis. Here, a total of 3000 shots (40 sub-spectra 
accumulated from 75 laser shots each) were in general acquired, and the timed-ion 
selector window was set to 250 resolution (FWHM), while the metastable suppressor 
was switched on.  If identification was still ambiguous, the samples were loaded on 
an automated nano-HPLC system (LC Packings-Dionex) and the separated peptides 
were detected on-line by an ESI-Q-TOF mass spectrometer (Micromass), as 
previously described5. In this method, an automated MS to MS/MS switching protocol 
was used for on-line LC-MS/MS analysis of the peptides. For identification, we 
generally performed a database search using a local MASCOT server6.  
 
FUNCTIONAL ANALYSIS AND STRUCTURE PREDICTION:  
Sequences of the genome of S. oneidensis MR-1 were downloaded from The 
Institute of Genomic Research and inserted as a separate dataset into the Gene 
Relational Database (GRDB)7. For each sequence, a family profile and secondary 
structure prediction was calculated as required by the ORFeus sequence alignment 
program8, which represents the main similarity search component of the GRDB 
system. The system also facilitates sequence alignments using PSI-Blast9 and RPS-
Blast. The datasets include families extracted from Pfam10, from COGs11 and other 
resources. The system was used to find homology between selected sequences from 
S. oneidensis MR-1 and protein families with known function.  
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PLANT GROWTH: 
Barley (Hordeum vulgare) genotypes (Jubilant, abiotic stress-susceptible, spring type 
and Mandolina, abiotic stress-tolerant, spring type) were sterilized with 3% H2O2 for 
30 min, and were soaked thereafter in MilliQ water, with frequent changes, for 2 
hours. Grains were germinated under sterile conditions on wet filter paper in Petri 
dishes (25 grains/dish), in the dark and in a thermostat (24°C) for 5 days. After this 
period of growth, half of the barley seedlings were subjected to a heat shock 
treatment at 40ºC for 2 hours, and protein extraction was immediately performed.   
 
PROTEIN EXTRACTION OF THE BARLEY SHOOTS: 
Barley shoots were crushed in liquid nitrogen and then homogenized with 10% TCA 
and 0.07% β-mercaptoethanol in cold acetone. Proteins were allowed to precipitate 1 
h at -20°C. After centrifugation (10 min at 16000g, 4°C), the pellets were washed 
twice with cold acetone containing 0.07% β-mercaptoethanol (1 h at -20°C). The 
supernatants were discarded and the pellets were vacuum-dried and dissolved in an 
extraction buffer (25µl per mg of dry matter) for 30 min on a shaker at 37°C.  This 
buffer consisted of 8 M urea, 40mM Tris-base, 4% CHAPS and 1mM PMSF. After 
centrifugation (10 min at 16000g, 4°C), the supernatant containing the soluble protein 
fraction was recovered and the protein concentration was determined using the 
Bradford Kit Assay (Bio-Rad, Hercules, Ca, USA). The samples were stored at -80°C 
until use.  
 
TWO-DIMENSIONAL GEL ELECTROPHORESIS 
Approximately 550 µg of protein was loaded on 18 cm immobilized pH gradient (IPG) 
strips, pH range 3-10L (Bio-Rad) via the passive in-gel rehydration protocol. The 
isoelectric focusing (IEF) was performed on a Multiphor II system (Amersham 
Biosciences, Uppsala, Sweden) running a standard program provided by the 
manufacturer. The temperature was kept at 18°C. After completion of the IEF 
program, the strips were equilibrated for 10 min in a 50mM Tris-HCl solution (pH 8.8) 
containing 6 M urea, 30% glycerol, 2% sodium dodecylsulfate (SDS) and 1% 
dithiothreitol (DTT).  Thereafter, the solution was replaced by the same Tris-HCl 
solution, except that DDT was exchanged for 2.5% iodoacetamide. The strips were 
then placed on home-casted SDS-PAGE gels (12.5% T and 2.6% C).  
Electrophoresis was carried out in a Protean Plus Dodeca Cell system  (Bio-Rad) at 
10mA/gel for 15 min, followed by a +/-10h run at  200 V, until the bromophenol blue 
front reached the bottom of the gel. Staining was performed using Coomassie Brillant 
Blue G-250 according to Anderson et al1.  The gel images were digitized with a 12-bit 
GS-710 calibrated densitometer (Bio-Rad) and analyzed with the PDQuest 7.1 
software (Bio-Rad).  After spot detection, the 2D maps were automatically aligned 
followed by manual spot editing to increase the correlation between the different 2D 
maps.  Statistical analysis of the relative abundance of each matched protein spot 
was accomplished by using a two-tailed t-test.  Only quantitative differences with a p-
value of at least < 0.05 were considered.  
 
IN-GEL DIGESTION: 
Protein digestion was performed according to Rosenfeld et al2, with minor 
modifications.  In short, the spots were excised from the gel and washed twice with 
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150 µl of 200mM ammonium bicarbonate in 50% acetonitrile/water (20 min at 30 ºC).  
After drying at room temperature, for 10 min, the tubes were chilled on ice.  
Afterwards, 8 µl of digestion buffer was added (50mM ammonium bicarbonate, pH 
7.8), containing 0.002 µg/µl trypsin. The samples were kept on ice (45 min), and 20 
µl of digestion buffer was added. After overnight incubation (37°C), the supernatant 
was recovered and the remaining peptides were extracted from the gel piece (60% 
acetonitrile/0.1% formic acid in water).  For mass spectrometric analysis, the samples 
were dried and then dissolved in 12 µl of 0.1% formic acid. 
 
PROTEIN IDENTIFICATION - MASS SPECTROMETRIC ANALYSES: 
The genome of Hordeum vulgare has not been fully sequenced, but several 
expressed sequence tag (EST) databases can be accessed on the World Wide Web.  
Such a suitable Hordeum vulgare EST database (www.ncbi.nlm.nih.gov) was 
downloaded and formatted to make it accessible via the database searching program 
MASCOT (www.matrixscience.com).  If mass spectral data fitted a translated EST 
sequence, this sequence was loaded into a BLAST query for annotation. 
Tryptic peptide mixtures were measured on a MALDI TOF/TOF mass spectrometer 
(Applied Biosystems, Framingham, CA, USA).  In the MS mode, the generated ions 
are accelerated at the source (20kV) and are separated in the second TOF tube.  In 
the MS/MS mode, the parent ion is focused into the gas cell where the peptide is 
fragmented using collision induced dissociation (CID).   The fragments formed are 
reaccelerated (15kV) and the m/z-values are then determined in the second TOF 
tube.  The voltage applied to the source was 8 kV and to the gas cell 7 kV; air          
(1 x 10 -6 Torr) was introduced in the cell as fragmenting gas. 
The peptide mixture (1 µl) was co-crystallized with an equal volume of matrix solution 
(100mM α-cyano-4-hydroxycinnamic acid dissolved in 50% v/v acetonitrile/0.1% TFA 
in water) and applied to the target plate. Prior to analysis, the instrument was 
externally calibrated with a standard peptide mixture, as outlined by the manufacturer. 
When the peptide mass fingerprinting was not conclusive, several peptides were 
subjected to further MS/MS analysis.  Mass spectral data were then submitted for 
database searching to our local MASCOT server for protein identification.  If the 
identification was uncertain, the peptide mixture was separated by nano-HPLC and 
detected on-line by an ESI-Q-TRAP mass spectrometer (Applied Biosystems).  The 
experimental setup of the separation system has been described elsewhere3.  Briefly, 
the samples were loaded onto the nano-column (PEPMAP, 150 mm x 75 µm I.D) 
using an in-line pre-concentration step on a micro pre-column cartridge (2 mm x 
800µm I.D.).  Afterwards, peptides were separated using a linear gradient from 5% 
acetonitrile/0.1% formic acid in water to 80% acetonitrile/0.1% formic acid in water, 
running over a period of 50 min.   The eluted peptides were ‘on-line’ detected by the 
Q-TRAP mass spectrometer.  In this method, an automated MS to MS/MS switching 
protocol was used.  First, an enhanced MS scan as survey scan (m/z 400 -1500) was 
performed, followed by an enhanced resolution scan of the two most intense ions.  
The last scan allowed to determine the charge state of the ions.  If their charge state 
was two or three, an enhanced product ion scan (MS/MS) of these ions was 
performed.  The total cycle time of this setup was approximately 4.5 sec.   
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ISOLATION OF MITOCHONDRIA : 
Mitochondria were isolated according to the method described by Scholte et al1. The 
heart tissue specimen used for isolation of mitochondria weighed 2.4 g. A volume of 
46 ml of buffer (10 mM Tris-HCl, 0.25 M sucrose, 2 mM EDTA, 50 U/ml heparine, pH 
7.4) was added to the heart tissue sample for homogenization in a glass/glass pestle. 
The homogenate was then centrifuged (5.600 x g) for 1 min. The supernatant was 
kept on ice. The pellet was suspended, homogenized and centrifuged again, and this 
procedure was repeated twice. The combined supernatant was centrifuged (37.500 x 
g) for 3 min. The resulting pellet was suspended once more in 46 ml homogenization 
buffer, and centrifuged (37.500 x g) for 3 min. The final pellet, containing the 
mitochondria (around 17 mg of protein), was kept frozen at -80°C.  
 
SOLUBILIZATION OF THE OXPHOS COMPLEXES:  
The solubilization of the complexes was performed according to a modified protocol 
of Schägger and von Jagow2. The mitochondrial pellet was suspended in 4 ml buffer 
(750 mM aminocaproic acid, 50 mM Bis-Tris, 20 µM PMSF, pH 7) and 500 µl 10% 
laurylmaltoside, and the mixture was subsequently centrifuged (100.000 x g) for 15 
min. Because of the large sample volume, a Beckman L8–70M ultracentrifuge 
equipped with a T55 rotor and sample tubes with a maximal volume of 5 ml were 
used. The supernatant containing the OXPHOS enzyme complexes was divided into 
aliquots of 1ml and kept at  -80°C.  
 
PREPARATION OF SAMPLES  
The protein concentration of the sample containing the dissolved OXPHOS 
complexes, assayed according to Bradford’s method3, was 1.9 µg/µl. To 350 µl of 
each sample, 18 µl of a 5% Serva Blue G solution in 750 mM aminocaproic acid was 
added before homogenization. The protein load of the lane was around 650 µg.  
 
FIRST-DIMENSIONAL ELECTROPHORESIS - BN-PAGE:  
BN-PAGE was performed in the Bio-Rad Protean II Xi cell using 20 x 20 x 0.15cm 
glass plates. The 5%–13% polyacrylamide gradient, as well as the buffers used for 
electrophoresis, was prepared as described by Schägger4. To remove small 
contaminating particles, the gel reagents were filtered using a 0.2 µm Acrodisc filter, 
diameter 32mm (Gelman Laboratory).  The cathodal and anodal buffers were filtered 
using a 0.2 µm Nalgene filter of 50mm diameter (Nalge Nunc International). A 
premixed 30% acrylamide solution from Bio-Rad was used; the volumes and amount 
of bisacrylamide added were recalculated to result in a stacking and resolving gel 
identical to those described in Schägger’s article. The gels were run at 4–7°C. 
Electrophoresis was started at 75 V until the entry of the protein sample into the 
stacking gel was achieved. The cathode buffer containing Serva Blue G was 
replaced by a buffer without the dye before the electrophoresis was continued 
overnight at 150 V. The experiment was stopped when the dye front had run off 
completely from the gel.  
 
SECOND-DIMENSIONAL ELECTROPHORESIS - TRICINE SDS-PAGE: 
The reagents for gel formation were prepared according to a protocol from Schägger 
et al.2. Filtration of gel reagents and buffers was as described for the first dimension. 
A 30% premixed acrylamide solution (Bio-Rad) was used; the volumes and amount 
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of bisacrylamide added were recalculated to result in a stacking and resolving gel 
identical to those described in reference 2. The excised lane (10 x 1.5 mm) was 
transferred to a 20 x 20 cm glass plate at the position of the sample gel and soaked 
with 1% SDS and 1% mercaptoethanol for 2 h. One millimeter spacers were 
positioned, a glass plate was placed above the gel and clamps were fixed. While still 
horizontal, mercaptoethanol was soaked off with a paper towel. The spacers and 
glass plates were aligned and vertically placed in the casting stand. The acrylamide 
solution (for a 16.5% T, 3% C Tricine-SDS-gel) was then injected between the glass 
plates up to 3 cm from the first-dimensional gel strip. The freshly poured gel was 
overlaid with a small amount of water. After polymerization, the water was decanted 
and a 2 cm layer of 10% T, 3% C Tricine-SDS-gel mixture was added. The gel was 
completely immersed in water and polymerized overnight. Finally, a 10% native gel 
was cast around the gel lane without covering it. In that gel, a cut comb between the 
gel lane and the spacer was placed in order to create a sample well for loading the 
molecular weight standards. The gel strip was covered with a 2 mm layer of solution 
containing 4% SDS, 10% glycerol, 2% mercaptoethanol, 0.03% Serva Blue G, 50 
mM Tris adjusted to pH 7. Fifteen microliters of molecular weight markers 
(Kaleidoscope prestained standard from Bio-Rad) was loaded. Electrophoresis was 
performed at room temperature, starting for 3 h at 75 V; the voltage was raised to 
150 V overnight (max. 50 mA).  
 
PROTEIN STAINING OF THE TRICINE SDS-PAGE GELS:  
The gels were stained with the Coomassie G-250 stain (Bio-Rad), and incubated 
under constant shaking for 30 min in a solution containing 40% methanol and 10% 
acetic acid. The gel was subsequently washed three times for 5 min in 400 ml water. 
After removal of the water, 100 ml of Coomassie stain was added. The gel was 
gently shaken for 1 h and washed overnight with water. The gels were scanned using 
a Sharp JX-330 scanner. On the printout we located the 2527 MS of BN-PAGE 
separated OXPHOS proteins spots to be excised and added an identification label. 
The gel was kept by –80°C up to the moment of excision of the spots.  
 
DIGESTIONS:  
Individual bands were excised and recuperated in Eppendorf tubes. The bands were 
washed twice with 150 µl of 200 mM ammonium bicarbonate in 50% acetonitrile. The 
washing procedure was repeated using 50 mM ammonium bicarbonate. The gel 
slices were allowed to dry in air and the tubes were placed on ice. Depending on the 
band intensity, 8–26 µl of a solution containing 2 ng/µl trypsin dissolved in 20 mM 
ammonium bicarbonate (sequencing-grade modified trypsin; Promega) were added 
and allowed to enter in the gel for 40 min while keeping the tube on ice. Then, 50 µl 
of 20 mM ammonium bicarbonate was added to cover the gel slice completely with 
digestion buffer, and the tubes were incubated overnight at 37°C. After digestion, the 
supernatant was recovered, together with the peptide extracts obtained after adding 
50 µl of 50% acetonitrile/0.1% formic acid. The combined fractions were dried in a 
Speedvac concentrator (Thermo Savant).  
 
MASS SPECTROMETRIC IDENTIFICATION: 
The dried peptide mixtures were dissolved in 12 µl of 5% acetonitrile/0.1% formic 
acid in water. One microliter of this sample was used for MALDI-TOF mass 
spectrometric analysis. It was mixed with an equivalent amount of matrix, 50 mM α-
cyano-hydroxycinnamic acid dissolved in 40% ethanol/59.9% acetonitrile/0.1% formic 
acid. The mixture was applied on the target and allowed to dry by air. MALDI-TOF 
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analyses were performed on a M@ldi mass spectrometer (Micromass). The 
remainder solution was used for nanoflow LC-MS/MS analysis on a Q-TOF mass 
spectrometer (Micromass). The setup for this experiment was previously published5. 
Basically, we used an Ultimate µLC system connected to a FAMOS autosampler 
(Dionex - LC-Packings). Samples were loaded onto the separating column after 
preliminary desalting/concentration on a precolumn using a column switching 
protocol. The peptide mixture was separated on a Pepmap C18 column, connected 
to the nanoflow source of the Q-TOF mass spectrometer. Compared to the published 
setup we slightly modified the source, now using a fused-silica spraying capillary 
(New Objective) connected to the column tubing with a simple Teflon sleeve. 
Interpretation of the MS/MS data was performed mainly manually, implementing 
MAXENT3 and PEPSEQ software tools delivered with the instruments. Database 
searching was performed using Protein Globalserver (Micromass), or the internet 
tools MASCOT (www.matrixscience.com) and Peptidesearch (www.narrador.embl-
heidelberg.de). 
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ISOLATION AND EXTRACTION OF MYELIN: 
Brain tissue of 8 weeks old mice (C57/bl6, Harlan Netherlands) was used for the 
isolation of myelin. Myelin was purified as previously described1-3 , with some 
modifications.  All steps were carried out at 4°C, unless otherwise stated.  Briefly, the 
brains of eight animals were pooled and homogenized with a glass homogenizer in 
0.32M sucrose buffer. The homogenate was then layered over a 0.85M sucrose 
buffer. After ultracentrifugation (SW-55 rotor, 28.000 rpm for 35 min, Beckman), the 
interface of the 0.32M/0.85M sucrose was recovered.  This fraction was washed 
twice in deionized water, stirred for 30 min and centrifuged at 28.000 rpm for 15 min. 
The pellet was suspended in 0.32M sucrose and layered over a 0.85M sucrose buffer. 
The ultracentrifugation step was repeated and the interface collected.  Afterwards, 
the washing step in deionized water was repeated.  This pellet was then delipidated 
four times with ether-ethanol 3:24. Samples were dried in a Speedvac and suspended 
in 500 µl buffer containing 7M urea/2M thio-urea, 4% CHAPS (w/v) and 1% DTT. The 
tube was sonicated and stirred for 30 min at room temperature. After centrifugation at 
13.200 rpm (Eppendorf) for 15 minutes, the supernatant containing the soluble 
protein fraction was separated from the detergent-insoluble pellet and the protein 
concentration was determined using the Protein Assay Kit (Bio-Rad).  
 
TWO-DIMENSIONAL GEL ELECTROPHORESIS: 
The protocol for 2D-PAGE has been published in detail elsewhere5.  Briefly, 400µg 
protein of the soluble protein fraction was applied on an IPG strip (pH3-10L) via 
passive in-gel rehydration. Iso-electric focusing (IEF) was performed using a 
Multiphor II system, followed by equilibration of the IPG strips. Afterwards, the IPG 
strips were placed on top of a SDS-gel (12.5%T and 2.6%C) and subjected to 
electrophoresis.  The 2D-gels were stained with CBB G-250. 
 
 IN-GEL DIGESTION - PROTEIN SPOT IDENTIFICATION: 
For more details about in-gel digestion, protein extraction, mass spectrometric 
analyses and protein identification strategy for 2D-PAGE separated proteins, we refer 
to previous published work6. Briefly, the excised spots were washed, air-dried, and 
then digested overnight with 0.02 µg modified trypsin (Promega, Madison, USA) per 
spot, in 50 mM ammonium bicarbonate at 37°C.  Peptides were extracted with 60% 
ACN/0.1% formic acid in water, dried and dissolved in 10 µl of 0.1% formic acid.  Two 
mass spectrometric strategies were used for further analysis of the samples. In a first 
attempt, we attempted to identify the protein spots by MALDI TOF/TOF MS (Applied 
Biosystems).  Here, 1 µl sample was mixed with 1 µl matrix (100 mM a-cyano-4-
hydroxycinnamic acid in 50% ACN/0.1% TFA in water) and the resultant mixture was 
applied onto a target. Samples that could not be identified by MALDI analysis were 
loaded on an automated nanoLC system (Dionex-LC Packings) coupled to a hybrid 
triple quadrupole/linear ion trap (Q-TRAP LC-MS/MS system, Applied Biosystems).  
 
PROTEIN IN-SOLUTION DIGESTION: 
To reduce and alkylate the protein mixture prior to injection to 2D-LC, 10 µl 10mM 
DTT was added to 100 µl of the sample (5µg/µl).  The Eppendorf tube was incubated 
for 30 min at 60°C.  After cooling for 5 min down to room temperature, 10 µl 100mM 
iodoacetamide was added and the mixture was placed in the dark for 30 min.  Then, 
20 µl out of the 120 µl of the reduced and alkylated sample was digested. This 
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sample was diluted in 60 µl 0.1% SDS/50mM Tris, pH 7.4, and 20 µl ACN, and 
incubated overnight with 100 µl 0.1µg/µl trypsin (Promega). The peptide mixture was 
dried in a Speedvac (Thermo Savant).  The sample was then dissolved in 20 µl 0.1% 
formic acid.  
 
MULTIDIMENSIONAL LIQUID CHROMATOGRAPHY: 
An Ultimate Plus Dual-Gradient Capillary/Nano LC system (Dionex-LC Packings) was 
used in the study.  This 2D-LC system consists of a capillary LC pump for the 
separation in the first dimension and a nano LC pump for the separation in the 
second dimension.  Both pumps are capable of delivering a gradient and are 
equipped with an active flow control system, using capillary and nano flow sensors.  
For the SCX chromatographic analyses, the sample (± 40 µg) was injected, using a 
Famos microautosampler (Dionex-LC packings) onto a 0.3 mm x 150 mm cation 
exchange column packed with POROS 10S; the injection loop had a volume of 10 µl 
loop.  The capillary LC pump operated at a continuous flow rate of 5 µl/min.    The 
mobile phases were as follows: (A) KH2PO4/5% ACN in water (pH 3), (B) 5mM 
KH2PO4/5% ACN/500mM KCl in water (pH 3).  The gradient profile used consisted of 
0% B for the first 20 min, a linear gradient of 0-40% B over 30 min, followed by a 
linear gradient of 40% to 100% B over 15 min.  The eluted peptides were fractionated 
in a 96 micro well-plate (conical shaped) at 2 min intervals using a Probot device.  
The column effluent was monitored using a 45 nl UV flow cell. 
The 96 micro well plate was then placed in the microautosampler and the samples 
were, one after the other, loaded onto a RP trapping column (Pepmap C18, 800µm x 
5mm) using the SWITCHOS device (Dionex-LCPackings), equipped with two micro 
2-position/10-port valves.  This loading pump was operated at 8 µl/min, and 0.05% 
TFA in water was used as mobile phase.  After 8 min, the valve was switched and 
the sample was eluted onto the analytical separation column (PepMap C18, 75 µm x 
150 mm) in the back-flush mode, using the nanoLC pump operated at 250 nl/min.  
The mobile phases used were 5% ACN/0.1% TFA (v/v) for Buffer A and 80% 
ACN/0.1% TFA (v/v) for Buffer B.  Peptides were resolved by gradient elution using a 
gradient of 0-50% Buffer B over 25 min, followed by a gradient of 50-100% Buffer B 
over 10 min.  Column effluent was monitored using a 3 nl UV flow cell (214 nm), and 
spotted directly onto a MALDI target using the Probot device. 
 
LC/MALDI MS: 
Prior to nanoLC analysis, a 192 well MALDI target was manually spotted with  0.4 µl 
MALDI matrix (8 mg/ml alfa-cyano-4-hydroxycinnamic acid dissolved in 50% 
ACN/0.1% TFA (v/v) containing 2mM dibasic ammonium citrate).  During separation 
in the second dimension, the column effluent was spotted onto this target at 30s 
intervals using the Probot as spotting device.  Here, the capillary outlet (a fused silica 
capillary of 20 µm ID) was placed in direct contact with the MALDI target.  After 
fractionation was completed, a saturated matrix solution (0.1 µl of 50% ACN/20% 
ethanol/0.1% TFA in water) was added on top of each spot and allowed to dry at 
open air.  The sample spots were then ready for both MALDI MS and MALDI MS/MS 
analysis.  The MALDI TOF-TOF MS was externally calibrated prior to analysis, as 
outlined by the manufacturer.  The result-dependent MS/MS experiments were 
performed on a 4700 Proteomics Analyzer equipped with GPS Explorer version 2.0, 
using the job-wide interpretation method.  In this strategy, the MS spectra were 
collected first, and masses were chosen for fragmentation from the spots in which 
they were the most intense.  The spot to spot precursor selection was set to 200 ppm, 
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and the S/N ratio of the parent ion was at least 40.  MS/MS analysis was performed 
from the highest to the least intense peak.  For MS data acquisition, a total of 2000 
shots were collected (40 sub-spectra accumulated from 50 laser shots each).  All 
MS/MS data was acquired in the 1keV MS/MS mode using air as the collision gas 
(1.2 x 10-7 torr).  A total of 3000 shots (40 sub-spectra accumulated from 75 laser 
shots each) were acquired and the timed-ion-selector window was set to 250 
resolution (FWHM). 
 
PEPTIDE IDENTIFICATION METHOD: 
The MS/MS data collected during a LC-MALDI run were submitted to the search 
software Mascot v1.97 using the GPS explorer v2.0 software.  Preliminary protein 
identifications were obtained by comparing experimental data to the NCBInr and 
Swiss-Prot databases.  The taxonomy was set to Mus musculus (mouse); 
carbamidomethyl and methionine oxidation were selected as variable modifications, 
and one missed cleavage was allowed with trypsin as the cleaving agent.  Searches 
were done with a tolerance of 100 ppm for the precursor ion and 0.4 Da in the 
MS/MS mode.  The MS/MS data was re-submitted to MASCOT with the same 
parameters, except that the cleaving agent was now set to 'none'.  The raw data were 
inspected manually for confirmation prior to acceptance. 
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Supplemental Table|  List of identified peptide sequences in the 2D-LC MALDI TOF-TOF setup of myelin. 
Protein namea Accession Nr.b Peptide sequencec 
14-3-3 protein epsilon P62259 DSTLIMQLLR 
14-3-3 protein epsilon P62259 EMQPTHPIR 
14-3-3 protein epsilon P62259 AASDIAMTELPPTHPIR 
14-3-3 protein epsilon P62259 YLAEFATGNDR 
14-3-3 protein epsilon P62259 HLIPAANTGESK 
14-3-3 protein zeta/delta P63101 SVTEQGAELSNEER 
2',3'-cyclic-nucleotide 3'-phosphodiesterase II P16330 AAGAEEYAQQEVVK 
2',3'-cyclic-nucleotide 3'-phosphodiesterase II P16330 AAGAEEYAQQEVVKR 
2',3'-cyclic-nucleotide 3'-phosphodiesterase II P16330 ADFSEAYKR 
2',3'-cyclic-nucleotide 3'-phosphodiesterase II P16330 AGQVFLEELGNHK 
2',3'-cyclic-nucleotide 3'-phosphodiesterase II P16330 AHVTLGCAADVQPVQTGLDLLDILQQVK  
2',3'-cyclic-nucleotide 3'-phosphodiesterase II P16330 AIFTGYYGK 
2',3'-cyclic-nucleotide 3'-phosphodiesterase II P16330 DFLPLYFGWFLTK  
2',3'-cyclic-nucleotide 3'-phosphodiesterase II P16330 EKLELVSYFGK 
2',3'-cyclic-nucleotide 3'-phosphodiesterase II P16330 EKPELQFPFLQDEDTVATLHECK # 
2',3'-cyclic-nucleotide 3'-phosphodiesterase II P16330 GGSQGEAVGELPR 
2',3'-cyclic-nucleotide 3'-phosphodiesterase II P16330 GKPVPIHGSR 
2',3'-cyclic-nucleotide 3'-phosphodiesterase II P16330 HFISGDEPK  
2',3'-cyclic-nucleotide 3'-phosphodiesterase II P16330 KAGQVFLEELGNHK 
2',3'-cyclic-nucleotide 3'-phosphodiesterase II P16330 LDEDLAGYCR # 
2',3'-cyclic-nucleotide 3'-phosphodiesterase II P16330 LDQLFEMADQYQYQVVLVEPK 
2',3'-cyclic-nucleotide 3'-phosphodiesterase II P16330 LELVSYFGK 
2',3'-cyclic-nucleotide 3'-phosphodiesterase II P16330 LSISALFVTPK 
2',3'-cyclic-nucleotide 3'-phosphodiesterase II P16330 NQWQLSADDLK 
2',3'-cyclic-nucleotide 3'-phosphodiesterase II P16330 NQWQLSADDLKK 
2',3'-cyclic-nucleotide 3'-phosphodiesterase II P16330 RLDEDLAGYCR # 
2',3'-cyclic-nucleotide 3'-phosphodiesterase II P16330 RPPGVLHCTTK # 
2',3'-cyclic-nucleotide 3'-phosphodiesterase II P16330 VLVLDDTNHER 
Actin P60710 AGFAGDDAPR 
Actin P60710 AVFPSIVGRPR 
Actin P60710 DLTDYLMK 
Actin P60710 DLYANTVLSGGTTMYPGIADR 
Actin P60710 GYSFTTTAER 
Actin P60710 HQGVMVGMGQK 
Actin P60710 QEYDESGPSIVHR 
Actin P60710 SYELPDGQVITIGNER 
Actin P60710 VAPEEHPVLLTEAPLNPK 
Adenine nucleotide translocase 1 P48962 LLLQVQHASK 
ADP-ribosylation factor 1 P84078 NISFTVWDVGGQDK 
Aldolase 1, A isoform P05064 ADDGRPFPQVIK 
Aldolase 1, A isoform P05064 FSNEEIAMATVTALR 
Aldolase 1, A isoform P05064 IGEHTPSALAIMENANVLAR 
Aldolase 1, A isoform P05064 PHPYPALTPEQK 
Alpha crystallin B chain P23927 HFSPEELK  
Alpha crystallin B chain P23927 VLGDVIEVHGK 
Aspartate aminotransferase P05202 DDNGKPYVLPSVR 
Aspartate aminotransferase P05202 FVTVQTISGTGALR 
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ATP synthase alpha chain Q03265 EAYPGDVFYLHSR 
ATP synthase alpha chain Q03265 HALIIYDDLSK 
ATP synthase alpha chain Q03265 ILGADTSVDLEETGR 
ATP synthase alpha chain Q03265 LYCIYVAIGQK # 
ATP synthase alpha chain Q03265 TGAIVDVPVGEELLGR 
ATP synthase beta chain P46480 AHGGYSVFAGVGER 
ATP synthase beta chain P46480 AIAELGIYPAVDPLDSTSR 
ATP synthase beta chain P46480 FLSQPFQVAEVFTGHMGK 
ATP synthase beta chain P46480 FTQAGSEVSALLGR 
ATP synthase beta chain P46480 IMDPNIVGNEHYDVAR 
ATP synthase beta chain P46480 IMNVIGEPIDER 
ATP synthase beta chain P46480 IPSAVGYQPTLATDMGTMQER 
ATP synthase beta chain P46480 IPVGPETLGR 
ATP synthase beta chain P46480 LVLEVAQHLGESTVR 
ATP synthase beta chain P46480 VALTGLTVAEYFR 
ATP synthase beta chain P46480 VALVYGQMNEPPGAR 
ATP synthase gamma chain Q91VR2 THSDQFLVSFK 
Calmodulin P62204 ADQLTEEQIAEFK 
Calmodulin P62204 EAFSLFDK 
Calmodulin P62204 EAFSLFDKDGDGTITTK 
Carbonic anhydrase II P00920 AVQQPDGLAVLGIFLK 
Carbonic anhydrase II P00920 DFPIANGDR 
Carbonic anhydrase II P00920 EPITVSSEQMSHFR 
Carbonic anhydrase II P00920 HNGPENWHK 
Carbonic anhydrase II P00920 SIVNNGHSFNVEFDDSQDNAVLK 
Carbonic anhydrase II P00920 YAAELHLVHWNTK 
Cofilin 1 P18760 HELQANCYEEVKDR # 
Cofilin 1 P18760 YALYDATYETK 
Contactin 1 P12960 EITHIHYQR 
Contactin 1 P12960 ELTITWAPLSR 
Contactin 1 P12960 FIPLIPIPER 
Contactin 1 P12960 HSIEVPIPR 
Contactin 1 P12960 IVESYQIR 
Contactin 1 P12960 TDGAAPNVAPSDVGGGGGTNR 
Contactin 1 P12960 VLSSSEISVHWK 
Contactin 1 P12960 VVATNTLGTGEPSIPSNR 
Contactin 1 P12960 YGHGVSEEDK 
Creatine kinase, B chain Q04447 DLFDPIIEER 
Creatine kinase, B chain Q04447 FPAEDEFPDLSSHNNHMAK 
Creatine kinase, B chain Q04447 GFCLPPHCSR # 
Creatine kinase, B chain Q04447 GIWHNDNK  
Creatine kinase, B chain Q04447 HGGYQPSDEHK 
Creatine kinase, B chain Q04447 PFSNSHNTQK  
Creatine kinase, B chain Q04447 TFLVWINEEDHLR 
Creatine kinase, B chain Q04447 VLTPELYAELR  
Cu/Zn-superoxide dismutase P08228 HGGPADEER 
Cu/Zn-superoxide dismutase P08228 VISLSGEHSIIGR 
Cytochrome c P62897 GITWGEDTLMEYLENPK 
Cytochrome c P62897 KTGQAAGFSYTDANK 
Cytochrome c P62897 TGPNLHGLFGR 
Cytochrome c oxidase subunit IV P19783 DYPLPDVAHVTMLSASQK 
Cytochrome c oxidase subunit IV P19783 SEDYAFPTYADR 
Cytochrome c oxidase subunit VIb P56391 GGDVSVCEWYR 
Cytochrome c oxidase subunit VIb P56391 NCWQNYLDFHR 
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Cytochrome c oxidase subunit VIIa P48771 LFQEDNGMPVHLK 
Cytochrome c oxidase subunit VIIc P17665 SHYEEGPGK 
Dihydropyrimidinase related protein-2 O08553 IVLEDGTLHVTEGSGR 
Dihydropyrimidinase related protein-2 O08553 MVIPGGIDVHTR 
Dihydropyrimidinase related protein-2 O08553 NLHQSGFSLSGAQIDDNIPR 
Ectonucleotide pyrophosphatase/phosphodiesterase 6 Q8B6N3 ADLAAIYHER  
Ectonucleotide pyrophosphatase/phosphodiesterase 6 Q8B6N3 GIFLAIGPDFK 
Ectonucleotide pyrophosphatase/phosphodiesterase 6 Q8B6N3 IDVEGHHYGPSSPQR 
Ectonucleotide pyrophosphatase/phosphodiesterase 6 Q8B6N3 SDYISEDALASLPGFR 
EH-domain containing 1 Q9WVK4 IILLFDAHK 
EH-domain containing 1 Q9WVK4 LLPLEEYYR 
Elongation factor 1-alpha 1 P10126 EHALLAYTLGVK  
Elongation factor 1-alpha 1 P10126 THINIVVIGHVDSGK 
Elongation factor 1-alpha 1 P10126 YYVTIIDAPGHR 
Enolase 1, alpha P17182 FTASAGIQVVGDDLTVTNPK 
Enolase 1, alpha P17182 GVSQAVEHINK 
Enolase 1, alpha P17182 IGAEVYHNLK 
Enolase 1, alpha P17182 LAMQEFMILPVGASSFR 
Enolase 1, alpha P17182 LAQSNGWGVMVSHR 
Enolase 2, gamma neuronal P17183 AAVPSGASTGIYEALELR  
Enolase 2, gamma neuronal P17183 LAMQEFMILPVGAESFR 
Enolase 2, gamma neuronal P17183 LAQENGWGVMVSHR  
FK506-binding protein 1A P26883 GVQVETISPGDGR 
FK506-binding protein 1A P26883 GWEEGVAQMSVGQR 
Glutamine synthetase P15105 DIVEAHYR 
Glutamine synthetase P15105 LTGFHETSNINDFSAGVANR 
Glutamine synthetase P15105 LVLCEVFK # 
Glutamine synthetase P15105 MGDHLWIAR 
Glutamine synthetase P15105 RPSANCDPYAVTEAIVR # 
Glutathione S-transferase P1 P19157 AFLSSPEHVNRPINGNGK 
Glutathione S-transferase P1 P19157 TIVYFPVR 
Glyceraldehyde-3-phosphate dehydrogenase P16858 IVSNASCTTNCLAPLAK # 
Glyceraldehyde-3-phosphate dehydrogenase P16858 LISWYDNEYGYSNR 
Glyceraldehyde-3-phosphate dehydrogenase P16858 LVINGKPITIFQER 
Glyceraldehyde-3-phosphate dehydrogenase P16858 MFQYDSTHGK  
Glyceraldehyde-3-phosphate dehydrogenase P16858 VIHDNFGIVEGLMTTVH 
Glyceraldehyde-3-phosphate dehydrogenase P16858 VIISAPSADAPMFVMGVNHEK 
Glyceraldehyde-3-phosphate dehydrogenase P16858 VPTPNVSVVDLTCR # 
Guanine nucleotide-binding protein G(S), alpha subunit P63094 IEDYFPEFAR 
Guanine nucleotide-binding protein, alpha subunit 1 P18872 AMDTLGVEYGDKER 
Guanine nucleotide-binding protein, alpha subunit 1 P18872 IIHEDGFSGEDVK 
Guanine nucleotide-binding protein, alpha subunit 1 P18872 TTGIVETHFTFK 
Guanine nucleotide-binding protein, alpha subunit 1 P18872 YYLDSLDR 
Guanine nucleotide-binding protein, beta subunit 1 P62874 AGVLAGHDNR  
Guanine nucleotide-binding protein, beta subunit 1 P62874 LIIWDSYTTNK 
Heat shock 70kD protein 8 P63017 EEFEHQQK 
Heat shock 70kD protein 8 P63017 FEELNADLFR 
Heat shock 70kD protein 8 P63017 LLQDFFNGK 
Heat shock 70kD protein 8 P63017 MVNHFIAEFK 
Heat shock 70kD protein 8 P63017 SQIHDIVLVGGSTR 
Heat shock 70kD protein 8 P63017 STAGDTHLGGEDFDNR 
Hemoglobin alpha P01942 IGGHGAEYGAEALER 
Hemoglobin alpha P01942 LRVDPVNFK 
Hemoglobin alpha P01942 MFASFPTTK 
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Hemoglobin alpha P01942 TYFPHFDVSHGSAQVK 
Hemoglobin alpha P01942 VADALANAAGHLDDLPGALSALSDLHAHK 
Hemoglobin beta P02088 DFTPAAQAAFQK 
Hemoglobin beta P02088 GTFASLSELHCDK # 
Hemoglobin beta P02088 KVITAFNDGLNHLDSLK 
Hemoglobin beta P02088 LHVDPENFR 
Hemoglobin beta P02088 LLGNMIVIVLGHHLGK 
Hemoglobin beta P02088 LLVVYPWTQR 
Hemoglobin beta P02088 VITAFNDGLNHLDSLK 
Hemoglobin beta P02088 VNADEVGGEALGR 
Hemoglobin beta P02088 VVAGVAAALAHK 
Hemoglobin beta P02088 YFDSFGDLSSASAIMGNAK 
Immunoglobulin superfamily, member 8 32189434 ATLQEVVGLHSDMAVEAGAPYAER 
Immunoglobulin superfamily, member 8 32189434 AVLAHVDVQTLSSQLAVTVGPGER 
Immunoglobulin superfamily, member 8 32189434 DSQFSYAVFGPR 
Immunoglobulin superfamily, member 8 32189434 HAAYSVGWEMAPAGAPGPGR 
Immunoglobulin superfamily, member 8 32189434 LVAQLDTEGIGSLGPGYEDR 
Immunoglobulin superfamily, member 8 32189434 VLPDELQVSAAPPGPR 
Isocitrate dehydrogenase 3 alpha subunit Q9D6R2 HMGLFDHAAK 
Isocitrate dehydrogenase 3 alpha subunit Q9D6R2 IAEFAFEYAR 
Isocitrate dehydrogenase 3 beta subunit Q91VA7 HNNLDLVIIR 
Isocitrate dehydrogenase 3 beta subunit Q91VA7 KLDLFANVVHVK 
Isocitrate dehydrogenase 3 beta subunit Q91VA7 SVIGHLHPHGG 
Junction adhesion molecule C Q9D8B7 DDSGQYYCIASNDAGAAR 
Junction adhesion molecule C Q9D8B7 HDGVNYIR 
Limbic system-associated membrane protein precursor Q8BLK3 EFEGEEEYLEILGITR 
Malate dehydrogenase 1 P14152 FVEGLPINDFSR 
Malate dehydrogenase 1 P14152 GEFITTVQQR 
Malate dehydrogenase 2 P08249 IFGVTTLDIVR 
Malate dehydrogenase 2 P08249 VNVPVIGGHAGK 
Malate dehydrogenase 2 P08249 FVFSLVDAMNGK 
Manganese superoxide dismutase P09671 HHAAYVNNLNATEEK 
MARCKS-related protein P28667 DEAAAAAGGEGAAAPGEQAGGAGAEGAAGGEPR 
Membrane glycoprotein/immunoglobulin superfamily member 4B 19068137 KGDQELHGDQTR 
Membrane glycoprotein/immunoglobulin superfamily member 4B 19068137 LLLHCEGR # 
Membrane glycoprotein/immunoglobulin superfamily member 4C 19068139 GSYLTHEASGLDEQGEAR 
Membrane glycoprotein/immunoglobulin superfamily member 4C 19068139 IHASQAVVR 
Membrane glycoprotein/immunoglobulin superfamily member 4C 19068139 LHQYDGSIVVIQNPAR 
Membrane glycoprotein/immunoglobulin superfamily member 4C 19068139 QTQYVLDVQYSPTAR 
Myelin basic protein 387419 DENPVVHFFK 
Myelin basic protein 387419 DTGILDSIGR  
Myelin basic protein 387419 DTGILDSIGRF 
Myelin basic protein 387419 ENPVVHFFK 
Myelin basic protein 387419 FSWGAEGQK 
Myelin basic protein 387419 FSWGAEGQKPGFGYGGR 
Myelin basic protein 387419 GAEGQKPGFGYGGR 
Myelin basic protein 387419 GAYDAQGTLSK 
Myelin basic protein 387419 HRDTGILDSIGR 
Myelin basic protein 387419 NPVVHFFK 
Myelin basic protein 387419 PGLCHMYK # 
Myelin basic protein 387419 SKYLATASTMDHAR  
Myelin basic protein 387419 SRPGLCHMYK # 
Myelin basic protein 387419 TASTMDHAR 
Myelin basic protein 387419 TQDENPVVHF 
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Myelin basic protein 387419 TQDENPVVHFFK 
Myelin basic protein 387419 TQDENPVVHFFKNIVTPR 
Myelin basic protein 387419 TTHYGSLPQK 
Myelin basic protein 387419 TTHYGSLPQKSQHGR 
Myelin basic protein 387419 VPWLKQSR 
Myelin basic protein 387419 YLATASTMDHAR 
Myelin proteolipid protein P60202 GLSATVTGGQK 
Myelin proteolipid protein P60202 GQHQAHSLER 
Myelin proteolipid protein P60202 LIETYFSK 
Myelin proteolipid protein P60202 MYGVLPWNAFPGK 
Myelin proteolipid protein P60202 TSASIGSLCADAR 
Myelin proteolipid protein P60202 VCGSNLLSICK 
Myelin-associated glycoprotein P20917 FDFPDELRPAVVH 
Myelin-associated glycoprotein P20917 NLYGTQSLELPFQGAHR 
Myelin-associated glycoprotein P20917 NVTESSSFSGGDNPHVLYSPEFR 
Myelin-associated glycoprotein P20917 NYPPVVFK  
Myelin-associated glycoprotein P20917 SGLLLTSILTIR 
Myelin-associated glycoprotein P20917 SNPEPSVAFELPSR 
Myelin-associated glycoprotein P20917 TQVVHESFQGR 
Myelin-associated oligodendrocytic basic protein 7330691 FSEHFSIHCCPPFTFLNSK # 
Myelin-associated oligodendrocytic basic protein 7330691 HQPAASPVVVR 
Myelin-associated oligodendrocytic basic protein 7330691 KEEDWICCACQK # 
Myelin-associated oligodendrocytic basic protein 7330691 SPLMPAKPR 
Myelin-associated oligodendrocytic basic protein 7330691 SPPRPAKPR 
Myelin-oligodendrocyte glycoprotein Q61885 AEVENLHR 
Myelin-oligodendrocyte glycoprotein Q61885 ALVGDEAELPCR # 
Myelin-oligodendrocyte glycoprotein Q61885 DHSYQEEAAMELK 
Myelin-oligodendrocyte glycoprotein Q61885 DQDAEQAPEYR 
Myelin-oligodendrocyte glycoprotein Q61885 FSDEGGYTCFFR # 
Myelin-oligodendrocyte glycoprotein Q61885 LAGQFLEELR 
Myelin-oligodendrocyte glycoprotein Q61885 LAGQFLEELRNPF 
Myelin-oligodendrocyte glycoprotein Q61885 LRAEVENLHR 
Myelin-oligodendrocyte glycoprotein Q61885 NGKDQDAEQAPEYR 
Myelin-oligodendrocyte glycoprotein Q61885 TFDPHFLR 
Myelin-oligodendrocyte glycoprotein Q61885 VIGPGYPIR  
Neural cell adhesion molecule 1 P13595 AGEQDASIHLK 
Neural cell adhesion molecule 1 P13595 ALASEWKPEIR 
Neural cell adhesion molecule 1 P13595 DIQVIVNVPPTVQAR 
Neural cell adhesion molecule 1 P13595 EANMEGIVTIMGLKPETR 
Neural cell adhesion molecule 1 P13595 FFLCQVAGDAK # 
Neural cell adhesion molecule 1 P13595 FIVLSNNYLQIR 
Neural cell adhesion molecule 1 P13595 HIFSDDSSELTIR 
Neural cell adhesion molecule 1 P13595 LASEWKPEIR 
Neural cell adhesion molecule 1 P13595 LPSGSDHVMLK 
Neural cell adhesion molecule 1 P13595 NVDKNDEAEYVCIAENK # 
Neural cell adhesion molecule 1 P13595 SLGEESWHFK 
Neurocalcin delta Q91X97 DCPSGHLSMEEFKK 
Neurocalcin delta Q91X97 IYGNFFPYGDASK 
Neurocalcin delta Q91X97 LSLEEFIR 
Neurocalcin delta Q91X97 MPEDESTPEKR 
Neuronal axonal membrane protein NAP-22 Q91XV3 AGEASAESTGAADGAAPEEGEAK 
Neuronal axonal membrane protein NAP-22 Q91XV3 APAPAAPAAAEPQAEAPAAAASSEQSVAVK 
Neuronal axonal membrane protein NAP-22 Q91XV3 APAPAAPAAAEPQAEAPAAAASSEQSVAVKE 
Neuronal axonal membrane protein NAP-22 Q91XV3 ESEPQAAADATEVK 
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Neuronal axonal membrane protein NAP-22 Q91XV3 ETPAASEAPSSAAK 
Neuronal axonal membrane protein NAP-22 Q91XV3 KTEAPAAAGPEAK 
Neuronal axonal membrane protein NAP-22 Q91XV3 TEAPAAAGPEAK 
N-myc downstream regulated 1 Q62433 EEIHNNVEVVHTYR 
Nucleoside diphosphate kinase A P15532 DRPFFTGLVK 
Nucleoside diphosphate kinase A P15532 TFIAIKPDGVQR 
Nucleoside diphosphate kinase A P15532 VMLGETNPADSKPGTIR 
Nucleoside diphosphate kinase B Q01768 GDFCIQVGR # 
Nucleoside diphosphate kinase B Q01768 NIIHGSDSVESAEK 
Oligodendrocyte-specific protein Q60771 FYYSSGSSSPTHAK 
Oligodendrocyte-specific protein Q60771 GLWADCVMATGLYH # 
p21-Rac1 P63001 HHCPNTPIILVGTK # 
p21-Rac1 P63001 TVFDEAIR 
Peptidyl-prolyl cis-trans isomerase A P17742 EGMNIVEAMER 
Peptidyl-prolyl cis-trans isomerase A P17742 FEDENFILK 
Peptidyl-prolyl cis-trans isomerase A P17742 IIPGFMCQGGDFTR # 
Peptidyl-prolyl cis-trans isomerase A P17742 VNPTVFFDITADDEPLGR 
Peroxiredoxin 5 P99029 THLPGFVEQAGALK 
Phenylpyruvate tautomerase P34884 LLCGLLSDR # 
Phenylpyruvate tautomerase P34884 PMFIVNTNVPR 
Phosphoglycerate kinase 1 P09411 FHVEEEGK 
Phosphoglycerate kinase 1 P09411 LGDVYVNDAFGTAHR 
Phosphoglycerate mutase 1 Q9DBJ1 HYGGLTGLNK 
Phosphoglycerate mutase 1 Q9DBJ1 VLIAAHGNSLR 
Protein CGI-38 homolog Q9CRB6 VINYEEFKK 
Pyruvate kinase, isozyme M2 P52480 IENHEGVR 
Pyruvate kinase, isozyme M2 P52480 LNFSHGTHEYHAETIK 
Rab GDP dissociation inhibitor a P50396 NTNDANSCQIIIPQNQVNR # 
Ras related protein Rab-10 P61027 LQIWDTAGQER 
Ras related protein Rab-10 P61027 NIDEHANEDVER 
Ras related protein Rap-1A P62835 INVNEIFYDLVR 
Ras related protein Rap-1A P62835 SALTVQFVQGIFVEK 
Ras related protein Rap-1A P62835 YDPTIEDSYR 
Septin-2 P42208 YLHDESGLNR 
Septin-7 O55131 DVTNNVHYENYR 
Septin-7 O55131 FEDYLNAESR 
Septin-7 O55131 SPLAQMEEERR 
Septin-8 Q8CHH9 SLFDYHDTR 
Sirtuin 2 Q8VDQ8 CYTQNIDTLER # 
Sirtuin 2 Q8VDQ8 EYTMGWMK 
Sirtuin 2 Q8VDQ8 FFSCMQSDFSK # 
Sirtuin 2 Q8VDQ8 HPEPFFALAK 
Sirtuin 2 Q8VDQ8 KHPEPFFALAK 
Sirtuin 2 Q8VDQ8 LLDELTLEGVTR 
Sirtuin 2 Q8VDQ8 NLFTQTLGLGSQK 
Sirtuin 2 Q8VDQ8 VICLVGAGISTSAGIPDFR # 
Sodium/potassium-transporting ATPase alpha-1 chain Q8VDN2 VDNSSLTGESEPQTR 
Sodium/potassium-transporting ATPase alpha-1 chain Q8VDN2 VIMVTGDHPITAK 
Sodium/potassium-transporting ATPase beta-1 chain P14094 AYGENIGYSEK 
Sodium/potassium-transporting ATPase beta-1 chain P14094 EGKPCIIIK # 
Sodium/potassium-transporting ATPase beta-1 chain P14094 ERGDINHER 
Sodium/potassium-transporting ATPase beta-1 chain P14094 SYEAYVLNIIR 
Sodium/potassium-transporting ATPase beta-1 chain P14094 TEISFRPNDPK 
Sodium/potassium-transporting ATPase beta-1 chain P14094 VAPPGLTQIPQIQK 
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Synaptosomal-associated protein 25 P60879 AWGNNQDGVVASQPAR 
Synaptosomal-associated protein 25 P60879 TLVMLDEQGEQLER 
Syntaxin 1B P61264 IEYNVEHSVDYVER 
Thy-1 membrane glycoprotein precursor P01831 DNSIQHEFSLTR 
Thy-1 membrane glycoprotein precursor P01831 HVLSGTLGIPEHTYR 
Thy-1 membrane glycoprotein precursor P01831 VTSLTACLVNQNLR # 
Transketolase P40142 LDNLVAIFDINR 
Triosephosphate isomerase P17751 DLGATWVVLGHSER 
Triosephosphate isomerase P17751 HVFGESDELIGQK 
Triosephosphate isomerase P17751 TATPQQAQEVHEK 
Tubulin alpha P05213 AFVHWYVGEGMEEGEFSEAR 
Tubulin alpha P05213 AVCMLSNTTAIAEAWAR # 
Tubulin alpha P05213 AVFVDLEPTVIDEVR 
Tubulin alpha P05213 EDAANNYAR 
Tubulin alpha P05213 EIIDLVLDR 
Tubulin alpha P05213 FDGALNVDLTEFQTNLVPYPR 
Tubulin alpha P05213 IHFPLATYAPVISAEK 
Tubulin alpha P05213 LIGQIVSSITASLR 
Tubulin alpha P05213 NLDIERPTYTNLNR 
Tubulin alpha P05213 QLFHPEQLITGK 
Tubulin alpha P05213 TIQFVDWCPTGFK # 
Tubulin beta 2 P68372 AILVDLEPGTMDSVR 
Tubulin beta 2 P68372 EIVHIQAGQCGNQIGAK 
Tubulin beta 2 P68372 FPGQLNADLR 
Tubulin beta 2 P68372 IREEYPDR 
Tubulin beta 2 P68372 ISEQFTAMFR 
Tubulin beta 2 P68372 LAVNMVPFPR 
Tubulin beta 2 P68372 MSATFIGNSTAIQELFK 
Tubulin beta 2 P68372 NSSYFVEWIPNNVK 
Tubulin beta 2 P68372 SGPFGQIFRPDNFVFGQSGAGNNWAK 
Tubulin beta 2 P68372 EVDEQMLNVQNK 
Tubulin beta 2 P68372 FPGQLNADLRK 
Tubulin beta 2 P68372 INVYYNEAAGNK 
Tubulin beta 2 P68372 YLTVAAIFR 
Tubulin beta 2 Q62364 LHFFMPGFAPLTSR 
Tubulin beta 2 Q62364 LTTPTYGDLNHLVSATMSGVTTCLR  
Tubulin beta 2 Q62364 TAVCDIPPR 
Tubulin beta 4 Q62364 GHYTEGAELVDSVLDVVR 
Tubulin beta 4 Q62364 ALTVPELTQQMFDAK 
Tubulin beta 4 Q62364 AVLVDLEPGTMDSVR 
Tubulin beta 4 Q62364 INVYYNEATGGNYVPR 
Tubulin beta 4 Q62364 IREEFPDR 
Tubulin beta 4 Q62364 YLTVAAVFR 
Ubc protein Q922B0 EGIPPDQQR 
Ubc protein Q922B0 ESTLHLVLR 
Ubiquinol cytochrome c reductase complex 14 kDa protein Q9D855 YEEDKFYLEPYLK 
Ubiquinol cytochrome c reductase core protein 2 Q9DB77 IIENLHDVAYK 
Ubiquinol cytochrome c reductase core protein 2 Q9DB77 YEDSNNLGTSHLLR 
Unnamed protein product 12843458 ADSVCDGHAAGQK # 
Unnamed protein product 12843458 DTENSPTTSANLK 
Unnamed protein product 12843458 EPAPCVQPPTVEANAMQTGDK # 
Unnamed protein product 12843458 HKDTENSPTTSANLK 
Unnamed protein product 12843458 SCSPPPPPPEPTSEGR # 
Unnamed protein product 12843458 TPSPPEPEPAGTAQK 
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Visinin like-3 P62748 EFIIALSVTSR 
Visinin like-3 P62748 IYANFFPYGDASK 
Visinin-like 1 P62761 EFICALSITSR # 
Visinin-like 1 P62761 MNEDGLTPEQR 
Visinin-like 1 P62761 NGDGTIDFR 
Visinin-like 3 P62748 FFPYGDASK 
a) Protein names are ordered alphabetically 
b) Swiss-Prot accession numbers begin with a letter (http://us.expasy.org). The other accession numbers are retrieved  
from the NCBI (http://www.ncbi.nlm.nih.gov). 
c) The sequence of the peptide identified by MS/MS. # indicates the presence of a carbamidomethyl-cysteine residue 
 
 
